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Romer,	  Eric	  Joseph.	  Ph.D.	  	  Biomedical	  Sciences	  Program,	  Wright	  State	  University,	  2013.	  
Reactive	  Oxygen	  Modulates	  B	  Lymphocyte	  Function	  Via	  the	  NF-­‐kappaB/Rel	  Pathway.	  	  
Reactive	  Oxygen	  Intermediates	  (ROI)	  can	  significantly	  affect	  B	  Lymphocyte	  
function,	  but	  the	  effects	  on	  key	  signaling	  pathways	  and	  gene	  expression	  in	  activated	  and	  
non-­‐activated	  B	  lymphocytes	  are	  largely	  undefined.	  	  This	  study	  demonstrates	  a	  
concentration	  dependent	  effect	  of	  exogenous	  H2O2	  on	  the	  transcriptional	  regulation	  of	  
a	  3’	  regulatory	  region	  of	  the	  Immunoglobulin	  heavy	  chain	  gene	  (3’IghRR).	  	  Specifically,	  
low	  µM	  H2O2	  induces	  an	  enhancing	  effect	  while	  higher	  µM	  H2O2	  (>	  100	  µM)	  is	  
suppressive.	  	  The	  enhancing	  effects	  of	  H2O2	  on	  3’IghRR	  activity	  are	  dependent	  on	  the	  
NFκB/Rel	  pathway,	  and	  appear	  to	  be	  most	  prominent	  in	  antigen	  activated	  B	  
lymphocytes.	  	  Moreover,	  treatment	  of	  activated	  B	  lymphocytes	  with	  a	  chemical	  
inhibitor	  of	  ROI	  producing	  enzymes	  inhibited	  3’IghRR	  activity,	  Ig	  production,	  and	  
NFκB/Rel	  activity,	  suggesting	  that	  endogenous	  ROI	  in	  part	  facilitate	  activation-­‐induced	  
Ig	  expression	  and	  NFκB/Rel	  activity.	  Furthermore,	  exposure	  of	  non-­‐activated	  B	  
lymphocytes	  with	  higher	  µM	  H2O2	  concentrations	  suppressed	  NFκB/Rel	  activity	  and	  
caused	  dramatic	  decreases	  in	  cellular	  viability.	  	  	  This	  effect	  of	  H2O2	  on	  viability	  was	  
suppressed	  by	  co-­‐treatment	  with	  a	  pan	  caspase	  inhibitor,	  thus	  indicating	  an	  important	  
role	  for	  caspases	  in	  the	  H2O2-­‐mediated	  cell	  death.	  	  	  H2O2-­‐induced	  caspase	  activity	  was	  
found	  to	  directly	  target	  critical	  components	  of	  the	  NFκB/Rel	  pathway,	  which	  is	  involved	  
iv	  
in	  maintaining	  cell	  survival	  signals	  in	  the	  B	  lymphocyte.	  	  	  We	  observed	  that	  H2O2	  
exposure	  induced	  caspase-­‐dependent	  cleavage	  of	  a	  critical	  NFκB/Rel	  regulatory	  protein,	  
IκBα	  that	  can	  result	  in	  a	  ΔN-­‐IκBα	  form	  and	  most	  notably	  a	  novel	  19	  kDa	  form	  of	  IκBα.	  	  
H2O2	  exposure	  also	  induced	  two	  caspase-­‐dependent	  cleavage	  products	  of	  a	  prominent	  
NFκB/Rel	  transcription	  factor,	  p65/RelA.	  We	  believe	  H2O2	  mobilizes	  caspases	  activity	  as	  
part	  of	  a	  mechanism	  to	  suppress	  the	  NFκB/Rel	  pathway	  during	  oxidative	  stress	  as	  co-­‐
treatment	  of	  H2O2	  -­‐exposed	  B	  lymphocytes	  with	  a	  pan	  caspase	  inhibitor	  markedly	  
increased	  the	  expression	  of	  an	  NFκB/Rel	  transcriptional	  reporter.	  	  	  These	  observations	  
demonstrate	  that	  ROI	  can	  modulate	  critical	  functions	  in	  the	  B	  lymphocyte	  such	  as	  Ig	  
expression	  and	  cellular	  viability	  in	  a	  manner	  that	  is	  dependent	  upon	  the	  activation	  state	  
of	  the	  cell,	  and	  at	  least	  in	  part,	  involves	  the	  modulation	  of	  the	  NFκB/Rel	  pathway.	  	  These	  
findings	  may	  be	  highly	  relevant	  to	  further	  understanding	  the	  effects	  of	  ROI	  on	  NFκB/Rel-­‐
dependent	  B	  lymphocyte	  function	  in	  adaptive	  immunity	  and	  many	  disease	  states	  and	  
treatments	  known	  to	  involve	  ROI.	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Chapter	  I:	  Introduction	  
Background	  
B	  lymphocytes	  
The	   lymphocyte	   lineage	   is	   a	   critical	   component	   of	   the	   adaptive	   immune	   response.	  
Adaptive	   immunity	   plays	   a	   primary	   role	   in	   targeting	   and	   facilitating	   the	   clearance	   of	  
specific	   antigens	   associated	   with	   infectious	   disease.	   	   The	   antigenic	   response	   by	  
lymphocytes	   is	   largely	   mediated	   through	   their	   antigen	   recognition	   receptors.	   B	  
lymphocytes	  are	  somewhat	  unique	  in	  that	  the	  antigen	  specific	  receptors	  can	  either	  be	  
membrane	  bound	  (i.e.	  B	  cell	  receptor/BCR)	  or	  excreted	  in	  a	  soluble	  form	  (i.e.	  antibody).	  	  
These	   receptors	  are	   tetrameric	   involving	   the	  associations	  of	   two	  heavy	  chain	  and	   two	  
light	  chain	  immunoglobulin	  subunits	  and	  in	  the	  tetrameric	  form	  are	  commonly	  referred	  
to	   as	   immunoglobulins	   (Ig).	   	   The	   recognition/association	   of	   an	   antigen	   occurs	   at	   the	  
antigen	   recognition	   site	   of	   the	   Ig,	  which	   is	   created	   by	   the	   association	   of	   the	   variable	  
region	   domains	   of	   the	   light	   and	   heavy	   chain	   subunits.	   	   The	   constant	   region	   of	   the	  
antigen	  bound	  Ig	  interacts	  with	  and	  signals	  other	  immune	  cells	  to	  clear	  the	  antigen	  (in	  
the	  soluble	  antibody	   form)	  or	   to	   initiate	   intracellular	   signaling	   in	   the	  B	   lymphocyte	   (in	  
the	  membrane	  bound	  BCR	  form).	  	  	  
A	   competent	   adaptive	   immune	   response	   requires	   the	   capacity	   to	   recognize	   a	  
diverse	  spectrum	  of	  antigens.	  Therefore,	  the	  B	  lymphocyte	  compartment	  must	  generate	  
an	  equally	  expansive	  array	  of	  potentially	  antigenic	  immunoglobulins	  that	  will	  not	  target	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endogenous/”self”	  molecules	  to	  avoid	  initiating	  an	  autoimmune	  response.	  Furthermore,	  
a	   robust	   adaptive	   immune	   response	   requires	   that	   the	   selected	   antigenic	   B	   cell	   can	  
clonally	  expand	  and	  all	  non-­‐antigenic	  and	  weakly	  antigenic	  B	  cells	  at	  the	  immunological	  
foci	   can	   be	   eliminated.	   	   	   Maintaining	   such	   a	   competent	   B	   lymphocyte	   compartment	  
involves	   a	   process	   of	   cellular	   differentiation	   that	   selects	   for	   antigenic	   B	   cells	   and	  
carefully	  eliminates	  irrelevant	  and	  potentially	  auto-­‐reactive	  B	  cells	  via	  Ig	  receptor	  editing	  
processes	  and	  more	  prominently	  by	  eliminating	  cells	  through	  programmatic	  cell	  death.	  
The	   function	   of	   the	   BCR/antibody	   is	   dependent	   upon	   its	   relative	   expression,	  
which	   is	   regulated	   at	   multiple	   checkpoints,	   and	   perhaps	   most	   importantly	   at	   the	  
transcriptional	   level.	   	   The	   transcription	   of	   Igh	   (immunoglobulin	   heavy	   chain)	   and	   Igl	  
(immunoglobulin	  light	  chain)	  coding	  sequences	  are	  carefully	  regulated	  by	  5’	  promoters,	  
as	  well	  as	  3’	  transactivation-­‐enhancing	  elements.	  	  The	  transcription	  of	  the	  Igh	  locus	  will	  
be	  focused	  on	  in	  this	  study	  which	  is	  governed	  by	  two	  3’	  regions:	  the	  µ	  enhancer	  (Eµ)	  and	  
the	   3’	   Igh	   regulatory	   region	   (3’IghRR)	   (see	   figure	   1)	   (Grosschedl	   &	   Baltimore,	   1985;	  
Mason	   et	   al.,	   1985;	  Hagman	   et	   al.,	   1990;	  Meyer	   et	   al.,	   1990;	   Pettersson	   et	   al.,	   1990;	  
Pinaud	   et	   al.,	   2011).	   	   These	   sequences	   will	   be	   discussed	   in	   more	   detail	   later	   in	   the	  
document.	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Figure	  1:	  Immunoglobulin	  Heavy	  Chain	  (Igh)	  Locus:	  	  
The	  schematic	  represents	  the	  full	  murine	   Igh	   locus.	   	  pVh	  represents	  the	  variable	  heavy	  
chain	  promoter	   region.	   	   The	  V	   (variable),	  D	   (diversity),	   and	   J	   (joining)	   represent	  exons	  
coding	  for	  Ig	  regions	  involved	  in	  antigen	  recognition.	  	  The	  Cµ-­‐Cα	  represent	  exons	  coding	  






The	   transcriptional	   regulation	   of	   these	   genes	   will	   coordinate	   the	   optimal	  
production	  of	  membrane	  bound	  Ig,	  the	  core	  component	  of	  the	  BCR	  that	  is	  expressed	  on	  
the	  membrane	  throughout	  B	  lymphocyte	  maturation	  and	  can	  initiate	  the	  signaling	  that	  
leads	  to	  B	  lymphocyte	  activation.	  	  B	  lymphocytes	  in	  a	  non-­‐activated	  or	  resting	  state	  such	  
as	   naïve	   or	   memory	   B	   lymphocytes	   have	   not	   encountered	   a	   cognate	   antigen	   that	  
specifically	  binds	  its	  BCR.	  	  Once	  a	  B	  lymphocyte	  has	  bound	  a	  cognate	  antigen	  causing	  it	  
to	   become	   activated,	   intracellular	   signaling	   is	   initiated	   that	   drives	   cellular	   activation	  
leading	   to	   proliferation	   and	   differentiation	   into	   memory	   cells	   or	   plasma	   cells	   that	  
generate	   and	   secrete	   antigen-­‐specific	   antibodies	   as	   a	   defense	   against	   the	   cognate	  
!"!" #$"$ %µ! 3a 1,2 3b 4 %""#$!$&'()*$ +$
,-#$!..$
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antigen.	  	  	  Ig	  transcription	  plays	  a	  critical	  role	  in	  this	  process	  and	  a	  more	  detailed	  review	  
of	  the	  Ig	  transcriptional	  regulation	  will	  be	  introduced	  later	  in	  this	  document.	  	  	  
Reactive	  oxygen	  intermediates	  and	  the	  redox	  hypothesis.	  
B	   lymphocyte	   function	   has	   been	   found	   to	   be	   associated	   with	   the	   exposure	   and	  
production	   of	   reactive	   oxygen	   intermediates	   (ROI),	   which	   are	   oxygen-­‐containing	  
compounds	   that	   readily	   react	   with	   a	   wide	   array	   of	   biological	   substrates	   (Vené	   et	   al.,	  
2010;	  Bertolotti	  et	  al.,	  2012)	  There	  are	  multiple	  forms	  of	  ROI	  (e.g.	  O2
•-­‐,	  OH•,	  H2O2,	  NO,	  
ONOO-­‐)	   produced	   from	   a	   number	   of	   disparate	   sources	   including	   cellular	   metabolism	  
(e.g.	   electron	   transport	   chain),	   oxidoreductase	   reactions	   (e.g.	   NADPH	   Oxidase,	   iNOS),	  
xenobiotics	   and	   xenobiotic	  metabolism	   (e.g.	   P450	   enzymes)	   (Valko	   et	   al.,	   2007).	   	   The	  
influence	  of	  ROI	  on	  cellular	   function	  can	   range	   from	  enhancing	  effects	   to	  cytotoxicity.	  
The	   nature	   of	   the	   effects	   can	   be	   cell-­‐type	   specific,	   and	   is	   dependent	   on	   the	  
concentration	  and	  forms	  of	  ROI,	  as	  well	  as	  the	  cellular	  capacity	  to	  neutralize	  them.	  ROI	  
are	   generally	   classified	   as	   free	   radical	   ROI,	   which	   harbor	   an	   unpaired	   electron	   in	   an	  
outer	  valence	  shell	   (e.g.	  O2
•-­‐,	  OH•.	  NO•),	  or	  as	  non-­‐radical	  ROI	  such	  as	  ONOO-­‐	  or	  H2O2.	  
Free	  radicals	  are	  generally	  more	  reactive	  and	  therefore	  have	  shorter	  half-­‐lives.	  	  They	  can	  
react	  with	  cellular	  constituents	  to	  form	  lipid,	  protein,	  or	  nucleic	  acid	  adducts	  or	  undergo	  
a	  more	   kinetically	   favorable	   neutralization	   into	   non-­‐radical	   ROI	   such	   as	   peroxides,	   or	  
non-­‐reactive	  compounds	  like	  H2O.	  	  The	  interaction	  of	  NO
•	  with	  O2
•-­‐	  forming	  ONOO-­‐	  and	  
the	   dismutation	   of	   O2
•-­‐
	   into	   H2O2	   by	   superoxide	   dismutase	   (SOD)	   are	   ubiquitous	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reactions	   that	   exemplify	   the	   favorable	   neutralization	   of	   free	   radicals	   into	   peroxides.	  	  
Models	  of	  ROI	  neutralization	  such	  as	  that	  (figure	  2;	  adapted	  from	  Go	  et	  al,	  2010)	  (Go	  &	  
Jones,	  2010)	  based	  on	  xanthine	  oxidase,	   illustrate	  how	  free	  radicals	  (e.g.	  O2
-­‐)	  are	  most	  
likely	  to	  be	  efficiently	  neutralized	  into	  non-­‐radicals,	  which	  are	  predominantly	  peroxides	  
(e.g.	  H202)	  Therefore,	  the	  flux	  of	  H2O2	  generated	  by	  the	  neutralization	  of	  O2
-­‐	  to	  H2O2	  is	  
referred	  to	  as	  O2
-­‐/H2O2.	  (Fridovich,	  1970;	  Auchère	  &	  Rusnak,	  2002;	  Go	  &	  Jones,	  2010).	  
Figure	  2:	  	  The	  Fate	  of	  Reactive	  Oxygen	  Intermediates:	  	  	  
The	  schematic	  represents	  the	  cellular	  flux	  of	  reactive	  oxygen	  intermediates	  based	  on	  a	  
Xanthine	  Oxidase	  model.	  	  This	  schema	  was	  derived	  from	  a	  figure	  from	  Go	  and	  Jones,	  















Alternatively,	  H2O2	  has	  also	  been	  found	  to	  directly	  arise	  from	  a	  growing	  number	  of	  
sources	   including	   enzymes	   involved	   in	   glutathione	   salvage	   pathways	   (e.g.	   γ-­‐glutamyl	  
transferase)	  and	  the	  autocatalytic	  production	  of	  H2O2	  via	  receptor	  ligand	  interactions	  of	  
a	   variety	   of	   cell	   surface	   receptors	   including	   immunoglobulins	   (Dominici	   et	   al.,	   1999;	  
Wentworth	   Jr,	   2001;	   DeYulia	   et	   al.,	   2005).	   The	   production	   and	   neutralization	   of	   free	  
radicals	   to	   peroxides,	   or	   the	   direct	   production	   of	   peroxides	   subsequently	  make	   them	  
prevalent	  forms	  of	  physiologically	  occurring	  ROI,	  and	  H2O2	   is	  arguably	  one	  of	  the	  most	  
widely	  studied	  peroxides.	  	  
H2O2	   is	   a	   relatively	   stable	   intermediate	   that	   can	   diffuse	   with	   a	   relatively	   large	  
extracellular	  radius	  of	  diffusion	  (1.5	  mm)	  (Winterbourn,	  2008).	   	   Its	  electrical	  neutrality	  
allows	   it	  to	  diffuse	  through	  a	   lipid	  bi-­‐layer	  making	   it	  a	  readily	  available	  extracellular	  or	  
intracellular	  oxidant.	  The	  reactivity	  of	  H2O2,	  relative	  to	  other	  common	  oxygen	  containing	  
compounds	  such	  as	  O2,	  is	  evident	  in	  its	  chemical	  structure	  which	  reveals	  a	  longer,	  lower	  
energy	  O-­‐O	   single	   bond	   susceptible	   to	   reactivity	   as	   compared	   to	   the	   relatively	   stable	  
O=O	   double	   bond	   of	  O2.	   	   Biologically,	   H2O2	   primarily	   reacts	   as	   a	   nucleophile	   via	   two-­‐
electron	   oxidation	   reactions	   with	  many	   cellular	   substrates	   (e.g.	   protein,	   lipid,	   nucleic	  
acid),	  but	  the	  probability	  of	  H2O2	  oxidizing	  any	  given	  biological	  substrate	   is	  dependent	  
upon	  a	  myriad	  of	  factors	   including	  the	  affinity	  and	  availability	  of	  the	  substrate	  to	  H2O2	  
and	   the	   capacity	   of	   the	   cellular	   antioxidant	   system.	   	   The	   promiscuity	   of	   H2O2	   would	  
presume	  that	  cellular	  exposure	  should	   lead	   to	  cytotoxic	  oxidative	  stress,	  however	   this	  
7	  
effect	   is	   often	   limited	   by	   its	   greater	   affinity	   and	   reactivity	   with	   select	   constituents	  
involved	  in	  intracellular	  redox	  responses.	  	  Therefore,	  H2O2	  oxidation	  is	  often	  controlled	  
before	   it	  can	  cause	  cytotoxicity	  or	   in	  more	  extreme	  cases	  organ	  toxicity.	   	  Some	  of	   the	  
major	  enzymes	  involved	  in	  controlling	  the	  levels	  and	  oxidative	  modifications	  of	  H2O2	  are	  
catalase	   (mainly	   relegated	   to	   the	   peroxisomes),	   and	   glutathione	   associated	   enzymes	  
(glutathione	   peroxidase	   (GPx),	   peroxiredoxins	   (Prx),	   glutaredoxins	   (Grx),	   glutahione-­‐S-­‐
transferase	  (GST)	  and	  thioredoxin	  (Trx)).	  	  	  The	  unique	  structural	  redox	  character	  of	  these	  
enzymes	   is	   key	   to	   how	   they	   functionally	   control	   of	   H2O2	   (Valko	   et	   al.,	   2007;	  
Winterbourn,	  2008).	  
	  	  	  	   The	   reactivity	   of	   H2O2	   with	   any	   given	   physiological	   constituent	   is	   dependent	  
upon	   the	   chemical	   composition	   and	   structure	   of	   the	   constituent.	   	   The	   oxidation	   of	  
peptides/proteins	  by	  H2O2	  is	  highly	  dependent	  upon	  the	  identity	  of	  the	  amino	  acids	  and	  
their	  relative	  tertiary	  structure	  at	  the	  site	  of	  oxidation.	  	  A	  key	  residue	  targeted	  by	  H2O2,	  
and	   subsequently	   a	   critical	   component	   of	   proteins	   involved	   in	   redox	   biochemistry,	   is	  
cysteine.	  Based	  upon	  the	  identity	  and	  dimensional	  proximity	  of	  neighboring	  amino	  acid	  
residues	  to	  cysteine,	  the	  thiol	  or	  selenol	  group	  of	  cysteine	  can	  be	  deprotonated	  under	  
physiological	   conditions	   and	   be	   more	   susceptible	   to	   H2O2	   oxidation.	   It	   is	   this	  
fundamental	  interface	  between	  oxidants	  (i.e.	  H2O2)	  and	  the	  proteome	  that	  is	  believed	  to	  
give	  way	  to	  a	  coordinated	  cellular	   redox	  response.	  This	   relationship	  has	   recently	  been	  
more	  clearly	  defined	  in	  the	  Redox	  Hypothesis	  (Jones,	  2008).	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The	  redox	  hypothesis	  poses	  that	  there	  are	  redox	  elements	  (e.g.	  cysteine-­‐thiols)	  that	  
are	  functionally	  situated	  in	  proteins	  involved	  in	  cellular	  response	  signaling	  within	  redox	  
circuits.	  	  These	  elements	  are	  readily	  oxidized	  through	  two	  electron	  reactions,	  which	  are	  
a	  hallmark	  H2O2	  oxidation.	  	  The	  oxidation	  states	  and	  redox-­‐mediated	  post-­‐translational	  
modifications	  (e.g.	  glutathionylation	  and	  nitrosylation)	  of	  these	  elements	  are	  regulated	  
by	   “nodes	   of	   control”,	   which	   normally	   involve	   the	   modification/reduction	   of	   the	  
elements	   via	   oxidoreductase	   enzymes	   (e.g.	   glutaredoxin	   and	   thioredoxin)	   and	   thiol	  
containing	   substrates	   (e.g.	   GSH).	   These	   relationships	   are	   the	   bases	   for	   redox	   circuits,	  
which	  allow	  the	  cell	   to	  respond	  to	  perturbations	   in	   the	  redox	  state	  of	   the	  cell.	   	  Redox	  
circuits	   are	   spatially	   and	   kinetically	   insulated	   from	   one	   another	   allowing	   for	   “gated”	  
responses.	  	  It	  is	  the	  segregation	  of	  these	  circuits,	  which	  allow	  them	  to	  transmit	  distinct	  
signals,	   creating	   a	   breadth	   of	   responses	   to	   the	   diverse	   range	   of	   redox	   changes	   a	   cell	  
might	   experience.	   	   These	   circuits	   can	   signal	   gene	   expression	   batteries	   that	   regulate	  
cellular	   responses	   such	  as	   the	   antioxidant	   response	   (e.g.	   via	  Nrf2),	   cell	   death	   (e.g.	   via	  
p53),	  metabolism	   (e.g.	   via	   glucocorticoid	   receptor),	   inflammation/pro-­‐survival	   (e.g.	   via	  
NFκB/Rel)	  (Matthews	  et	  al.,	  1992;	  Makino	  et	  al.,	  1999;	  Ueno	  et	  al.,	  1999;	  Köhle	  &	  Bock,	  
2006;	  Thimmulappa,	  2006;	  Velu	  et	  al.,	  2007;	  Jones,	  2008;	  Vallabhapurapu	  &	  Karin,	  2009;	  
Go	  &	   Jones,	   2010).	   	   The	  exposures	   to	  ROI	   and	   the	   subsequent	   cellular	   effects	   involve	  
cell-­‐type/tissue	   specific	   protective	   and	   response	   mechanisms	   (Brigelius-­‐Flohé,	   1999;	  
Jones	   et	   al.,	   2000;	  Gloire	   et	   al.,	   2006b;	  Oliveira-­‐Marques	   et	   al.,	   2009b).	   	   	   The	   current	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study	   is	   focused	   on	   the	   effects	   of	   ROI	   on	   B	   lymphocytes;	   therefore	   it	   is	   important	   to	  
understand	  the	  B	  lymphocyte	  specific	  relationship	  to	  ROI.	  
B	  lymphocytes	  are	  exposed	  to	  endogenous	  and	  exogenous	  ROI	  
	   The	   relationship	   between	   lymphocytes	   and	  ROI	   production/exposure	  has	   been	  
well	   documented	   and	   has	   lead	   to	   a	   number	   of	   studies	   aimed	   at	   understanding	   the	  
sources	  of	  ROI	  and	  their	  functional	  effects	  on	  adaptive	  immunity	  and	  lymphocytes.	  	  The	  
capacity	  of	   lymphocytes	  to	  circulate	  through	  the	  vascular	  and	  lymphatic	  system	  allows	  
for	  potential	  exposure	  to	  ROI.	  	  Immunological	  foci	  harbor	  a	  variety	  of	  immune	  cells	  that	  
generate	  extracellular	  ROI,	  and	   local	  extracellular	  concentrations	  have	  been	  measured	  
ranging	   from	   low	  µM	   to	   >100	  µM	  H2O2	   (Zoschke	  &	   Staite,	   1987;	   Hyslop	   et	   al.,	   1995;	  
McNaught	   &	   Jenner,	   2000).	   Furthermore,	   exposure	   to	   environmental	   contaminants	  
such	  as	  cigarette	  smoke	  that	  contain	  high	  levels	  of	  ROI	  can	  increase	  H2O2	  in	  peripheral	  
blood	   cells	   (Valavanidis	   et	   al.,	   2009;	   Tanni	   et	   al.,	   2012).	   	  Moreover,	  ROI	   generated	  by	  
other	   neighboring	   cell	   types	   can	   affect	   B	   lymphocytes.	   	   It	   has	   been	   found	   that	  
macrophage	  generated	  ROI	  can	  inhibit	  B	  lymphocyte	  activation	  (Ishida	  et	  al.,	  2009).	  The	  
rather	   large	   radius	  of	  diffusion	  and	  electrical	  neutrality	  of	   common	  ROI,	   such	  as	  H2O2,	  
increase	  the	  likelihood	  that	  B	  lymphocytes	  can	  be	  exposed	  to	  exogenous	  ROI	  which	  can	  
cross	  the	  plasma	  membrane	  and	  result	  in	  an	  intracellular	  exposure.	  
Furthermore,	   upon	   antigen	   activation,	   B	   lymphocytes	   have	   been	   found	   to	  
enzymatically	   generate	   O2
-­‐/H2O2	   through	   the	   induction	   of	   the	   NADPH	   Oxidase	   which	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utilizes	   NADPH	   as	   an	   electron	   donor	   to	   reduce	  O2	   and	   form	  O2
-­‐/H2O2	   and	   as	  well	   as,	  
through	   the	  activation-­‐induced	  metabolism	   involving	   complex	   I	   and	   III	   of	   the	  electron	  
transport	   chain	   (Kobayashi	   et	   al.,	   1990;	   Singh	   et	   al.,	   2005;	   Bertolotti	   et	   al.,	   2012).	   	   In	  
addition	   to	   activation-­‐induced	   enzymatic	   sources	   of	   ROI,	   xenobiotic	   exposure	   can	  
induce	  Phase	  I	  metabolic	  enzymes	  such	  as	  cytochrome/P450	  enzymes	  that	  leak	  O2
-­‐	  as	  a	  
function	  of	  their	  catalytic	  cycle	  (Jimenez	  Del	  Rio	  &	  Velez-­‐Pardo,	  2008;	  Sánchez-­‐Duffhues	  
et	   al.,	   2009).	   	   Additionally,	   the	   production	   of	   immunoglobulins	   by	   lymphocytes	   can	  
create	   high	   levels	   of	   ROI	   localized	   in	   the	   endoplasmic	   reticulum	   especially	   in	   the	  
activated	   state	   (Masciarelli	   &	   Sitia,	   2008;	   Bertolotti	   et	   al.,	   2012).	   	   As	   was	  mentioned	  
earlier	   (see	   page	   6),	   immunoglobulins	   and	  other	   receptor/ligand	   complexes	   can	   auto-­‐
catalytically	   produce	   H2O2	   at	   the	   cell	   surface.	   While	   the	   functional	   relevance	   of	   this	  
source	   of	   H2O2	   has	   not	   been	   fully	   determined,	   it	   is	   believed	   to	   play	   some	   role	   in	  
receptor-­‐mediated	   signal	   transduction	   (Wentworth	   Jr,	   2001;	   DeYulia	   et	   al.,	   2005).	  	  	  
Nitric	  Oxide	   (NO)	   can	   be	   generated	   by	   the	   inducible	   nitric	   oxide	   synthatase	   (iNOS)	   in	  
activated	   and	   malignant	   B	   lymphocytes.	   	   NO	   is	   found	   to	   react	   with	   O2
-­‐	   to	   from	  
peroxynitrite,	   a	   nitrogen	   based	   peroxide	   (Tiscornia	   et	   al.,	   2003;	   Winterbourn,	   2008;	  
Tumurkhuu	  et	  al.,	  2010;	  Vené	  et	  al.,	  2010).	  Collectively,	  this	  body	  of	  evidence	  suggests	  
that	   B	   lymphocytes	   can	   potentially	   experience	   ROI	   exposure	   derived	   from	   a	   diverse	  
array	  of	  exogenous	  and	  endogenous	  sources	  of	  ROI	  (figure	  3).	  
11	  
Figure	  3:	  	  Potential	  Sources	  of	  Exogenous	  and	  Intracellular	  Reactive	  Oxygen:	  	  
The	  schematic	  represents	  the	  potential	  sources	  of	  reactive	  oxygen	  intermediates	  (ROI).	  	  
Black	  stars	  represent	  ROI	  produced	  by	  intercellular	  sources	  such	  as	  the	  activation	  
induced	  NADPH	  oxidase	  located	  at	  the	  plasma	  membrane,	  autocatalytic	  ROI	  production	  
from	  receptor/ligand	  interactions	  such	  as	  the	  B	  cell	  receptor	  at	  the	  plasma	  membrane,	  
Complex	  I	  of	  the	  Electron	  Transport	  chain	  located	  in	  the	  mitochondria	  inner	  membrane,	  
leakage	  from	  cytochrome	  P450	  metabolism	  and	  inducible	  nitric	  oxide	  synthetase	  (iNOS).	  	  


















	   	  
In	   defining	   the	  multiple	   exogenous	   and	   endogenous	   avenues	   through	  which	   B	  
lymphocytes	  might	  encounter	  ROI,	  arises	  the	  question	  of	  how	  to	  understand	  the	  effects	  
of	  ROI	  exposures.	  To	  further	  refine	  that	  question,	  what	  intracellular	  concentrations	  are	  
physiologically	  relevant?	  	  While	  the	  technology	  exists	  to	  measure	  a	  relative	  intracellular	  
flux	  of	  ROI,	  the	  discrete	   in	  vivo	  measurement	  of	  intracellular	  concentrations	  of	  specific	  
ROI	  is	  still	  out	  of	  reach.	  Therefore,	  quantitatively	  understanding	  the	  effect	  of	  disparate	  
sources	  of	  ROI	  on	  transient	  intracellular	  concentrations	  of	  ROI	  is	  difficult	  and	  unreliable.	  	  
There	   is	   a	   general	   consensus,	   however,	   that	   while	   mM	   exogenous	   and	   endogenous	  
concentrations	  of	  H2O2	  probably	  occur	   infrequently	   in	  physiologic	  contexts,	  exogenous	  
treatment	  with	  µM	  concentrations,	  as	  was	  measured	  in	  extracellular	  fluid	  at	  an	  immune	  
foci,	  is	  within	  the	  range	  of	  concentrations	  that	  B	  lymphocytes	  might	  likely	  encounter	  in	  
vivo	  (Hyslop	  et	  al.,	  1995;	  Antunes	  &	  Cadenas,	  2000;	  Oliveira-­‐Marques	  et	  al.,	  2009b).	  	  
While	   it	   is	   established	   that	   there	   are	   multiple	   ways	   in	   which	   B	   lymphocytes	   can	  
encounter	  ROI,	   the	   cellular	  effects	  of	  ROI	  on	  B	   lymphocytes	   require	  a	  greater	   level	  of	  
understanding.	   It	   has	   been	   shown	   that	   the	   viability	   of	   B	   lymphocyte	   cell	   lines	   and	  
primary	   B	   lymphocytes	   is	   highly	   sensitive	   to	   H2O2	   exposure.	   Specifically,	   induction	   of	  
H2O2	  generated	  from	  glucose/glucose	  oxidase	  method	  resulted	  in	  approximately	  a	  50%	  
decrease	   in	  B	   lymphocyte	   viability	  but	   interestingly	   there	  were	  negligible	   effects	  on	  T	  
lymphocyte	  viability.	  These	  data	  suggest	  a	  cell-­‐type	  specific	   redox	  response	  within	  the	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lymphocyte	   lineage	   (Farber	   et	   al.,	   1984).	   Furthermore,	   there	   is	   evidence	   that	   the	  
differentiation	  state	  of	   the	  B	   lymphocyte	  may	   influence	  how	  the	  cell	   responds	   to	  ROI.	  	  
Nilsson	  et	  al	  showed	  that	  clonal	  B	  cell	  lines	  derived	  from	  different	  B	  cell	  differentiation	  
stages	   exhibited	   different	   levels	   of	   thioredoxin	   expression,	   a	   central	   redox	   node	   of	  
control.	   	   Specifically,	   the	   early	   differentiation	   stages	   (pro	   and	   pre	   B)	   and	   the	   late	  
differentiation	  stage	  (Plasma	  cell)	  had	  the	  highest	  levels	  of	  thioredoxin	  expression	  than	  
the	  middle	  small	   resting	  B	  cell	   stages.	   	  While	   these	  data	  are	   limited	   in	   scope,	   they	  do	  
suggest	   that	   differentiation	   state	   may	   refine	   the	   redox	   character	   of	   a	   cell,	   and	  
underscores	   the	   importance	  of	  considering	  cell-­‐type	  specific	   responses	  to	  ROI	   (Nilsson	  
et	  al.,	  2004).	  
	   As	  mentioned	  earlier,	  the	  activation	  of	  B	   lymphocytes	   involves	  the	   induction	  of	  
NADPH	  oxidase	  and	  O2
-­‐/H2O2	  flux.	  	  B	  lymphocytes	  appear	  to	  respond	  to	  the	  flux	  in	  ROI	  
by	   triggering	   redox-­‐signaling	   circuits,	   which	   induce	   expression	   of	   genes	   involved	   in	  
metabolic	   capacity	   and	   redox	   control	   (van	  Anken	   et	   al.,	   2003).	   For	   instance,	  mouse	  B	  
lymphocytes	   activated	   by	   an	   antigen	   from	   gram-­‐negative	   bacteria	   (LPS,	  
lipopolysaccharide)	  generate	  ROI	  from	  enzymatic	  sources	  (Wheeler	  &	  DeFranco,	  2012).	  	  
Co-­‐treatment	   of	   LPS-­‐activated	   B	   lymphocytes	   with	   diphenyliodonium	   (DPI),	   a	   NADPH	  
oxidase/	   complex	   I	   Inhibitor,	   inhibits	  ROI	   (i.e.	  H2O2)	  production	  and	   subsequently	   IgM	  
secretion	   suggesting	   that	   the	   production	   of	   O2
-­‐/H2O2	   is	   directly	   linked	   to	   antigen-­‐
mediated	   activation	   of	   B	   lymphocytes	   (Vené	   et	   al.,	   2010).	   	   The	   mechanisms	   of	   how	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enzymatically-­‐produced	  ROI	   influences	   IgM	  secretion	  are	  not	   fully	  known.	  To	  this	  end,	  
there	  is	  evidence	  demonstrating	  that	  H2O2	  can	  enhance	  signal	  transduction	  by	  inducing	  
serine	  and	  tyrosine	  phosphorylation	  in	  B	  and	  T	  lymphocytes	  (Schieven	  et	  al.,	  1993;	  Ding,	  
2000;	  Takada	  et	  al.,	  2003).	  	  Other	  related	  studies	  demonstrate	  that	  H2O2	  can	  transiently	  
inactivate	   phosphatases	   through	   the	   oxidation	   of	   critical	   cysteine	   residues,	   as	  well	   as	  
activate	  kinases	  (Denu	  &	  Tanner,	  1998;	  Lee	  &	  Koh,	  2003;	  Takada	  et	  al.,	  2003;	  Chen	  et	  al.,	  
2009).	  The	  inhibition	  of	  phosphatases	  coupled	  with	  activation	  of	  kinases	  can	  induce	  or	  
enhance	   kinase-­‐mediated	   signal	   transduction	   pathways	   leading	   to	   the	   downstream	  
activation	  of	  nuclear	  transcription	  factors.	  	  Some	  of	  the	  early	  studies,	  (e.g.	  Schreck	  et	  al,	  
1991)	   elucidating	   this	   phenomena	  were	   done	   in	   T	   lymphocytes	   and	   showed	   that	  µM	  
concentrations	   of	   H2O2	   can	   enhance	   the	   binding	   of	   NFκB/Rel	   family	   of	   transcription	  
factors	  to	  κB	  DNA	  consensus	  sequences	  and	  induce	  NFκB/Rel-­‐mediated	  transcriptional	  
activity	   (Schreck	   et	   al.,	   1991;	   Schreck	   et	   al.,	   1992).	   A	   number	   of	   subsequent	   studies	  
done	  primarily	  in	  T	  lymphocyte	  cell	  lines	  have	  supported	  this	  finding	  (Israël	  et	  al.,	  1992;	  
Los	   et	   al.,	   1995;	   Schoonbroodt	   et	   al.,	   2000;	   Takada	   et	   al.,	   2003;	   Pyo	   et	   al.,	   2008).	  	  	  
Understanding	   how	   H2O2	   might	   influence	   signal	   transduction	   pathways	   such	   as	  
NFκB/Rel	   and	   influence	   gene	   expression	   in	   B	   lymphocytes	   could	   lead	   to	   a	   better	  
understanding	  of	  how	  ROI	  might	  affect	  IgM	  secretion	  and	  other	  core	  cellular	  functions	  
that	  rely	  on	  signal	  transduction	  and	  gene	  expression.	  
The	  NFκB/Rel	  pathway	  and	  redox	  effects	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   The	   NFκB/Rel	   family	   of	   transcription	   factors	   was	   originally	   discovered	   in	   B	  
lymphocytes	   and	   characterized	   as	   transcriptional	   regulators	   of	   the	  κ	   immunoglobulin	  
light	   chain	   (Igl)	   (Sen	  &	  Baltimore,	   1986)	   and	   immunoglobulin	   heavy	   chain	   (Igh)	   genes	  
(Sha	  et	  al.,	  1995;	  Michaelson	  et	  al.,	  1996;	  Doi	  et	  al.,	  1997;	  Horwitz	  et	  al.,	  1999;	  Hsing	  &	  
Bishop,	  1999).	  NFκB/Rel	  has	  subsequently	  been	  found	  to	  regulate	  a	  multitude	  of	  genes	  
(Vallabhapurapu	  &	  Karin,	  2009).	  	  NFκB/Rel	  family	  proteins	  are	  transcription	  factors	  that	  
contain	   a	   N-­‐terminal	   Rel	   homology	   domain,	   which	   facilitates	   DNA	   and	   protein	  
interactions	   and	   a	   C-­‐terminal	   transactivation	   domain	   that	   facilitates	   transcriptional	  
activity.	   	   NFκB/Rel	   generally	   transactivate	   as	   a	   heterodimer	   that	   is	   comprised	   of	   one	  
NFκB	  subunit	   (p50	  or	  p52)	  and	  one	  Rel	  subunit	   (RelA/p65,	  RelB,	  or	  c-­‐Rel)	  containing	  a	  
transcriptional	   activation	   domain;	   the	   p50/RelA	   heterodimer	   is	   the	   most	   well	  
characterized	   heterodimer.	   	   Homodimers	   of	   p50	   tend	   to	   be	   associated	   with	   an	  
inhibitory	  effect	  on	  transcription.	  NFκB/Rel	  can	  promote	  transcription	  through	  the	  Rel	  
transactivation	   domains	   and	   by	   recruiting	   chromatin	   remodeling	   factors	   such	   as	   the	  
histone	  acetyl	  transferases	  and	  other	  co-­‐activator	  proteins	  (Buerki	  et	  al.,	  2008;	  Tahan	  et	  
al.,	  2008;	  Vallabhapurapu	  &	  Karin,	  2009;	  Wort	  et	  al.,	  2009).	  
	  	  	  	  	  In	   B	   lymphocytes	   and	   many	   other	   cell	   types,	   NFκB/Rel	   is	   characterized	   to	   be	  
sequestered	   in	   the	  cytoplasm	  by	   interacting	  with	  an	   Inhibitory	  κB	   (e.g.	   IκBα),	  until	  an	  
activating	  stimulus	  (e.g.	  receptor	  mediated	  signaling)	  triggers	  kinase-­‐mediated	  signaling	  
that	   results	   in	   the	   liberation	   of	   NFκB/Rel	   from	   IκBα.	   	   In	   the	   canonical	   pathway	   the	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stimulus-­‐mediated	  activation	   (e.g.	  BCR	  activation)	  of	   the	   Inhibitory	  κB	  kinase	  complex	  
(IKK)	   results	   in	   the	   phosphorylation	   of	   IκBα	   at	   Serines	   32	   and	   36	   of	   its	   N-­‐terminal	  
regulatory	   domain.	   	   This	   modification	   causes	   IκBα	   to	   dissociate	   from	   the	   NFκB/Rel	  
heterodimer	  (p50/p65	  or	  p50/c-­‐rel)	  and	  be	  targeted	  for	  proteosomal	  degradation,	  thus	  
transiently	  liberating	  NFκB/Rel	  for	  translocation	  into	  the	  nucleus	  where	  it	  targets	  genes	  
by	   binding	   consensus	   DNA	   sequences	   (i.e.	   κB	   sites)	   and	   can	   promote	   transcription.	  	  
There	  are	  other	  pathways	  of	  NFκB/Rel	  activation.	  The	  non-­‐canonical	  pathway	   involves	  
the	  activation	  of	  a	  p100/RelB	  heterodimer	  sequestered	  in	  the	  cytoplasm.	  	   	  The	  kinase-­‐
mediated	  phosphorylation	  of	  p100	  results	  in	  its	  proteolytic	  cleavage	  into	  a	  smaller	  p52	  
molecule	   while	   still	   complexed	   to	   RelB.	   This	   p52/RelB	   heterodimer	   is	   then	   able	   to	  
translocate	   into	   the	   nucleus.	   	   Furthermore,	   ROI	   can	   stimulate	   the	   phosphorylation	   of	  
IκBα	   at	   tyrosine	   42	   causing	   its	   dissociation	   from	   NFκB/Rel	   but	   no	   proteosomal	  
degradation	   of	   IκBα	   (figure	   4)	   (Schoonbroodt	   et	   al.,	   2000;	   Vallabhapurapu	   &	   Karin,	  
2009).	  	  
Figure	  4:	  NFκB/Rel	  pathway	  activation	  in	  the	  B	  lymphocyte	  
The	  schematic	  represents	  the	  activation	  of	  the	  NFκB/Rel	  pathway	  in	  B	  lymphocytes	  
initiated	  by	  cell	  surface	  receptors	  such	  as	  BCR	  (B	  cell	  receptor),	  TLRs	  (toll	  like	  receptors),	  
CD40	  receptor,	  or	  BAFFR	  (B	  cell	  activating	  factor	  receptor).	  	  These	  receptors	  can	  induce	  
canonical	  NFκB/Rel	  activation	  through	  IκK	  phosphorylation	  of	  IκBα	  or	  alternative	  
NFκB/Rel	  activation	  through	  IκK	  phosphorylation	  and	  proteolytic	  processing	  of	  p100.	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The	  bifurcated	  arrow	  indicates	  potential	  for	  receptors	  to	  activate	  both	  canonical	  and	  
alternative	  pathways.	  	  ROI	  has	  been	  found	  to	  modulate	  kinase	  activity,	  and	  can	  induce	  
atypical	  NFκB/Rel	  activation	  via	  tyr-­‐42	  phosphorylation.	  	  The	  ultimate	  effect	  NFκB/Rel	  
activation	  is	  the	  liberation	  and	  nuclear	  translocation	  of	  heterodimers	  such	  as	  p50/p65	  
(canonical)	  and	  p52/RelB	  	  (alternative)	  that	  bind	  κB	  DNA	  consensus	  sequences	  and	  
































	  	  	  	  	  	  	  	  	  	  The	  effects	  of	  H2O2	  on	   the	  NFκB/Rel	  pathway	  have	  been	  studied	   in	  multiple	  cell	  
types	  with	   results	   ranging	   from	   no	   effect	   to	   a	   concentration	   dependent	   activation	   or	  
inhibition,	  with	   lymphocytes	  and	  epithelial	   cells	   appearing	   to	  be	   consistently	   sensitive	  
(Oliveira-­‐Marques	   et	  al.,	  2009b).	   	  A	  great	  deal	  of	  work	  has	  been	  done	   in	   investigating	  
the	  mechanism	  of	  H2O2-­‐mediated	  NFκB/Rel	  activation	  in	  T	  lymphocytes.	  	  Following	  the	  
seminal	   observation	   by	   Schreck	   et	   al,	   that	   µM	   H2O2	   could	   activate	   NFκB/Rel	   in	   the	  
Jurkat	   human	   T	   lymphocyte	   cell	   line,	   it	   was	   found	   that	  µM	  H2O2	   activated	   upstream	  
kinases	  	  (p56Luck	  and	  syk)	  resulting	  in	  the	  phosphorylation	  of	  IκBα	  at	  tyrosine	  42,	  which	  
caused	  a	  dissociation	  of	  NFκB/Rel	  heterodimers	  without	  degradation	  of	  IκBα	  leading	  to	  
nuclear	  translocation	  of	  NFκB/Rel	  and	  DNA	  binding	  (Schoonbroodt	  et	  al.,	  2000;	  Takada	  
et	   al.,	   2003;	   Gloire	   et	   al.,	   2006b).	   	   These	   data	   lead	   to	   the	   theory	   that	   H2O2	   activates	  
NFκB/Rel	   through	   an	   atypical	   pathway	   that	   does	   not	   involve	   canonical	   IκBα	  
degradation.	   This	   view	   was	   eventually	   challenged	   by	   a	   study	   demonstrating	   that	   the	  
atypical	   H2O2-­‐mediated	   NFκB/Rel	   activation	   (tyrosine	   42)	   was	   dependent	   upon	  
abrogation	   of	   a	   specific	   phosphatase	   (SHIP-­‐1)	   activity	   that	   was	   upstream	   of	   IKK	  
activation	   (Schoonbroodt	   et	   al.,	   2000).	   When	   SHIP-­‐1	   activity	   was	   restored	   in	   SHIP-­‐1	  
negative	   Jurkat	   cells,	   H2O2	   induced	   canonical	   IKK-­‐mediated	   IκBα	   degradation.	   	   This	  
effect	  was	  confirmed	   in	  other	  T	  cell	   lines	   that	  did	  not	  exhibit	   impaired	  SHIP-­‐1	  activity,	  
and	  µM	  H2O2	  was	  also	  found	  to	  stimulate	  the	  canonical	  NFκB/Rel	  pathway	  in	  epithelial	  
cells	   (Storz	   &	   Toker,	   2003;	   Gloire	   et	   al.,	   2006a;	   Gloire	   et	   al.,	   2006b).	   The	   current	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prevailing	   theory	  of	  H2O2-­‐mediated	  NFκB/Rel	  activation	   is	   that	  H2O2	  generally	   induces	  
IKK-­‐mediated	   IκBα	   phosphorylation	   and	   degradation,	   but	   alterations	   in	   the	   pathway	  
(e.g.	   decreased	   SHIP-­‐1	   expression)	   can	   induce	   an	   atypical	   pathway	   of	   activation	  
involving	  tyrosine	  42	  phosphorylation	  of	  IκBα.	  	  While	  a	  great	  deal	  of	  this	  work	  has	  been	  
done	  in	  T	  lymphocytes	  showing	  H2O2	  can	  activate	  NFκB/Rel	  at	  low	  levels	  (<100	  µM)	  and	  
high	   levels	  of	  H2O2	   (>	  100	  µM),	   there	   is	   limited	  work	   in	  B	   lymphocytes	   (Schreck	  et	  al.,	  
1991;	  Takada	  et	  al.,	  2003).	  Liu	  et	  al,	  demonstrated	  that	  >100	  µM	  H2O2	  can	  inhibit	  CD40	  
activation	  induced	  NFκB/Rel	  DNA	  binding	  and	  IgM	  secretion	  in	  mature	  B	   lymphocytes,	  
but	  they	  only	  examined	  one	  form	  of	  activation	  (anti-­‐CD40),	  used	  a	  limited	  range	  of	  H2O2	  
concentrations,	   and	   did	   not	   examine	   NFκB/Rel	   gene	   expression	   or	   transcriptional	  
activity	   (Liu	   et	   al.,	   2007).	   	   	   The	   paucity	   of	   information	   regarding	   the	   effects	   of	   H2O2	  
exposure	   on	   B	   lymphocytes	   and	   the	   inherent	   cell-­‐type	   differences	   between	   B	   and	   T	  
lymphocytes,	   including	   differential	   sensitivity	   to	   H2O2,	   underscore	   the	   need	   to	   more	  
fully	  understand	  how	  H2O2	  exposure	  might	  affect	  NFκB/Rel	  activation	  in	  B	  lymphocytes.	  
Beyond	  the	  upstream	  activation	  of	  NFκB/Rel,	  there	  are	  yet	  other	  points	  of	  redox	  
regulation	  within	  the	  NFκB/Rel	  pathway.	   	  Matthews	  et	  al	  made	  a	  seminal	  discovery	  of	  
the	  direct	  oxidation	  of	  the	  NFκB	  p50	  subunit	  at	  cysteine	  62,	  that	  then	  requires	  reduction	  
in	   the	   nuclear	   fraction	   for	   NFκB/p50	   DNA	   binding	   (Matthews	   et	   al.,	   1992).	  
Subsequently,	   other	   oxidative	   modifications	   of	   NFκB/Rel	   family	   members	   have	   been	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discovered,	   such	   as	   the	   inhibitory	   effect	   of	   S-­‐glutathionylation	   on	   NFκB/Rel	   proteins.	  	  
Although	   the	   functional	   significance	   of	   these	   modifications	   has	   not	   been	   fully	  
characterized,	   IKKβ	   kinase	   activity	   was	   inhibited	   by	   glutathionylation,	   p65/RelA	  
glutathionylation	  exhibited	  decreased	  DNA	  binding	   (Reynaert	  et	  al.,	  2006;	  Qanungo	  et	  
al.,	   2007).	   Furthermore,	   glutathionylated	   IκBα	   is	   a	   poor	   substrate	   for	   IκK	  
phosphorylation	   and	   ubiquitination	   causing	   it	   to	   be	   resistant	   to	   the	   transient	  
degradation	  that	  is	  required	  for	  NFκB/Rel	  activation	  (Kil	  et	  al.,	  2008).	  
While	   Scheck	   et	   al	   and	   others	   demonstrated	   that	   µM	   H2O2	   alone	   can	   affect	  
NFκB/Rel	  activity,	  it	  has	  also	  been	  shown	  that	  in	  lymphocytes	  and	  other	  cell	  types	  ≤100	  
µM	  H2O2	  can	  enhance	  NFκB/Rel	  transcriptional	  activity	  in	  cells	  activated	  by	  stimuli	  such	  
as	   TNFα	   or	   phorbol	  myristate	   acetate	   (PMA)	   (Schreck	   et	   al.,	   1991;	   Israël	   et	   al.,	   1992;	  
Schreck	  et	  al.,	  1992;	  Los	  et	  al.,	  1995;	  Schoonbroodt	  et	  al.,	  2000;	  Takada	  et	  al.,	  2003;	  de	  
Oliveira-­‐Marques	  et	  al.,	  2007;	  Pyo	  et	  al.,	  2008;	  Oliveira-­‐Marques	  et	  al.,	  2009a).	  Oliveira-­‐
Marques	  et	  al	  demonstrated	  that	  this	  enhancing	  effect	  may	  be	  a	  function	  of	  sub-­‐optimal	  
stimulus-­‐mediated	   activation	   (e.g.	   TNFα)	   of	   NFκB/Rel,	   which	   results	   in	   a	   paucity	   of	  
NFκB/Rel	  dimers	  binding	   low	  and	  medium	  affinity	  κB	  sites.	   	   The	  authors	   showed	   that	  
co-­‐stimulation	  with	  H2O2	  enhanced	  TNFα-­‐mediated	  NFκB/Rel-­‐mediated	   transcriptional	  
activation	  of	  reporters	  bearing	  low	  and	  medium	  affinity	  κB	  sites	  but	  not	  in	  high	  affinity	  
κB	   sites.	   	   The	  authors	  believe	   that	   the	  H2O2	  enhancing	  effects	   increased	   the	   levels	  of	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nuclear	  NFκB/Rel	  transactivating	  dimers	  and	  by	  mass	  action	  increased	  the	  likelihood	  of	  
the	  low	  and	  mid	  affinity	  κB	  sites	  being	  bound	  (de	  Oliveira-­‐Marques	  et	  al.,	  2007;	  Oliveira-­‐
Marques	   et	   al.,	   2009a).	   	   It	   is	   also	   important	   to	   note	   that	   there	   is	   a	   wide	   range	   of	  
sequence	  identity	  for	  NFκB/Rel	  consensus	  binding	  sequences	  that	  allows	  for	  a	  log-­‐scale	  
range	  of	  NFκB/Rel	  dimer	  binding	  affinities	  (Udalova	  et	  al.,	  2002;	  de	  Oliveira-­‐Marques	  et	  
al.,	  2007;	  Oliveira-­‐Marques	  et	  al.,	  2009a,	  b;	  Siggers	  et	  al.,	  2011).	  There	  is	  a	  κB	  sequence	  
in	   the	  hs1,2	  enhancer	  of	   the	  3’IghRR	  which	  regulates	   Igh	  expression	   in	  B	   lymphocytes	  
that	  is	  nearly	  identical	  to	  the	  low	  affinity	  κB	  sequence	  identified	  by	  Oliveira-­‐Marques	  et	  
al	  (Oliveira-­‐Marques	  et	  al.,	  2009a).	  	  There	  is	  also	  a	  κB	  sequence	  in	  the	  hs4	  of	  the	  3’IghRR	  
that	  is	  also	  nearly	  identical	  to	  a	  κB	  sequence	  that	  Siggers	  et	  al	  characterized	  to	  have	  a	  
markedly	  lower	  affinity	  than	  the	  high	  affinity	  sequence	  utilized	  in	  the	  Oliveira-­‐Marques	  
et	   al	   study	   (Oliveira-­‐Marques	   et	   al.,	   2009a;	   Siggers	   et	   al.,	   2011).	   	   Presence	   of	   low	   to	  
medium	   affinity	   κB	   sequences	   in	   the	   3’IghRR	   may	   explain	   data	   from	   our	   laboratory	  
showing	  that	  <100	  µM	  H2O2	  could	  significantly	  enhance	  the	  LPS-­‐mediated	  activation	  of	  
an	  3’IghRR-­‐regulated	   Ig	  heavy	  chain	   reporter	   in	  a	  B	  cell	  model	   (Henseler	  et	  al.,	  2009).	  
The	  inherent	  plasticity	  associated	  with	  NFκB/Rel	  DNA	  binding	  may	  not	  only	  help	  explain	  
the	  enhancing	  effects	  of	  H2O2,	  but	  underscores	  the	  importance	  of	  characterizing	  gene-­‐
specific	   regulation	   by	  NFκB/Rel	   rather	   than	   relying	   solely	   on	   data	   derived	   from	  more	  
generic	  NFκB/Rel	  activity	  assays.	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Transcriptional	  regulation	  of	  the	  Igh	  locus	  by	  a	  3’	  regulatory	  region	  and	  the	  
involvement	  of	  the	  NFκB/Rel	  pathway.	  
The	  presence	  of	  κB	  sequences	  in	  the	  3’IghRR	  that	  could	  be	  influenced	  as	  a	  
function	  of	  ROI	  exposure	  could	  be	  very	  important	  to	  understanding	  Igh	  transcription	  
since	  the	  3’IghRR	  is	  a	  critical	  regulatory	  region	  that	  governs	  Igh	  expression	  (Pettersson	  
et	  al.,	  1990;	  Lieberson	  et	  al.,	  1991;	  Pinaud	  et	  al.,	  2011).	  	  The	  importance	  of	  the	  3’IghRR	  
was	  demonstrated	  in	  studies	  showing	  that	  the	  deletion	  of	  the	  3’IghRR	  severely	  impairs	  
class-­‐switch	  recombination	  and	  Igh	  transcription	  (Gregor	  &	  Morrison,	  1986;	  Lieberson	  et	  
al.,	  1995;	  Vincent-­‐Fabert	  et	  al.,	  2010).	  	  	  
	   The	   murine	   3’IghRR	   regulates	   variable	   heavy	   chain	   promoter	   (Vh-­‐promoter)	  
transcriptional	  initiation	  through	  at	  least	  four	  of	  its	  constituent	  hypersensitive	  sites	  (5’-­‐
hs3a;	  hs1,2;	  hs3b;	  hs4-­‐3’),	  which	  interact	  with	  transcription	  factors	  and	  exhibit	  enhancer	  
activity.	  	  The	  hs1,2	  (flanked	  by	  quasi-­‐palindromic	  hs3a	  and	  hs3b	  enhancers)	  and	  the	  hs4	  
enhancers	   have	   the	   highest	   density	   of	   transcription	   factor	   binding	   sites	   of	   the	   four	  
enhancers	   with	   both	   sites	   containing	   NFκB/Rel,	   Pax5,	   and	   OCA-­‐B	   and	   Oct	   sites	  
(Michaelson	  et	  al.,	  1996;	  Singh	  &	  Birshtein,	  1996;	  Sepulveda	  et	  al.,	  2004;	  Pinaud	  et	  al.,	  
2011).	   The	   in	   vitro	   analysis	   of	   the	   isolated	   hs1,2	   and	   the	   hs4	   enhancers	   demonstrate	  
that	  they	  exhibit	  the	  greatest	  enhancer	  activity	  (Michaelson	  et	  al.,	  1996).	  	  However,	  the	  
targeted	  deletion	  of	  hs1,2	  within	  the	  context	  of	  the	  full	  3’IghRR	  had	  little	  to	  no	  effect	  on	  
IgM	   expression,	   but	   impacted	   class	   switch	   recombination	   (Cogne	   et	   al.,	   1994).	   The	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targeted	  deletion	  of	  the	  hs3b	  and	  hs4	  enhancer	  pair	  inhibits	  µIgh	  expression	  in	  resting	  B	  
cells	  suggesting	  that	  this	  enhancer	  pair	  plays	  a	  role	  in	  basal	  transcription	  (Pinaud	  et	  al.,	  
2001).	  The	  targeted	  deletion	  of	  the	  hs4	  alone	  did	  not	  result	  in	  any	  effects	  on	  class	  switch	  
recombination	  but	  did	  exhibit	  decreased	  surface	  IgM	  expression	  in	  resting	  B	  cells,	  while	  
hs3b	  deletion	  did	  not	  exhibit	  any	  changes	  in	  Ig	  expression	  (Vincent-­‐Fabert	  et	  al.,	  2009;	  
Bebin	  et	  al.,	  2010).	   	  These	  results	  together	  suggest	  that	  there	  is	  some	  redundancy	  and	  
compensation	  within	  the	  3’IghRR	  and	  no	  single	  enhancer	  is	  essential	  for	  it	  to	  optimally	  
influence	   Igh	   activity.	   Furthermore,	   the	   hs12	   and	   the	   hs4	   enhancers	   interact	   with	   a	  
variety	   of	   transcription	   factors	   and	   are	   likely	   key	   components	   involved	   in	   the	  
transcriptional	  and	  recombination	  activity	  of	  the	  3’IghRR.	  
As	  was	  mentioned	  above,	  NFκB/Rel	  has	  been	  shown	  to	  associate	  with	  3’IghRR	  at	  
putative	  κB	  binding	  sites	  within	  the	  hs1,2	  and	  hs4	  enhancers	  via	  electrophoretic	  
mobility	  shift	  assay	  (EMSA)	  (Michaelson	  et	  al.,	  1996;	  Sulentic	  et	  al.,	  2000;	  Sepulveda	  et	  
al.,	  2004).	  	  Michaelson	  et	  al	  showed	  that	  a	  reporter	  construct	  comprised	  of	  an	  hs4-­‐
regulated	  variable	  Ig	  promoter	  driving	  a	  reporter	  gene	  with	  a	  mutated	  κB	  binding	  
sequence	  exhibited	  lower	  transcriptional	  activity	  than	  the	  hs4	  control	  reporter	  with	  the	  
non-­‐mutated	  κB	  sequence	  (Michaelson	  et	  al.,	  1996).	  	  Sepulveda	  et	  al	  showed	  significant	  
NFκB/Rel	  binding	  to	  the	  hs4	  κB	  sequence	  in	  multiple	  B	  cell	  lines,	  and	  presented	  
evidence	  that	  the	  hs4	  NFκB/Rel	  complex	  was	  at	  least	  partially	  composed	  of	  
p50/p65(RelA)	  transactivating	  heterodimers	  (Sepulveda	  et	  al.,	  2004).	  	  Kanda	  et	  al	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confirmed	  binding	  of	  the	  p50/p65	  complex	  to	  the	  hs4	  (human	  and	  murine	  hs4	  
sequences)	  in	  yet	  a	  different	  B	  lymphocyte	  cell	  line.	  	  The	  authors	  went	  on	  to	  
demonstrate	  the	  importance	  of	  NFκB/Rel	  in	  regulating	  3’IghRR	  activity	  in	  the	  context	  of	  
a	  naturally	  occurring	  mutation	  involving	  a	  chromosomal	  translocation	  that	  physically	  
links	  the	  3’IghRR	  with	  the	  MYC	  promoter.	  	  The	  transcriptional	  activity	  of	  a	  reporter	  
plasmid	  comprised	  of	  an	  3’IghRR-­‐deregulated	  MYC	  promoter	  with	  a	  mutated	  κB	  binding	  
site	  within	  the	  hs4	  enhancer	  was	  significantly	  inhibited	  relative	  to	  the	  control	  reporter	  
with	  a	  non-­‐mutated	  κB	  sequence	  (Kanda,	  2000).	  	  	  
While	  there	  is	  very	  little	  published	  regarding	  the	  direct	  effects	  of	  ROI	  on	  
NFκB/Rel-­‐mediated	  3’IghRR	  activity	  our	  laboratory	  has	  shown,	  as	  mentioned	  above	  (see	  
page	  21),	  that	  in	  a	  murine	  B	  lymphoma	  cell	  line,	  H2O2	  can	  enhance	  LPS-­‐mediated	  
3’IghRR	  transcriptional	  activation	  (Henseler	  et	  al.,	  2009).	  	  We	  have	  also	  demonstrated	  
that	  2,3,7,8-­‐tetrachloro-­‐p-­‐dioxin	  (TCDD),	  a	  compound	  known	  to	  induce	  NFκB/Rel	  
activation	  via	  ROI	  production	  (Yao	  et	  al.,	  1995;	  Knerr	  et	  al.,	  2006),	  can	  inhibit	  µ	  Igh	  
transcription	  via	  the	  3’IghRR	  (Sulentic	  et	  al.,	  2000;	  Sulentic	  et	  al.,	  2004a),	  and	  
preliminary	  results	  suggest	  that	  co-­‐treatment	  with	  TCDD	  and	  a	  potent	  anti-­‐oxidant,	  N-­‐
acetyl-­‐L-­‐cysteine,	  appears	  to	  partially	  suppress	  the	  inhibitory	  effects	  of	  TCDD	  on	  3’IghRR	  
transcriptional	  activity	  (unpublished	  data).	  The	  mechanism	  of	  TCDD-­‐mediated	  inhibition	  
of	  the	  3’IghRR	  activity	  likely	  involves	  the	  NFκB/Rel	  pathway	  as	  TCDD	  modulates	  
NFκB/Rel	  binding	  at	  the	  hs4	  and	  hs1,2	  regions	  of	  the	  3’IghRR,	  (Sulentic	  et	  al,	  2000;	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unpublished	  data).	  	  We	  have	  also	  shown	  that	  deletion	  of	  κB	  sites	  within	  the	  hs4	  can	  
inhibit	  basal	  and	  TCDD-­‐mediated	  transcriptional	  activity	  of	  that	  enhancer(Sulentic	  et	  al.,	  
2004b).	  	  Moreover,	  the	  expression	  of	  a	  non-­‐degradable	  mutant	  form	  of	  IκBα	  (IκBαAA),	  
which	  behaves	  as	  constitutive	  repressor	  of	  NFκB/Rel	  activity,	  can	  inhibit	  TCDD’s	  
modulation	  of	  3’IghRR	  and	  hs4	  enhancer	  activity	  (unpublished	  data).	  	  	  While	  other	  
pathways	  are	  most	  definitely	  involved	  in	  the	  effect	  of	  TCDD	  on	  3’IghRR	  (i.e.	  aryl	  
hydrocarbon	  receptor	  pathway),	  these	  data	  do	  provide	  some	  insight	  into	  how	  oxidizing	  
exposures	  might	  affect	  NFκB/Rel-­‐mediated	  3’IghRR	  transcriptional	  activity.	  
H2O2	  induces	  caspase	  activity	  that	  proteolytically	  regulates	  the	  NFκB/Rel	  pathway.	  
	   The	  effects	  of	  ROI	  on	  cells	  are	  concentration	  dependent.	  	  While,	  low-­‐level	  ROI	  
can	  have	  beneficial	  functional	  effects	  as	  observed	  in	  the	  activation	  of	  B	  lymphocytes,	  
higher	  levels	  of	  ROI	  can	  induce	  cell	  death	  (Farber	  et	  al.,	  1984;	  Dumont	  et	  al.,	  1999;	  Vené	  
et	  al.,	  2010).	  	  One	  hallmark	  of	  cell	  death	  is	  caspase	  activation	  as	  a	  function	  of	  
mitochondrial	  stress.	  	  Caspases	  are	  cysteine-­‐dependent	  aspartate	  proteases	  that	  target	  
proteins	  presenting	  Asp	  residues	  in	  selective	  contexts	  for	  proteolytic	  cleavage.	  
Mitochondrial-­‐mediated	  caspase	  activation	  is	  a	  process	  that	  contributes	  to	  B	  
lymphocyte	  cell	  death.	  	  Mitochondrial-­‐mediated	  caspase	  activation	  is	  induced	  by	  an	  
increase	  in	  mitochondrial	  outer	  membrane	  permeability.	  	  This	  permeability	  allows	  for	  
the	  release	  of	  cytochrome	  C	  from	  the	  mitochondria	  into	  the	  cytosol	  where	  it	  interacts	  
with	  APAF-­‐1	  and	  the	  initiator	  caspase-­‐9	  to	  form	  the	  apoptosome.	  	  The	  apoptosome	  can	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cleave	  and	  activate	  effector	  caspases	  (e.g.	  caspase-­‐3	  and	  7),	  which	  can	  subsequently	  
cleave	  a	  variety	  of	  downstream	  targets	  ultimately	  causing	  cell	  death	  (Xu	  et	  al.,	  2007).	  	  
	   Mitochondrial	  outer	  membrane	  permeability	  is	  caused	  by	  the	  formation	  of	  
permeability	  pores	  that	  include	  the	  pro-­‐apoptotic	  proteins	  (e.g.	  Bax	  and	  Bak).	  	  	  The	  
formations	  of	  the	  permeability	  pores	  are	  countered	  by	  anti-­‐apoptotic	  bcl-­‐2	  proteins	  
(e.g.	  bcl2,	  bcl-­‐xL,	  bfl-­‐1/A1),	  which	  bind	  and	  sequester	  Bax	  and	  Bak	  from	  the	  pores.	  	  The	  
anti-­‐apoptotic	  effects	  of	  the	  bcl2	  family	  proteins	  can	  be	  inhibited	  by	  decreased	  
expression.	  	  	  Bcl-­‐2,	  bcl-­‐xL,	  and	  bfl-­‐1/A1	  are	  all	  NFκB/Rel	  dependent	  genes	  (Dong	  et	  al.,	  
2002;	  Viatour	  et	  al.,	  2003;	  Loughran	  et	  al.,	  2011).	  	  Furthermore,	  XIAP,	  which	  is	  also	  a	  
NFκB/Rel-­‐dependent	  gene	  exercises	  its	  pro-­‐survival	  function	  by	  directly	  antagonizing	  
caspase	  activity	  (Rosato	  et	  al.,	  2007;	  Xu	  &	  Shi,	  2007).	  
	   Exogenous	   µM	   H2O2	   treatment	   has	   been	   shown	   to	   induce	   caspase	   activity	   in	  
lymphocytes	  involving	  caspase-­‐3	  activity	  via	  an	  intrinsic	  mitochondria-­‐induced	  pathway	  
that	  involves	  mitochondrial	  release	  of	  cytochrome	  C,	  an	  event	  upstream	  of	  apoptosome	  
formation,	  caspase	  activation,	  and	  cell	  death	  (Hampton	  &	  Orrenius,	  1997;	  Stridh	  et	  al.,	  
1998).	   	  Caspase-­‐3	  activation	  has	  been	  found	  to	  a	  reliable	   indicator	  for	  general	  caspase	  
activation	  in	  B	  lymphocyte	  malignancies,	  which	  demonstrates	  a	  strong	  linear	  correlative	  
relationship	  with	  PARP	  cleavage,	  a	  standard	  indicator	  for	  caspase	  activity	  (Dukers	  et	  al.,	  
2002).	   	   Interestingly,	   H2O2	   has	   also	   been	   found	   to	   cause	   reversible	   inactivation	   of	  
caspase-­‐3	  and	  there	  is	  evidence	  that	  reversible	  glutathionylation	  of	  caspase-­‐3	  can	  act	  as	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a	   redox	   switch	   that	   controls	   its	   activity	   (glutathionylation	   inactivates	   caspase-­‐3)	  
(Borutaite	  &	  Brown,	  2001;	  Pan	  &	  Berk,	  2007).	  	  	  These	  data	  imply	  that	  caspase	  activation	  
can	  result	  from	  H2O2	  exposure	  and	  there	  are	  mechanisms	  that	  might	  delay	  or	  inhibit	  this	  
activation.	  
	   Caspase	   activity	   has	   been	   found	   to	   be	   important	   in	  maintaining	   appropriate	   B	  
lymphocyte	  populations.	  The	  knock-­‐out	  of	  caspase-­‐3	  was	  found	  to	  result	  in	  “enhanced”	  
proliferation	  and	  hyper-­‐proliferation	  in	  response	  to	  mitogenic	  stimuli	   in	  B	  lymphocytes	  
indicating	  that	  caspase	  activity	  plays	  a	  role	  in	  B	  lymphocyte	  selection	  (Woo	  et	  al.,	  2003).	  	  
Moreover,	   in	   B	   lymphocyte	   activation-­‐induced	   cell	   death	   (AICD),	   an	   apoptotic	  
mechanism	   of	   cell	   death	   utilized	   during	   B	   cell	   differentiation	   to	   eliminate	   potentially	  
auto-­‐reactive	  or	   irrelevant	  B	  cells,	  B	  cells	  are	  signaled	  to	   initiate	   intrinsic	  apoptosis	  via	  
sub-­‐optimal	   BCR	   ligation.	   	   This	   process	   requires	   increased	   production	   of	   H2O2	   and	  
ceramide	  to	  induce	  mitochondrial	  membrane	  permeability	  and	  ultimately	  the	  activation	  
of	  caspases	  (i.e.	  caspase-­‐3)	  (Chen	  et	  al.,	  1998;	  Fang	  et	  al.,	  2000;	  Kroesen	  et	  al.,	  2001).	  	  
	   These	  data	  suggest	  that	  while	  H2O2	  can	  induce	  or	  facilitate	  cell	  death	  via	  caspase	  
activation,	  it	  does	  so	  in	  a	  unique	  fashion	  that	  involves	  redox	  control	  mechanisms.	  	  Cell	  
type	   specific	   responses	   to	   ROI	   as	   well	   as	   cross-­‐talk	   between	   redox	   pathways	   and	  
receptor-­‐mediated	   pathways	   of	   cell	   death	   (e.g.	   AICD)	   may	   add	   yet	   another	   level	   of	  
complexity	   to	   the	   question	   of	   how	   cells	   die.	   It	   is	   therefore,	   important	   to	   fully	  
characterize	   and	   understand	   ROI-­‐mediated	   caspase	   activation	   and	   cell	   death	   in	   B	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lymphocytes.	  Interestingly,	  as	  was	  discussed	  earlier	  (see	  pp	  18-­‐19),	  H2O2	  can	  have	  a	  cell	  
type	   dependent	   effect	   on	   NFκB/Rel	   activity	   and	   NFκB/Rel	   activity	   can	   play	   cell	   type	  
specific	   roles	   in	   cellular	   viability	   and	  death.	   	   The	  higher	   concentrations	   	   (>100	  µM)	  of	  
H2O2	  that	  activate	  NFκB/Rel	  in	  other	  cell-­‐types	  like	  HeLa	  cells	  cause	  cell	  death,	  while	  B	  
lymphocyte	  cell	  death	  requires	  decreased	  NFκB/Rel	  activity	  (Wu	  et	  al.,	  1996;	  Dumont	  et	  
al.,	  1999).	  	  This	  suggests	  that	  cytotoxic	  effects	  of	  H2O2	  on	  B	  lymphocytes	  might	  correlate	  
with	  decreased	  NFκB/Rel	  activity,	  and	  raises	  the	  question	  if	  caspase	  activation	  could	  be	  
involved	  in	  the	  inhibition	  of	  the	  NFκB/Rel	  pathway.	  	  	  
	   Activated	  caspases	  have	  been	  shown	  to	  target	  the	  NFκB/Rel	  pathway.	  Multiple	  
studies	   have	   shown	   that	   caspases	   can	   cleave	   p65/RelA.	   	   N-­‐terminal	   cleavage	   of	  
p65/RelA	  can	  be	  induced	  by	  TRAIL-­‐mediated	  apoptosis	  and	  the	  C-­‐terminal	  cleavage	  can	  
be	   induced	   by	   growth	   factor	   deprivation	   and	   FasL-­‐mediated	   apoptosis.	   The	   caspase	  
cleavage	  products	  of	  p65/RelA	  inhibit	  NFκB/Rel	  transcriptional	  activity	  by	  disrupting	  the	  
protein’s	   transcriptional	   activation	   domain	   (c-­‐terminal)	   or	   its	   DNA	   binding	   activity	   (N-­‐
terminal)	   (Ravi	   et	   al.,	   1998;	   Levkau	   et	   al.,	   1999;	   Kim,	   2005).	   Over-­‐expression	   of	   a	  
cleavage	  resistant	  mutant	  of	  p65/RelA	  has	  been	  found	  to	  protect	  cellular	  viability	  during	  
serum	   deprivation	   relative	   to	   over-­‐expression	   of	   wild	   type	   p65/RelA	   (Levkau	   et	   al.,	  
1999).	  
	   NFκB/Rel	   transcription	   factors	   are	   not	   the	   only	   substrates	   of	   caspases	   in	   the	  
NFκB/Rel	  family.	   	  The	  caspase-­‐mediated	  cleavage	  of	   IκBα	  at	  Asp31	  results	   in	  a	  34	  kDa	  
29	  
cleavage	  product	  of	  IκBα	  that	  has	  been	  found	  to	  occur	  in	  multiple	  cell	  types	  in	  response	  
to	  different	  cellular	  stresses	  and	  cell	  death	  signaling	  including	  serum	  starvation,	  tyrosine	  
kinase	  inhibition	  (genistein	  treatment),	  extrinsic	  apoptotic	  signals	  (e.g.	  TNFα,	  Fas	  ligand	  
mimetic,	  TRAIL),	  and	  cytokine	  deprivation	  (IL-­‐3	  withdrawal)	  (Barkett	  et	  al.,	  1997;	  Jung	  et	  
al.,	  1998;	  Reuther	  &	  Baldwin,	  1999;	  Baxa	  &	  Yoshimura,	  2003).	  	  While	  it	  is	  possible	  that	  
multiple	  caspases	  are	  capable	  of	  IκBα	  cleavage,	  Barkett	  et	  al	  showed	  that	  chicken	  and	  
human	  IκBα	  were	  substrates	  for	  a	  chicken	  ortholog	  of	  caspase-­‐3	  in	  vitro	  (Barkett	  et	  al.,	  
1997).	   	   The	   formation	   of	   p65/RelA	   or	   IκBα	   caspase	   cleavage	   products	   has	   not	   been	  
directly	  observed	   in	   response	   to	  ROI	   exposure.	   The	  unique	   capacity	  of	  ROI	   to	  directly	  
and	   indirectly	   modulate	   the	   NFκB/Rel	   pathway	   could	   influence	   caspase-­‐mediated	  
targeting	   of	   the	   NFκB/Rel	   proteins	   and	   result	   in	   a	   distinct	   pattern	   of	   cleavage	   as	  
compared	  to	  other	  stimuli	  that	  induce	  caspase	  cleavage	  of	  NFκB/Rel	  proteins.	  	  
The	  effects	  of	  ROI	  on	  caspase	  activation	  and	  the	  caspase-­‐mediated	  regulation	  of	  
NFκB/Rel	   activity	   may	   have	   significance	   to	   disease	   states	   such	   as	   B	   lymphocyte	  
malignancies.	  	  It	  has	  been	  shown	  that	  a	  subset	  of	  diffuse	  large	  B	  cell	  lymphomas	  (DLBCL)	  
exhibit	  increased	  NFκB/Rel	  activity	  and	  NFκB/Rel-­‐dependent	  gene	  expression	  relative	  to	  
other	  DLBCLs,	  and	  have	  notably	  worse	  prognoses	  (Davis	  et	  al.,	  2001;	  Pavan	  et	  al.,	  2008).	  	  	  
Other	   studies	   have	   shown	   that	   chemotherapeutics	   known	   to	   induce	   ROI	   cause	   cell	  
death	  in	  B	  lymphocyte	  malignancy	  models	  in	  a	  manner	  that	  is	  highly	  associated	  with	  the	  
inhibition	   of	   NFκB/Rel	   activity,	   notably	   involving	   p65/RelA	   (Alvarez-­‐Maqueda	   et	   al.,	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2004;	   Jazirehi	   et	  al.,	  2005;	  Piva,	  2005;	  Alexandre	   et	  al.,	  2006;	  Hewamana	   et	  al.,	  2008;	  
Hewamana	   et	   al.,	   2009;	   Shanmugam	   et	   al.,	   2010).	   Furthermore,	   the	   Raji	   Burkitt	  
lymphoma	   cell	   line,	   is	   resistant	   to	   cell	   death	   induction	   by	   the	   oxidative	   stress	   agents	  
(e.g.	   diamide	   and	   tert-­‐butyl	   hydroperoxide)	   as	   compared	   to	   other	   Burkitt	   Lymphoma	  
cell	   lines.	   	   Interestingly,	   despite	   the	   resistance	   to	   cell	   death	   the	   treatments	   induced	  
functional	   caspase	   activation	   suggesting	   the	   mechanism	   of	   chemoresistance	   is	  
downstream	  of	  caspase	  activation,	  that	  is,	  caspases	  were	  not	  adequately	  cleaving	  all	  of	  
their	   targets.	   	   The	   authors	  were	  not	   able	   to	   ascertain	  which	   target(s)	  were	   not	   being	  
effectively	   cleaved,	   but	   as	   the	   Raji	   cell	   line	   is	   characterized	   to	   exhibit	   constitutive	  
NFκB/Rel	  activity(Goldfeld	  et	  al.,	  1991),	  the	  NFκB/Rel	  family	  of	  proteins	  would	  be	  logical	  
candidates	   (Hirokawa	   et	   al.,	   2002).	   If	   caspase-­‐mediated	   cleavage	   of	   NFκB/Rel	   family	  
proteins	  is	  disabled	  or	  attenuated	  the	  enduring	  NFκB/RelA	  pathway	  would	  continue	  its	  
prescribed	  role	  of	  anti-­‐apoptotic	  signaling	  and	  promote	  lymphoma	  cell	  survival	  (Fan	  et	  
al.,	  2008).	  	  	  
Therefore,	   if	   B	   cell	   lymphoma	   chemoresistance	   is	   associated	   with	   elevated	  
NFκB/Rel	  and	  inefficient	  cleavage	  of	  caspase	  targets	  is	  one	  of	  the	  possible	  mechanisms	  
of	   chemoresistance,	   ROI-­‐induced	   caspase	   mediated	   cleavage	   of	   NFκB/Rel	   could	   be	   a	  
potential	  mechanism	  to	  be	  exploited	  in	  the	  development	  of	  more	  effective	  treatments	  
for	  B	  cell	  lymphomas.	  
Significance	  and	  Central	  Hypothesis	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Lymphocytes	  are	  exposed	  to	  ROI.	  
	   Lymphocytes	  encounter	  a	  wide	  variety	  of	  environments	  within	  an	  organism,	  
which	  present	  many	  opportunities	  for	  exposure	  to	  both	  exogenously	  derived	  ROI	  and	  
endogenously	  derived	  ROI	  generated	  as	  a	  function	  of	  lymphocyte	  activation,	  both	  
predominantly	  manifesting	  in	  the	  form	  of	  peroxide.	  	  Exposures	  to	  ROI	  can	  induce	  a	  
transient	  oxidizing	  shift	  in	  the	  redox	  potential.	  	  These	  exposures	  can	  be	  sensed	  by	  the	  
anti-­‐oxidant	  response	  system,	  evolved	  to	  maintain	  a	  steady-­‐state	  redox	  potential	  that	  is	  
optimal	  for	  cellular	  viability	  and	  function,	  which	  triggers	  redox	  circuits	  that	  signal	  the	  
cell	  to	  respond	  appropriately.	  
B	  lymphocytes	  respond	  uniquely	  to	  ROI	  exposure,	  which	  may	  impact	  immunity	  and	  
disease.	  	  
	   The	  magnitude	  of	  the	  oxidizing	  shift	  in	  redox	  potential	  can	  determine	  the	  effects	  
on	  cellular	  functions.	  Modest	  shifts	  can	  activate	  redox	  circuits	  that	  activate	  or	  enhance	  
cellular	  signaling	  pathways	  involved	  in	  physiological	  cell	  function,	  while	  more	  dramatic	  
oxidative	  shifts	  can	  signal	  the	  cell	  to	  halt	  growth	  or	  induce	  caspase	  activity	  that	  can	  
eventually	  lead	  to	  cell	  death.	  Moreover,	  the	  redox-­‐mediated	  effects	  on	  signaling	  
pathways	  can	  be	  dependent	  on	  the	  duration	  of	  exposure,	  form,	  and	  concentration	  of	  
the	  ROI.	  However,	  the	  effects	  are	  not	  universal	  across	  all	  cell	  types.	  	  For	  instance,	  B	  
lymphocyte	  viability	  has	  been	  found	  to	  be	  more	  sensitive	  to	  H2O2	  than	  T	  lymphocyte	  
viability,	  and	  the	  response	  (activation	  or	  inhibition)	  as	  well	  as	  the	  sensitivity	  (effective	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concentration)	  of	  the	  NFκB/Rel	  signaling	  pathway	  to	  H2O2	  have	  been	  found	  to	  vary	  in	  a	  
cell-­‐type	  specific	  manner	  (Farber	  et	  al.,	  1984;	  Oliveira-­‐Marques	  et	  al.,	  2009b).	  	  	  
	   Therefore	  understanding	  the	  cell-­‐type	  specific	  effects	  of	  transient	  shifts	  in	  the	  
redox	  state	  caused	  by	  ROI	  is	  physiologically,	  toxicologically,	  and	  therapeutically	  relevant	  
to	  cell	  types	  such	  as	  B	  lymphocytes	  that	  have	  the	  potential	  to	  be	  exposed	  to	  a	  variety	  of	  
oxidizing	  environments.	  	  For	  example,	  a	  chemoresistant	  B	  cell	  lymphoma	  line	  HOB1/VCR	  
has	  been	  characterized	  to	  be	  resistant	  to	  ROI	  producing	  chemotherapeutic	  (i.e.	  
vincristine	  and	  cisplatin)	  and	  H2O2-­‐mediated	  (100	  µM)	  cell	  death,	  while	  the	  
chemotherapeutic/H2O2-­‐sensitive	  HOB1	  control	  cell	  line	  was	  protected	  from	  
chemotherapeutic	  and	  H2O2	  cell	  death	  by	  co-­‐treatment	  with	  the	  anti-­‐oxidant	  N-­‐acetyl-­‐L-­‐
cysteine.	  	  Interestingly,	  the	  ROI	  levels	  were	  lower	  in	  HOB1/VCR	  resistant	  cell	  line	  than	  
the	  HOB1	  control	  cell	  line	  following	  chemotherapeutic	  treatment.	  This	  was	  believed	  to	  
be	  a	  function	  of	  increased	  levels	  of	  glutathione	  peroxidase,	  and	  H2O2	  neutralizing	  
enzyme,	  in	  the	  HOB1/VCR	  cell	  line	  relative	  to	  the	  control	  HOB1	  cell	  line.	  	  This	  suggests	  
that	  chemoresistance	  in	  B	  cell	  lymphomas	  can	  involve	  decreased	  sensitivity	  to	  ROI-­‐
mediated	  cell	  death	  via	  increased	  capacity	  to	  neutralize	  H2O2	  (Tsai	  et	  al.,	  2007).	  	  
Furthermore,	  understanding	  how	  H2O2	  modulates	  cellular	  signaling	  to	  induce	  cell	  death	  
in	  lymphoma	  or	  impacts	  signaling	  relevant	  to	  other	  pathophysiological	  states	  such	  as	  
autoimmunity	  or	  critical	  physiological	  processes	  such	  as	  adaptive	  immunity	  could	  be	  
important	  for	  maintaining	  health	  and	  treating	  disease.	  	  The	  NFκB/Rel	  pathway	  is	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integrated	  into	  the	  cellular	  signaling	  that	  regulates	  B	  lymphocyte	  function.	  	  It	  facilitates	  
B	  lymphocyte-­‐mediated	  adaptive	  immunity	  and	  can	  impact	  B	  lymphocyte	  disease.	  	  
Therefore,	  understanding	  the	  effects	  of	  ROI	  on	  B	  lymphocyte	  function	  with	  a	  focus	  on	  
NFκB/Rel	  pathway	  could	  provide	  important	  insights	  on	  redox	  cell	  signaling	  that	  affects	  B	  
lymphocyte	  function	  and	  disease.	  
ROI	  exposure	  can	  modulate	  the	  NFκB/Rel	  pathway	  
	   The	  NFκB/Rel	  pathway	  is	  directly	  and	  indirectly	  influenced	  by	  H2O2	  at	  multiple	  
points	  in	  its	  signaling	  cascade	  in	  a	  cell-­‐type	  specific	  manner.	  	  	  While	  T	  lymphocytes	  have	  
been	  studied	  extensively	  in	  this	  regard,	  very	  little	  research	  on	  the	  effects	  of	  ROI	  on	  
NFκB/Rel	  has	  been	  done	  in	  B	  lymphocytes.	  The	  relationship	  between	  the	  NFκB/Rel	  
pathway	  and	  B	  lymphocytes	  was	  originally	  discovered	  as	  an	  important	  transcription	  
factor	  that	  targets	  immunoglobulin	  loci	  in	  B	  lymphocytes.	  Specifically,	  inhibition	  of	  
NFκB/Rel	  activity	  has	  been	  found	  to	  inhibit	  Ig	  expression	  (Sen	  &	  Baltimore,	  1986;	  Hsing	  
&	  Bishop,	  1999).	  	  	  The	  NFκB/RelA	  pathway	  has	  subsequently	  been	  found	  to	  be	  involved	  
in	  the	  regulation	  of	  a	  multitude	  of	  other	  genes,	  notably,	  genes	  involved	  in	  B	  Lymphocyte	  
cellular	  survival	  such	  as	  bcl-­‐xl	  and	  xiap	  (Yi	  &	  Krieg,	  1998;	  Deveraux	  et	  al.,	  1999;	  Fang	  et	  
al.,	  2000;	  Dong	  et	  al.,	  2002;	  Scott	  et	  al.,	  2005;	  Rosato	  et	  al.,	  2007).	  	  Therefore,	  the	  
effects	  of	  ROI	  on	  NFκB/Rel-­‐mediated	  Ig	  or	  cell	  survival	  gene	  expression	  could	  
significantly	  impact	  adaptive	  immunity	  and	  cell	  survival.	  	  	  
Can	  ROI	  influence	  cell	  survival	  by	  disabling	  NFκB/Rel	  pathway?	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   We	  have	  found	  that	  >	  100	  µM	  H2O2	  exposure	  causes	  a	  marked	  decrease	  in	  
viability	  in	  non-­‐activated	  B	  lymphocytes	  (Romer	  &	  Sulentic,	  2011).	  	  This	  may	  be	  in	  part	  
explained	  by	  the	  fact	  that	  H2O2	  exposure	  has	  been	  shown	  to	  activate	  caspases	  as	  a	  
function	  of	  cell	  death	  in	  lymphocytes	  (Hampton	  &	  Orrenius,	  1997).	  	  Caspase	  activity	  is	  
also	  linked	  to	  the	  NFκB/Rel	  pathway	  in	  that	  cell	  stress/death	  inducing	  signals	  activate	  
caspases	  that	  target	  and	  cleave	  NFκB/Rel	  family	  proteins	  such	  as	  p65/RelA	  and	  IκBα,	  
and	  the	  cleavage	  of	  both	  these	  proteins	  is	  associated	  with	  the	  inhibition	  of	  NFκB/Rel-­‐
mediated	  transcriptional	  activity	  (Ravi	  et	  al.,	  1998;	  Reuther	  &	  Baldwin,	  1999).	  	  	  Although	  
very	  little	  is	  known	  about	  ROI-­‐induced	  caspase	  cleavage	  of	  NFκB/Rel,	  the	  ROI-­‐mediated	  
activation	  of	  caspases	  in	  B	  lymphocytes	  could	  potentially	  inhibit	  NFκB/Rel-­‐mediated	  
anti-­‐apoptotic	  gene	  expression	  and	  potentiate	  the	  cell	  death	  process.	  	  This	  mechanism	  
could	  be	  involved	  in	  the	  B	  lymphocyte	  selection	  processes	  such	  as	  BCR-­‐induced	  cell	  
death,	  which	  involves	  a	  dramatic	  increase	  in	  ROI	  production	  as	  a	  part	  of	  mitochondrial	  
cell	  death	  (Bouchon	  et	  al.,	  2000).	  Treatment	  with	  antioxidants	  can	  repress	  BCR-­‐induced	  
cell	  death	  and	  enhance	  the	  protein	  expression	  of	  the	  NFκB/Rel-­‐dependent	  pro-­‐survival	  
bcl-­‐xl	  (Hamano	  et	  al.,	  2002).	  	  
ROI-­‐induced	  caspase	  cleavage	  of	  NFκB/Rel	  could	  also	  be	  important	  in	  
chemotherapeutic	  regimens	  because	  anthracyclines	  (ROI-­‐generating	  compounds)	  are	  
utilized	  in	  the	  treatment	  of	  lymphoma.	  Moreover,	  co-­‐treatment	  of	  a	  chemoresistant	  T	  
lymphocyte	  cell	  line	  with	  doxorubicin	  (an	  anthracycline)	  and	  an	  oxidizing	  compound	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(buthionine	  sulfoximine)	  can	  enhance	  caspase	  activation	  and	  apoptosis	  in	  a	  manner	  that	  
involves	  the	  inhibition	  of	  Bcl-­‐xL	  protein	  expression	  (a	  NFκB/Rel-­‐dependent	  gene)	  
(Friesen	  et	  al.,	  2004).	  Furthermore,	  the	  chemoresistant	  mechanisms	  of	  diffuse	  large	  B	  
cell	  lymphomas	  have	  been	  characterized	  to	  involve	  increased	  NFκB/Rel	  activity.	  	  There	  
is	  also	  evidence	  for	  a	  chemoresistant	  mechanism	  believed	  to	  involve	  inefficient	  cleavage	  
of	  downstream	  caspase	  targets	  in	  a	  B	  cell	  lymphoma	  line	  that	  exhibits	  constitutive	  
NFκB/Rel	  activity;	  perhaps	  inefficient	  cleavage	  of	  NFκB/Rel	  could	  be	  involved	  in	  that	  
chemoresistant	  mechanism	  	  (see	  background	  pp	  29-­‐30)	  (Goldfeld	  et	  al.,	  1991;	  Davis	  et	  
al.,	  2001;	  Hirokawa	  et	  al.,	  2002).	  	  If	  ROI-­‐induced	  caspase	  activation	  leads	  to	  the	  disabling	  
of	  the	  NFκB/Rel	  pathway	  and	  promotes	  cell	  death,	  such	  a	  mechanism	  could	  be	  
exploited	  to	  develop	  more	  effective	  treatments	  for	  diseases	  such	  B	  lymphocyte	  
malignancies	  with	  poor	  prognoses	  that	  that	  involve	  the	  NFκB/Rel	  pathway	  such	  as	  
multiple	  myeloma	  and	  activated	  B	  cell-­‐diffuse	  large	  B	  cell	  lymphoma	  (Pavan	  et	  al.,	  2008;	  
Ang	  et	  al.,	  2009;	  Liu	  et	  al.,	  2012).	  
Can	  ROI	  influence	  3’IghRR-­‐regulated	  Igh	  transcriptional	  activity	  via	  the	  NFκB/Rel	  
pathway?	  
	   ROI-­‐exposure	  likely	  influences	  NFκB/Rel	  regulation	  of	  functions	  other	  than	  cell	  
survival,	  such	  as	  Ig	  expression,	  which	  is	  necessary	  for	  adaptive	  immunity	  as	  well	  as	  
cellular	  selection.	  	  As	  discussed	  earlier,	  Igh	  expression	  requires	  3’IghRR-­‐activity	  and	  the	  
NFκB/Rel	  pathway	  is	  found	  to	  target	  this	  region	  (see	  background	  page	  22-­‐23).	  	  	  This	  was	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shown	  in	  studies	  that	  identified	  putative	  NFκB/Rel	  binding	  sites	  within	  the	  3’IghRR	  that	  
regulate	  transcriptional	  activity,	  and	  the	  mutation	  of	  a	  κB	  sequence	  within	  the	  hs4	  
enhancer	  inhibited	  3’IghRR-­‐regulated	  activity	  of	  a	  c-­‐myc	  promoter	  (Michaelson	  et	  al.,	  
1996;	  Kanda,	  2000).	  	  Our	  laboratory	  has	  found	  that	  inhibition	  of	  NFκB/Rel	  activity	  by	  the	  
expression	  of	  a	  degradation	  resistant	  form	  of	  IκBα	  inhibits	  3’IghRR	  transcriptional	  
activity	  (Romer	  &	  Sulentic,	  2011).	  	  	  Recently,	  our	  laboratory	  has	  also	  discovered	  that	  in	  
activated	  B	  lymphocytes,	  low	  µM	  (30	  µM)	  concentrations	  of	  H2O2	  can	  enhance	  the	  
transcriptional	  activity	  of	  a	  stably	  integrated	  reporter	  transgene	  linking	  the	  3’IghRR	  with	  
the	  Ig	  heavy	  chain	  promoter,	  while	  higher	  µM	  concentrations	  of	  H2O2	  (100	  µM)	  can	  
inhibit	  the	  activity	  (Henseler	  et	  al.,	  2009).	  	  We	  therefore	  hypothesize	  that	  “low	  levels	  of	  
ROI”	  (e.g.	  <100	  µM	  exogenous	  H2O2,	  or	  endogenously	  derived	  ROI)	  have	  a	  potential	  for	  
enhancing	  effects	  while	  “high	  levels	  of	  ROI”	  (e.g.	  >	  100	  µM	  exogenous	  H2O2)	  will	  have	  a	  
greater	  potential	  for	  inhibitory	  effects	  on	  3’IghRR	  activity.	  	  It	  is	  important	  to	  note	  that	  
our	  seminal	  observation	  described	  above	  does	  not	  discern	  whether	  the	  H2O2-­‐effect	  
targets	  the	  Vh-­‐promoter	  or	  the	  3’IghRR,	  nor	  does	  it	  determine	  if	  the	  NFκB/Rel	  pathway	  
is	  involved.	  We	  believe	  it	  is	  likely	  that	  NFκB/Rel	  is	  involved	  because	  low	  µM	  
concentrations	  of	  H2O2	  have	  been	  found	  to	  induce	  NFκB/Rel	  activity	  in	  lymphocytes	  
(Schreck	  et	  al.,	  1991;	  Israël	  et	  al.,	  1992).	  	  We	  believe	  H2O2	  is	  modulating	  3’IghRR	  activity	  
in	  a	  NFκB/Rel-­‐dependent	  manner	  because	  the	  3’IghRR	  is	  the	  predominant	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transcriptional	  regulatory	  region	  of	  the	  Igh	  locus	  that	  contains	  putative	  κB	  DNA	  
consensus	  sequences,	  and	  3’IghRR	  activity	  can	  be	  suppressed	  by	  the	  inhibition	  of	  
NFκB/Rel	  activity	  (Michaelson	  et	  al.,	  1996;	  Vincent-­‐Fabert	  et	  al.,	  2010;	  Romer	  &	  
Sulentic,	  2011).	  
	   The	  possibility	  that	  concentration-­‐dependent	  exposures	  of	  ROI	  could	  modulate	  
3’IghRR	  activity	  in	  an	  NFκB/Rel-­‐dependent	  manner	  has	  significant	  implications	  on	  
immunity	  and	  pathophysiology.	  Aging	  is	  associated	  with	  increased	  levels	  of	  ROI	  in	  
lymphocytes	  as	  well	  as	  with	  a	  decline	  in	  adaptive	  immunity	  characterized	  by	  declines	  in	  
peripheral	  mature	  B	  lymphocyte	  cell	  numbers,	  serum	  Ig,	  and	  antibody	  response	  
(Buckley	  &	  Dorsey,	  1970;	  Paganelli	  et	  al.,	  1992;	  Reddy	  Thavanati	  et	  al.,	  2008;	  Frasca	  et	  
al.,	  2010;	  Frasca	  &	  Blomberg,	  2011).	  	  	  Research	  aimed	  at	  the	  impact	  of	  ROI	  on	  B	  
lymphocyte	  function	  involving	  the	  3’IghRR	  could	  be	  important	  in	  understanding	  the	  
effect	  of	  age	  on	  adaptive	  immunity.	  	  
3’IghRR	  activity	  has	  been	  implicated	  in	  a	  number	  of	  disease	  states	  including	  
lymphoma	  and	  autoimmune	  diseases	  such	  as	  rheumatoid	  arthritis	  (Wang	  &	  Boxer,	  2005;	  
Tolusso	  et	  al.,	  2009).	  Both	  of	  these	  groups	  of	  diseases	  have	  been	  found	  to	  involve	  
oxidative	  conditions	  (Cerimele	  et	  al.,	  2005;	  Wang,	  2006;	  Pedersen-­‐Lane	  et	  al.,	  2007).	  If	  
ROI	  can	  modulate	  3’IghRR	  activity,	  then	  it	  can	  likely	  influence	  the	  initiation	  and	  
progression	  of	  diseases	  associated	  with	  inappropriate	  3’IghRR	  activity.	  	  
	   Considerable	  uncertainty	  exists	  regarding	  the	  biological	  impact	  of	  ROI	  exposure	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on	  NFκB/Rel-­‐mediated	  B	  Lymphocyte	  cellular	  functions	  such	  as	  Ig	  expression	  and	  
NFκB/Rel	  family	  protein	  cleavage.	  	  It	  is	  therefore	  hypothesized	  that	  the	  exposure	  of	  B	  
lymphocytes	  to	  low	  levels	  of	  reactive	  oxygen	  intermediates	  (ROI)	  enhances	  3’IghRR-­‐
mediated	  Igh	  transcriptional	  activity	  via	  the	  NFκB/Rel	  pathway,	  while	  exposure	  to	  
high	  levels	  of	  ROI	  inhibits	  3’IghRR-­‐mediated	  Igh	  transcriptional	  activity	  and	  disables	  
the	  NFκB/Rel	  pathway	  by	  caspase-­‐mediate	  cleavage	  of	  IκBα 	  and	  p65/RelA.	  
	   In	  an	  effort	  to	  better	  understand	  the	  concentration-­‐dependent	  effects	  of	  
exogenous	  H2O2	  on	  NFκB/Rel-­‐mediated	  Igh	  transcriptional	  activity	  in	  the	  context	  of	  non-­‐
activated	  and	  activated	  B	  lymphocytes,	  Specific	  aim	  1	  will	  determine	  if	  exposure	  of	  B	  
lymphocytes	  to	  exogenous	  H2O2	  results	  in	  altered	  3’IghRR-­‐mediated	  Igh	  transcriptional	  
activity	  that	  is	  dependent	  on	  the	  H2O2	  concentration,	  NFκB/Rel	  activity,	  and	  the	  cellular	  
activation	  state.	  
	   Antigen	  activation	  of	  B	  lymphocytes	  has	  been	  found	  to	  simultaneously	  increase	  
the	  levels	  of	  intracellular	  H2O2	  and	  activate	  the	  NFκB/Rel	  pathway.	  	  In	  an	  effort	  to	  
further	  understand	  the	  impact	  of	  these	  effects	  on	  3’IghRR-­‐regulated	  Igh	  expression,	  
Specific	  aim	  2	  will	  determine	  if	  the	  inhibition	  of	  activation-­‐induced	  enzymatic	  ROI	  
production	  concomitantly	  inhibits	  NFκB/Rel	  activity	  and	  Ig	  expression	  via	  effects	  on	  
3’IghRR	  activity.	  
	   Exposure	  of	  B	  lymphocytes	  to	  higher	  µM	  concentrations	  of	  H2O2	  results	  in	  a	  
novel	  cleavage	  of	  IκBα	  and	  decreased	  cellular	  viability.	  	  We	  believe	  these	  effects	  require	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the	  targeting	  of	  the	  NFκB/Rel	  pathway	  by	  caspases,	  therefore,	  Specific	  aim	  3	  will	  
determine	  if	  H2O2	  induces	  caspase	  activity	  that	  suppresses	  NFκB/Rel	  activity	  and	  induces	  
cleavage	  of	  IκBα	  and	  p65/RelA	  in	  B	  lymphocytes.	  
	  
	  
Chapter	  II:	  Specific	  Aim	  Rationale,	  Results,	  and	  Discussion	  
Specific	  Aim	  1:	  determine	  if	  exposure	  of	  B	  Lymphocytes	  to	  exogenous	  H2O2	  results	  in	  
altered	  3’IghRR-­‐mediated	  Igh	  transcriptional	  activity	  that	  is	  dependent	  on	  the	  H2O2	  
concentration,	  NFκB/Rel	  activity,	  and	  the	  cellular	  activation	  state.	  
Rationale:	  SA1	  
	   B	  lymphocytes	  are	  widely	  disbursed	  throughout	  the	  body	  thus	  increasing	  the	  
likelihood	  for	  its	  exposure	  to	  a	  variety	  of	  oxidizing	  environments.	  	  Immune	  foci	  are	  likely	  
sites	  for	  exposure	  to	  ROI	  as	  many	  activated	  immune	  cell	  types,	  including	  B	  lymphocytes,	  
generate	  ROI.	  	  Other	  sources	  of	  ROI	  such	  as	  xenobiotics	  (e.g.	  chemotherapeutics	  and	  
environmental	  toxicants)	  are	  yet	  additional	  avenues	  to	  exposure	  (Reth,	  2002).	  	  
Collectively,	  the	  diversity	  in	  potential	  routes	  of	  exposure	  to	  ROI	  emphasizes	  the	  
significance	  of	  studying	  ROI-­‐mediated	  effects	  on	  the	  primary	  physiological	  functions	  of	  B	  
lymphocytes,	  which	  may	  provide	  insight	  into	  adaptive	  immunity	  and	  pathophysiological	  
mechanisms	  of	  ROI-­‐associated	  disease	  states	  such	  as	  autoimmunity	  and	  lymphoma.	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   The	  appropriate	  range	  of	  ROI	  exposure	  to	  study	  is	  somewhat	  challenging,	  as	  we	  
do	  not	  have	  the	  technology	  to	  accurately	  measure	  the	  dynamic	  range	  of	  all	  the	  possible	  
in	  vivo	  exposure	  scenarios.	  	  	  It	  has	  been	  shown	  that	  levels	  of	  H2O2	  can	  exceed	  100	  µM	  in	  
the	  extracellular	  environment	  at	  immunological	  foci,	  but	  as	  H2O2	  has	  a	  relatively	  large	  
extracellular	  radius	  of	  diffusion	  it	  is	  likely	  that	  transient	  concentrations	  proximal	  to	  the	  
ROI	  source(s)	  may	  be	  higher	  (Hyslop	  et	  al.,	  1995;	  Winterbourn,	  2008).	  	  In	  vitro	  analysis	  
has	  shown	  that	  exposure	  to	  the	  µM	  range	  of	  exogenous	  H2O2	  generally	  elicits	  effects	  
such	  as	  stimulation	  of	  cell	  growth	  at	  sub-­‐100	  µM	  H2O2	  to	  growth	  arrest	  at	  >100	  µM	  and	  
necrosis	  at	  1	  mM	  (Wiese	  et	  al.,	  1995).	  	  The	  effects	  of	  exogenous	  H2O2	  are	  dependent	  
upon	  the	  cell	  type,	  the	  context	  of	  exposure,	  and	  the	  pathways	  being	  activated	  (Farber	  et	  
al.,	  1984;	  Forman,	  2007;	  Oliveira-­‐Marques	  et	  al.,	  2009b).	  	  In	  an	  effort	  to	  better	  
understand	  the	  functional	  effects	  of	  exogenous	  H2O2	  on	  B	  lymphocytes,	  analysis	  should	  
include	  a	  wide	  range	  of	  H2O2	  concentrations	  that	  span	  potentially	  enhancing	  (sub-­‐100	  
µM)	  to	  oxidative	  stress-­‐associated	  concentrations	  (>	  100	  µM).	  	  
	   There	  are	  a	  number	  of	  studies	  substantiating	  the	  functional	  effects	  of	  µM	  H2O2	  
exposure.	  	  The	  exposure	  of	  T	  lymphocytes	  to	  exogenous	  µM	  H2O2	  as	  low	  as	  30-­‐50	  µM	  
has	  been	  found	  to	  enhance	  NFκB/Rel	  DNA	  binding	  and	  NFκB/Rel-­‐mediated	  
transcriptional	  activity	  (Schreck	  et	  al.,	  1991;	  Israël	  et	  al.,	  1992).	  	  	  However,	  fewer	  studies	  
have	  investigated	  the	  effects	  of	  H2O2	  on	  B	  lymphocytes.	  Because	  the	  B	  lymphocyte	  has	  a	  
significant	  potential	  to	  experience	  ROI,	  understanding	  the	  functional	  effects	  of	  ROI	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exposure	  may	  provide	  important	  insights	  into	  redox-­‐mediated	  B	  lymphocyte	  function	  
and	  adaptive	  immunity.	  	  	  	  B	  lymphocyte	  viability	  is	  more	  sensitive	  to	  H2O2	  exposure	  than	  
that	  of	  T	  lymphocytes,	  which	  suggests	  that	  there	  may	  be	  B	  lymphocyte	  specific	  effects	  
to	  ROI	  exposure	  (Farber	  et	  al.,	  1984).	  While	  there	  has	  not	  been	  a	  great	  deal	  of	  research	  
on	  the	  effects	  of	  ROI	  on	  the	  B	  lymphocyte,	  it	  has	  also	  been	  shown	  that	  µM	  H2O2	  can	  
activate	  NFκB/Rel	  in	  a	  pre-­‐B	  cell	  line	  and	  high	  levels	  of	  ROI	  (>100	  µM)	  inhibit	  CD40-­‐
mediated	  IgM	  secretion	  and	  NFκB/Rel	  DNA	  binding	  in	  mature	  B	  lymphocytes	  (Lee	  &	  
Koh,	  2003;	  Liu	  et	  al.,	  2007).	  	  The	  activating	  effects	  of	  low	  level	  H2O2	  on	  NFκB/Rel	  (a	  
regulator	  of	  Igh	  expression)	  and	  the	  inhibitory	  effects	  of	  high	  level	  H2O2	  on	  IgM	  
expression	  suggest	  there	  could	  be	  a	  concentration	  dependent	  effect	  of	  H2O2	  on	  Igh	  
transcriptional	  regulation	  in	  the	  B	  lymphocyte.	  Effects	  on	  Igh	  expression	  could	  impact	  
antibody	  production	  and	  subsequently	  the	  adaptive	  immune	  response.	  There	  are,	  
however,	  points	  of	  redox	  regulation	  other	  than	  transcriptional	  control	  that	  affect	  the	  
translation,	  packaging,	  and	  secretion	  of	  Ig,	  that	  could	  also	  impact	  Ig	  production	  
(Bertolotti	  et	  al.,	  2012).	  	  	  Therefore	  the	  direct	  effects	  of	  a	  wide	  range	  of	  µM	  H2O2	  on	  the	  
transcriptional	  activity	  of	  the	  Igh	  locus	  or	  the	  role	  of	  the	  NFκB/Rel	  pathway	  in	  this	  
process	  is	  unknown.	  	  Furthermore,	  3’IghRR-­‐regulation	  is	  necessary	  for	  optimal	  Igh	  
expression	  and	  NFκB/Rel	  activity	  plays	  a	  significant	  role	  in	  3’IghRR	  activity	  (Michaelson	  
et	  al.,	  1996;	  Sepulveda	  et	  al.,	  2004;	  Vincent-­‐Fabert	  et	  al.,	  2010).	  	  Therefore,	  modulation	  
of	  NFκB/Rel	  and/or	  3’IghRR	  by	  ROI	  could	  impact	  Ig	  expression	  and	  adaptive	  immunity.	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In	  considering	  all	  the	  available	  evidence,	  there	  appears	  to	  be	  a	  hole	  in	  the	  
understanding	  of	  how	  ROI	  and	  the	  NFκB/Rel	  pathway	  might	  converge	  to	  influence	  
3’IghRR-­‐regulation	  and	  impact	  immunity	  and	  disease	  states.	  	  	  While	  our	  seminal	  data	  
suggests	  that	  30	  µM	  H2O2	  is	  able	  to	  enhance	  LPS-­‐activated	  transcriptional	  activity	  of	  a	  
stably	  integrated	  3’IghRR-­‐regulated	  reporter	  transgene	  (Henseler	  et	  al.,	  2009),	  there	  are	  
no	  studies	  that	  have	  fully	  investigated	  the	  concentration-­‐dependent	  effects	  of	  ROI	  
exposure	  on	  3’IghRR-­‐mediated	  transcriptional	  activity	  in	  B	  lymphocytes	  or	  the	  role	  of	  
the	  NFκB/Rel	  pathway	  in	  these	  effects.	  	  	  The	  modulation	  of	  3’IghRR-­‐activity	  by	  ROI	  could	  
not	  only	  affect	  immunity	  but	  disease	  states	  that	  involve	  3’IghRR-­‐regulation	  such	  as	  
adaptive	  immunity	  and	  the	  initiation,	  progression,	  and	  treatment	  of	  autoimmune	  
diseases	  and	  cancer	  (Wang	  &	  Boxer,	  2005;	  Tolusso	  et	  al.,	  2009).	  	  	   	  
	   As	  previously	  mentioned,	  B	  Lymphocytes	  primarily	  exist	  in	  either	  a	  naive	  (non-­‐
activated)	  or	  activated	  state	  (see	  background,	  pp.	  3-­‐4).	  	  It	  is	  therefore,	  necessary	  to	  
assess	  the	  effects	  of	  ROI	  in	  either	  state	  to	  more	  fully	  understand	  how	  ROI	  might	  impact	  
B	  lymphocyte	  functionality.	  	  ROI-­‐mediated	  modulation	  of	  3’IghRR	  activity	  could	  affect	  Ig	  
expression	  in	  naive	  B	  lymphocytes.	  	  	  The	  enhancement	  of	  Ig	  production	  could	  facilitate	  
adaptive	  immunity	  and	  Ig-­‐mediated	  immune	  surveillance	  or	  increase	  levels	  of	  auto-­‐
antibodies	  that	  could	  contribute	  to	  the	  initiation	  and	  progression	  of	  autoimmunity.	  	  A	  
decrease	  in	  surface	  Ig	  expression	  could	  repress	  the	  capacity	  of	  B	  lymphocytes	  to	  detect	  
antigen	  causing	  immunodeficiency.	  	  In	  activated	  cells,	  ROI	  could	  enhance	  3’IghRR	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activity	  by	  bolstering	  the	  activation	  and	  recruitment	  of	  NFκB/Rel	  to	  potentially	  lower	  
affinity	  κB	  sites	  in	  the	  3’IghRR	  (see	  background	  page	  21).	  	  This	  could	  boost	  production	  of	  
Ig	  and	  enhance	  the	  maturation	  process.	  	  Furthermore,	  as	  previously	  mentioned,	  the	  
3’IghRR	  can	  be	  involved	  disease-­‐related	  regulation	  of	  non-­‐Ig	  genes	  as	  many	  lymphomas	  
harbor	  chromosomal	  translocation	  mutations	  that	  link	  the	  3’IghRR	  with	  a	  proto-­‐
oncogene	  (Boerma	  et	  al.,	  2008).	  This	  linkage	  results	  in	  a	  deregulation	  of	  a	  proto-­‐
oncogene,	  which	  can	  promote	  oncogenesis	  during	  or	  post	  germinal	  center	  activation.	  	  
While	  the	  cell	  may	  not	  be	  optimally	  activated,	  subsequent	  transformed	  clones	  often	  
display	  signatures	  of	  activation	  such	  as	  increased	  NFκB/Rel	  activity	  (Pavan	  et	  al.,	  2008).	  	  
Understanding	  how	  3’IghRR	  activity	  is	  affected	  by	  ROI	  and	  the	  role	  of	  NFκB/Rel	  in	  the	  
activated	  state	  could	  provide	  meaningful	  insight	  into	  the	  regulation	  of	  3’IghRR	  linked	  
oncogenes	  and	  the	  mechanisms	  of	  lymphoma.	   	  
	   In	  considering	  the	  potential	  for	  H2O2-­‐mediated	  effects	  on	  3’IghRR-­‐regulated	  
transcriptional	  activity	  involving	  the	  NFκB/Rel	  pathway,	  the	  studies	  in	  Specific	  Aim	  1	  
determined	  if	  low	  levels	  of	  H2O2	  enhance	  and	  high	  levels	  of	  H2O2	  inhibit	  3’IghRR-­‐
mediated	  Igh	  transcriptional	  activity	  via	  the	  NFκB/Rel	  pathway	  in	  both	  non-­‐activated	  
and	  activated	  B	  lymphocytes.	  	   	  	  
Results:	  SA1	  
H2O2	  modulates	  3’IghRR	  and	  NFκB/Rel	  activity	  in	  a	  concentration-­‐	  and	  activation	  
state-­‐dependent	  manner.	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The	  effects	  of	  a	  range	  of	  µM	  H2O2	  concentrations	  on	  3’IghRR-­‐mediated	  Igh	  
transcriptional	  activity	  were	  assayed	  by	  measuring	  the	  activity	  of	  transiently	  transfected	  
luciferase	  transcriptional	  reporter	  plasmids	  derived	  from	  the	  mouse	  Igh	  locus	  in	  both	  
LPS-­‐activated	  and	  non-­‐activated	  B	  lymphocytes	  (figure	  5).	  	  	  The	  cells	  were	  treated	  
according	  to	  the	  experimental	  design	  outlined	  in	  figure	  6.	  	  	  
Figure	  5:	  	  Igh	  locus	  and	  transcriptional	  reporter	  constructs:	  	  
	  (A)	  The	  schematic	  represents	  the	  full	  murine	  Igh	  locus.	  	  (B)	  The	  schematics	  represent	  
the	  luciferase	  reporter	  DNA	  plasmids	  designed	  to	  assess	  regulation	  of	  transcriptional	  
activity	  by	  constituent	  Igh	  enhancer	  (hs4	  or	  3’IghRR)	  and/or	  promoter	  (Vh)	  sequences.	  
The	  Igh	  reporter	  plasmids	  are	  derived	  from	  the	  mouse	  Igh	  locus	  (Figure	  5A)	  and	  drive	  
luciferase	  expression	  under	  1)	  the	  regulation	  of	  the	  variable	  heavy	  Igh	  promoter	  	  (Vh)	  
alone	  (Vh-­‐Luc),	  or	  under	  2)	  the	  regulation	  of	  the	  Vh	  and	  the	  3’IghRR	  (Vh-­‐Luc-­‐3’IghRR),	  or	  
under	  3)	  the	  Vh	  and	  the	  hs4	  enhancer	  of	  the	  3’IghRR	  (Vh-­‐Luc-­‐hs4).	  	  	  NFκB/Rel	  
transcriptional	  activity	  will	  be	  measured	  utilizing	  the	  3x-­‐NF-­‐κB-­‐Luc	  reporter	  containing	  3	  
consensus	  κB	  DNA	  binding	  sequences	  derived	  from	  the	  Ig	  κ	  light	  chain	  conjugated	  to	  









Figure	  6:	  	  Experimental	  design	  of	  luciferase	  reporter	  experiments.	  
The	  schematic	  represents	  the	  workflow	  for	  the	  luciferase	  transcriptional	  reporter	  
experiments.	  	  Briefly,	  CH12IκBαAA	  cells	  were	  transiently	  transfected	  with	  one	  of	  the	  
luciferase	  reporter	  plasmids,	  diluted	  to	  2.0	  x	  105	  C/mL	  and	  split	  into	  two	  groups.	  	  The	  
groups	  were	  either	  treated	  or	  not	  treated	  with	  100	  µM	  Isopropyl	  β-­‐D-­‐1-­‐
thiogalactopyranoside	  (IPTG)	  for	  2	  hours	  to	  activate	  the	  stably	  integrated	  IκBαAA	  
transgene.	  	  The	  cells	  were	  then	  treated	  with	  increasing	  concentrations	  of	  µM	  H2O2	  (0-­‐
200	  µM)	  and	  either	  not	  activated	  or	  activated	  with	  1.0	  µg/mL	  Lipopolysaccharide,	  
plated	  in	  triplicate	  for	  each	  condition,	  and	  incubated	  for	  24	  or	  48	  hr.	  	  The	  cells	  were	  
then	  harvested	  for	  whole	  cell	  protein	  lysates	  and	  equal	  volumes	  of	  the	  lysate	  were	  














The	  Vh-­‐Luc	  reporter	  plasmid	  was	  included	  in	  this	  study	  to	  control	  for	  effects	  on	  
the	  promoter	  alone	  in	  contrast	  to	  the	  hs4	  enhancer	  or	  the	  3’IghRR	  regulated	  Vh-­‐
promoter.	  The	  hs4	  region	  is	  one	  of	  the	  more	  active	  enhancer	  elements	  within	  the	  
3’IghRR	  containing	  a	  high	  density	  of	  transcription	  factor	  binding	  sites	  including	  a	  κB	  
binding	  site	  (Michaelson	  et	  al.,	  1996;	  Kanda,	  2000;	  Sepulveda	  et	  al.,	  2004).	  	  	  Analysis	  of	  
Vh-­‐Luc-­‐hs4	  reporter	  plasmid	  expression	  was	  included	  in	  this	  study	  to	  determine	  if	  H2O2	  
could	  influence	  the	  activity	  of	  a	  κB	  site	  bearing	  enhancer	  element	  within	  the	  3’IghRR.	  
The	  direct	  effects	  of	  H2O2	  on	  NFκB/Rel	  transcriptional	  activity,	  as	  compared	  to	  the	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3’IghRR	  (containing	  multiple	  different	  transcription	  factor	  binding	  sites),	  were	  measured	  
with	  a	  3x-­‐NFκB-­‐Luc	  reporter	  plasmid	  that	  drives	  luciferase	  expression	  with	  a	  promoter	  
containing	  three	  consensus	  κB	  binding	  sequences	  derived	  from	  a	  conalbumin	  promoter	  
(Arenzana-­‐Seisdedos	  et	  al.,	  1993).	  	  Additionally,	  NFκB/Rel	  activity	  was	  experimentally	  
suppressed	  by	  expression	  of	  a	  constitutive	  NFκB/Rel	  inhibitor,	  the	  IκBαAA	  super-­‐
repressor	  (see	  materials	  and	  methods).	  This	  tool	  enabled	  the	  discrimination	  of	  whether	  
or	  not	  the	  effects	  of	  H2O2	  on	  3’IghRR	  transcriptional	  activity	  involved	  the	  NFκB/Rel	  
pathway.	  
The	  effects	  of	  H2O2	  exposure	  on	  non-­‐activated	  cells:	  
	   The	  results	  from	  the	  non-­‐activated	  cells	  treated	  for	  48	  hr	  demonstrated	  a	  
significant	  2	  fold	  enhancement	  of	  Vh-­‐Luc-­‐3’IghRR	  transcriptional	  activity	  with	  lower	  µM	  
H2O2	  (30-­‐40	  µM)	  (figure	  7A)	  relative	  to	  the	  naïve	  control,	  which	  was	  suppressed	  by	  the	  
expression	  of	  the	  IκBαAA	  super-­‐repressor	  (figure	  7B).	  The	  enhancement	  was	  decreased	  
dramatically	  with	  increasing	  concentrations	  of	  H2O2	  and	  resulted	  in	  a	  significant	  
inhibition	  at	  200	  µM	  H2O2.	  	  The	  Vh-­‐Luc	  reporter	  demonstrated	  only	  a	  significant	  
concentration-­‐dependent	  inhibition	  (30-­‐200	  µM	  H2O2)	  and	  the	  Vh-­‐Luc-­‐hs4	  reporter	  was	  
less	  sensitive	  with	  significant	  inhibition	  occurring	  in	  75-­‐200	  µM	  H2O2.	  
The	  NFκB/Rel-­‐dependent	  enhancement	  of	  3’IghRR-­‐activity	  by	  H2O2	  suggests	  
H2O2	  is	  to	  some	  degree	  activating	  the	  cell.	  	  Optimal	  activation-­‐induced	  Ig	  expression	  
takes	  2-­‐5	  days	  suggesting	  induction	  of	  Igh	  is	  a	  late	  response	  gene	  (Snapper	  et	  al.,	  1993).	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It	  has	  also	  been	  shown	  that	  H2O2	  can	  activate	  NFκB/Rel	  binding	  and	  transcriptional	  
reporter	  activity	  by	  or	  before	  24	  hr	  in	  T	  lymphocytes	  (Schreck	  et	  al.,	  1991;	  Israël	  et	  al.,	  
1992).	  	  It	  is	  therefore	  not	  clear	  if	  H2O2	  treatment	  modulates	  3’IghRR	  transcriptional	  
activity	  <	  24	  hr	  or	  closer	  to	  the	  48	  hr	  time	  frame,	  thus	  requiring	  analysis	  at	  both	  of	  these	  
time	  points.	  	  Interestingly,	  the	  24	  hr	  (figure	  8A)	  results	  showed	  a	  concentration	  
dependent	  inhibition	  of	  all	  the	  reporters,	  with	  Vh-­‐Luc-­‐3’IghRR	  inhibition	  occurring	  in	  the	  
40-­‐200	  µM	  H2O2	  range.	  	  	  The	  3x-­‐NFκB-­‐Luc	  demonstrated	  a	  concentration	  dependent	  
inhibition	  at	  24	  hr	  (40-­‐200	  µM)	  (figure	  8A)	  and	  48	  hr	  (50-­‐200	  µM)	  (figure	  9A),	  which	  was	  
not	  significantly	  altered	  by	  IκBαAA	  expression.	  	  These	  results	  suggest	  that	  in	  the	  non-­‐
activated	  state	  low	  µM	  H2O2	  can	  initially	  inhibit	  (24	  hr,	  figure	  8A)	  and	  then	  enhance	  (48	  
hr,	  figure	  7A)	  only	  the	  full	  3’IghRR-­‐regulated	  transcriptional	  activity,	  and	  the	  
enhancement	  can	  be	  suppressed	  by	  inhibition	  of	  NFκB/Rel	  activity.	  	  	  Interestingly,	  the	  
hs4	  and	  3x-­‐NFκB-­‐Luc	  plasmids	  did	  not	  demonstrate	  an	  enhancement	  profile.	  	  This	  could	  
be	  due	  to	  the	  fact	  that	  the	  full	  3’IghRR	  has	  a	  more	  extensive	  sequence	  than	  either	  the	  
3x-­‐NFκB-­‐Luc	  or	  the	  hs4,	  which	  provides	  a	  greater	  diversity	  of	  transcription	  factor	  
binding	  sites,	  and	  multiple	  NFκB/Rel	  binding	  sites	  (hs4	  and	  hs1,2)	  that	  cooperate	  to	  
make	  a	  more	  sensitive	  target	  for	  modest	  NFκB/Rel	  activation	  mediated	  by	  H2O2	  alone.	  	  
Moreover,	  the	  absence	  of	  hs4	  enhancement	  suggests	  that	  the	  hs1,2	  enhancer	  is	  likely	  
involved	  in	  the	  H2O2-­‐mediated	  enhancement	  of	  the	  Vh-­‐3’IghRR-­‐Luc	  reporter	  in	  the	  non-­‐
activated	  state.	  	  The	  modest	  inhibition	  of	  Vh-­‐3’IghRR-­‐Luc	  at	  24	  hr	  by	  the	  40	  µM	  H2O2	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which	  is	  then	  resolved	  into	  an	  enhancement	  at	  48	  hr	  suggests	  that	  there	  may	  be	  an	  
initial	  modest	  suppressive	  signal	  that	  is	  reversed	  or	  overridden	  by	  an	  enhancing	  signal	  
involving	  NFκB/Rel	  activation.	  	  The	  sustained	  inhibition	  observed	  with	  the	  higher	  
concentrations	  (200	  µM	  H2O2)	  suggests	  there	  is	  a	  concentration	  threshold	  that	  when	  
achieved	  inhibits	  3’IghRR	  and	  NFκB/Rel	  activity.	  	  As	  this	  concentration	  threshold	  for	  
3’IghRR-­‐activity	  correlates	  with	  decreased	  cellular	  viability	  it	  may	  involve	  caspase-­‐
mediated	  regulation	  of	  the	  NFκB/Rel	  pathway,	  which	  will	  be	  discussed	  in	  specific	  aim	  3	  
(Romer	  &	  Sulentic,	  2011).	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Figure	  7:	  H2O2	  differentially	  modulates	  regulated	  and	  unregulated	  Vh-­‐promoter	  
activity	  in	  a	  concentration-­‐dependent	  manner	  in	  non-­‐activated	  cells.	  	  	  	  
	  CH12IκBαAA	  cells	  were	  transfected	  with	  the	  respective	  luciferase	  reporter	  
plasmids,	  and	  either	  treated	  with	  IPTG	  to	  activate	  the	  IκBαAA	  transgene	  which	  inhibits	  
NFκB/Rel	  activity	  (B)	  or	  left	  not	  treated	  (A).	  	  The	  cells	  were	  then	  treated	  with	  the	  
indicated	  concentrations	  of	  µM	  H2O2,	  plated	  in	  triplicate,	  incubated	  for	  48	  hr,	  and	  
harvested	  for	  whole	  cell	  protein	  lysates,	  which	  were	  assayed	  for	  luciferase	  activity.	  	  
Results	  are	  displayed	  as	  the	  fold	  change	  of	  the	  mean	  relative	  light	  units	  for	  at	  least	  3	  
separate	  experiments	  for	  each	  reporter	  and	  normalized	  to	  the	  NA	  (naïve)	  control.	  
Statistically	  significant	  differences	  between	  treatment	  groups	  of	  no	  IκBαAA	  (A)	  and	  
IκBαAA	  (B)	  expressing	  cells	  were	  determined	  by	  a	  2-­‐way	  ANOVA	  with	  Bonferroni	  post-­‐
hoc	  test.	  *	  p	  <0.05	  for	  Vh-­‐Luc-­‐3’IghRR	  and	  †	  p<0.05	  for	  Vh-­‐Luc-­‐hs4	  relative	  to	  
corresponding	  H2O2	  treatment	  group.	  	  Statistically	  significant	  H2O2	  enhancements	  
relative	  to	  naïve	  control	  (A)	  are	  signified	  by	  “+”	  (p<0.05).	  	  Statistically	  significant	  H2O2	  
inhibitions	  relative	  to	  naïve	  control	  (A)	  are	  not	  denoted	  on	  the	  graph	  but	  are	  as	  follows:	  
30-­‐200	  µM	  H2O2	  for	  Vh-­‐Luc,	  75-­‐200	  µM	  H2O2	  for	  Vh-­‐Luc-­‐hs4;	  200	  µM	  for	  Vh-­‐Luc-­‐3’IghRR.	  	  
All	  statistically	  significant	  differences	  relative	  to	  naïve	  were	  determined	  by	  1-­‐way	  





















































































Figure	  8:	  	  H2O2	  inhibits	  regulated	  and	  unregulated	  Vh-­‐promoter	  activity	  in	  a	  
concentration-­‐dependent	  manner	  at	  24	  hr.	  	  
CH12IκBαAA	  cells	  were	  transfected	  with	  the	  respective	  luciferase	  reporter	  plasmid,	  and	  
either	  activated	  with	  1.0	  µg/mL	  LPS	  (B)	  or	  remained	  non-­‐activated	  (A)	  and	  treated	  with	  
the	  indicated	  concentrations	  of	  µM	  H2O2.	  	  The	  treated	  cells	  were	  then	  plated	  in	  
triplicate,	  incubated	  for	  24	  hr,	  and	  harvested	  for	  whole	  cell	  protein	  lysates,	  which	  were	  
assayed	  for	  luciferase	  activity.	  Results	  are	  displayed	  as	  the	  fold	  change	  of	  the	  mean	  
relative	  light	  units	  for	  at	  least	  3	  separate	  experiments	  for	  each	  reporter	  normalized	  to	  
either	  NA	  (A)	  or	  LPS	  (B)	  control.	  	  The	  statistically	  significant	  inhibitions	  relative	  to	  naïve	  
or	  LPS	  control	  are	  not	  denoted	  on	  the	  graph	  but	  are	  as	  follows:	  A)	  30-­‐200	  µM	  H2O2	  for	  
Vh-­‐Luc,	  40-­‐200	  µM	  H2O2	  for	  Vh-­‐Luc-­‐hs4,	  Vh-­‐Luc-­‐3’IghRR,	  and	  3x-­‐NFκB-­‐Luc	  B)	  30-­‐200	  µM	  
H2O2	  for	  Vh-­‐Luc	  and	  Vh-­‐Luc-­‐hs4,	  30-­‐200	  µM	  H2O2	  for	  3x-­‐NFκB-­‐Luc	  and	  100-­‐200	  µM	  H2O2	  
for	  Vh-­‐Luc-­‐3’IghRR.	  	  All	  statistically	  significant	  differences	  relative	  to	  naïve	  were	  
determined	  by	  1-­‐way	  ANOVA	  with	  Dunnett’s	  post	  hoc	  test;	  p<0.05.	  Error	  bars	  represent	  









































































Figure	  9:	  	  H2O2	  differentially	  modulates	  NFκB/Rel	  transcriptional	  activity	  in	  a	  
concentration	  dependent	  manner.	  
	  CH12IκBαAA	  cells	  were	  transfected	  with	  the	  3x-­‐NFκB-­‐Luc	  luciferase	  reporter	  plasmid,	  
and	  either	  treated	  with	  IPTG	  to	  activate	  the	  IκBαAA	  transgene	  which	  inhibits	  NFκB/Rel	  
activity	  or	  left	  not	  treated	  as	  indicated.	  	  The	  cells	  were	  then	  either	  activated	  with	  1.0	  
µg/mL	  LPS	  (B)	  or	  remained	  non-­‐activated	  (A)	  and	  treated	  with	  the	  indicated	  
concentrations	  of	  µM	  H2O2.	  	  The	  treated	  cells	  were	  then	  plated	  in	  triplicate,	  incubated	  
for	  48	  hr,	  and	  harvested	  for	  whole	  cell	  protein	  lysates,	  which	  were	  assayed	  for	  luciferase	  
activity.	  	  Results	  are	  displayed	  as	  the	  fold	  change	  of	  the	  mean	  relative	  light	  units	  for	  3	  
separate	  experiments	  for	  each	  reporter	  normalized	  to	  either	  NA	  (A)	  or	  LPS	  (B)	  control.	  *	  
p<0.05	  signifies	  statistically	  significant	  differences	  between	  No	  IκBαAA	  	  and	  IκBαAA	  as	  
per	  2-­‐way	  ANOVA	  with	  a	  Bonferroni	  post-­‐hoc	  test.	  Statistically	  significant	  H2O2	  
enhancements	  relative	  to	  naïve	  (A)	  and	  LPS	  control	  (B)	  in	  the	  “no	  IκBαAA”	  group	  are	  
signified	  by	  +	  (p<0.05).	  Statistically	  significant	  H2O2	  inhibitions	  relative	  to	  naïve	  control	  
(A)	  were	  found	  to	  occur	  with	  50-­‐200	  µM	  H2O2	  and	  in	  the	  LPS	  control	  (B)	  was	  found	  to	  
occur	  at	  200	  µM	  H2O2	  (not	  denoted	  on	  the	  graph).	  Statistically	  significant	  differences	  
relative	  to	  the	  “no	  IκBαAA”	  naïve	  and	  LPS	  controls	  were	  determined	  by	  1-­‐way	  ANOVA	  













































































The	  effects	  of	  H2O2	  on	  LPS-­‐activated	  cells:	  	  	  
	   LPS,	  as	  expected,	  activated	  Vh-­‐Luc-­‐3’IghRR	  transcriptional	  activity	  (an	  average	  of	  
16-­‐fold)	  and	  co-­‐treatment	  with	  low	  levels	  of	  H2O2	  (30-­‐50	  µM)	  resulted	  in	  a	  significant	  3	  
fold	  enhancement	  of	  activity,	  which	  was	  significantly	  suppressed	  by	  the	  expression	  of	  
the	  IκBαAA	  super-­‐repressor	  (figure	  10A	  &	  B).	  The	  enhancement	  was	  decreased	  with	  
increasing	  concentrations	  of	  H2O2	  but	  there	  was	  no	  significant	  inhibition	  relative	  to	  the	  
LPS	  control	  activity	  even	  at	  the	  highest	  concentration	  (200	  µM	  H2O2).	  	  The	  Vh-­‐Luc-­‐hs4	  
reporter	  demonstrated	  a	  similar	  pattern	  of	  enhancement	  (50	  µM	  H2O2	  enhancement	  
was	  statistically	  significant)	  that	  was	  significantly	  suppressed	  by	  IκBαAA	  suppression.	  	  
The	  enhancement	  was	  also	  decreased	  in	  a	  concentration-­‐dependent	  manner	  but	  again	  
there	  was	  no	  inhibition	  relative	  to	  the	  LPS	  control.	  	  	  The	  3x-­‐NFκB-­‐Luc	  expressed	  a	  similar	  
profile	  to	  the	  Vh-­‐Luc-­‐hs4	  although	  the	  fold	  change	  in	  enhancement	  observed	  with	  40-­‐50	  
µM	  H2O2	  was	  slightly	  lower,	  and	  there	  was	  a	  significant	  inhibition	  with	  the	  200	  µM	  H2O2	  
treatment	  (figure	  9B).	  	  The	  Vh-­‐Luc	  reporter	  activity	  was	  not	  enhanced	  by	  H2O2	  but	  did	  
exhibit	  a	  significant	  inhibition	  at	  the	  highest	  concentrations	  (100-­‐200	  µM	  H2O2),	  
suggesting	  that	  additional	  regulatory	  sequences	  (i.e.	  3’IghRR-­‐derived	  sequence)	  were	  
required	  for	  the	  enhancement	  of	  the	  Vh-­‐promoter.	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Figure	  10:	  	  H2O2	  differentially	  modulates	  regulated	  and	  unregulated	  Vh-­‐promoter	  
activity	  in	  a	  concentration	  dependent	  manner	  in	  LPS-­‐activated	  cells.	  	  	  	  
CH12IκBαAA	  cells	  were	  transfected	  with	  the	  respective	  luciferase	  reporter	  plasmids,	  
and	  either	  treated	  with	  IPTG	  to	  activate	  the	  IκBαAA	  transgene	  which	  inhibits	  NFκB/Rel	  
activity	  (B)	  or	  left	  not	  treated	  (A).	  	  The	  cells	  were	  then	  treated	  with	  1.0	  µg/mL	  LPS	  and	  
treated	  with	  the	  indicated	  concentrations	  of	  µM	  H2O2.	  	  The	  treated	  cells	  were	  then	  
plated	  in	  triplicate,	  incubated	  for	  48	  hr,	  and	  harvested	  for	  whole	  cell	  protein	  lysates,	  
which	  were	  assayed	  for	  luciferase	  activity.	  Results	  are	  displayed	  as	  the	  fold	  change	  of	  
the	  mean	  relative	  light	  units	  for	  at	  least	  3	  separate	  experiments	  for	  each	  reporter	  and	  
normalized	  to	  the	  LPS	  control.	  Statistically	  significant	  differences	  between	  treatment	  
groups	  of	  no	  IκBαAA	  (A)	  and	  IκBαAA	  (B)	  expressing	  cells	  were	  determined	  by	  a	  2-­‐way	  
ANOVA	  with	  Bonferroni	  post-­‐hoc	  test.	  *	  p	  <0.05	  for	  Vh-­‐Luc-­‐3’IghRR	  and	  †	  p<0.05	  for	  Vh-­‐
Luc-­‐hs4	  relative	  to	  corresponding	  H2O2	  treatment	  group.	  	  Statistically	  significant	  H2O2	  
enhancements	  relative	  to	  LPS	  control	  (A)	  are	  signified	  by	  +	  p<0.05	  for	  Vh-­‐Luc-­‐3’IghRR	  
and	  #	  p<0.05	  for	  VH-­‐Luc-­‐hs4.	  The	  Vh-­‐Luc	  was	  the	  only	  reporter	  to	  demonstrate	  
statistically	  significant	  inhibition	  relative	  to	  LPS	  control	  at	  100-­‐200	  µM	  H2O2	  (not	  
denoted	  on	  graph).	  All	  statistically	  significant	  differences	  relative	  to	  LPS	  control	  (A)	  were	  
determined	  by	  1-­‐way	  ANOVA	  with	  Dunnett’s	  post	  hoc	  test;	  p<0.05.	  Error	  bars	  represent	  



































































	   Consistent	  with	  the	  non-­‐activated	  results,	  the	  24	  hr	  H2O2	  treatment	  of	  LPS-­‐
activated	  cells	  did	  not	  result	  in	  an	  enhancement	  at	  any	  concentration	  (figure	  8B).	  	  	  The	  
Vh-­‐Luc-­‐3’IghRR	  only	  demonstrated	  a	  significant	  inhibition	  at	  the	  100-­‐200	  µM	  H2O2,	  while	  
the	  Vh-­‐Luc	  control,	  Vh-­‐Luc-­‐hs4	  and	  3x-­‐NFκB-­‐Luc	  demonstrated	  a	  concentration-­‐
dependent	  inhibition	  with	  a	  much	  wider	  range	  of	  concentrations	  (e.g.	  30-­‐200	  µM	  H2O2),	  
suggesting	  that	  the	  full	  3’IghRR	  is	  more	  resistant	  to	  inhibitory	  effects	  of	  H2O2	  at	  the	  24	  
hr	  time	  point.	  	  	  	  	  
	   It	  appears	  that	  H2O2-­‐exposure	  in	  the	  LPS-­‐activated	  state	  results	  in	  a	  greater	  
relative	  enhancement	  of	  the	  3’IghRR-­‐regulated	  transcriptional	  activity	  than	  in	  the	  non-­‐
activated	  state	  (3-­‐fold	  versus	  2-­‐fold),	  both	  of	  which	  are	  suppressed	  by	  the	  inhibition	  of	  
NFκB/Rel	  activity.	  	  The	  kinetics	  of	  the	  effect	  demonstrate	  that	  there	  is	  initially	  an	  
inhibitory	  effect	  induced	  by	  the	  high	  levels	  of	  H2O2	  that	  is	  reversed	  to	  a	  no-­‐effect	  level	  at	  
48	  hr,	  suggesting	  the	  inhibitory	  effect	  happens	  early	  (i.e.	  by	  24	  hr)	  but	  is	  mitigated	  as	  
the	  H2O2-­‐enhanced	  LPS-­‐activation	  develops	  over	  the	  48	  hr	  period.	  	  	  Furthermore,	  the	  
enhancing	  effects	  induced	  by	  the	  low	  level	  H2O2	  appear	  to	  occur	  in	  pace	  with	  the	  LPS	  
activation	  (i.e.	  optimal	  activity	  at	  48	  hr),	  lending	  evidence	  to	  the	  concept	  that	  H2O2	  is	  an	  
enhancing	  stimulus	  working	  through	  the	  same	  pathways	  or	  pathways	  integrated	  with	  
LPS-­‐activation	  (e.g.	  NFκB/Rel).	  	  	  The	  concentration-­‐dependent	  decrease	  in	  activity	  of	  the	  
3’IghRR	  from	  the	  peak	  enhancing	  concentration	  (e.g.	  40	  µM)	  to	  200	  µM	  H2O2	  occurring	  
in	  both	  the	  activated	  and	  non-­‐activated	  cells	  at	  48	  hr,	  suggests	  that	  there	  is	  an	  initial	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concentration-­‐dependent	  inhibitory	  effect	  at	  24	  hr,	  which	  is	  sustained	  to	  48	  hr.	  	  The	  
delayed	  enhancing	  effect	  of	  the	  lower	  concentrations	  of	  H2O2	  (e.g.	  40	  µM	  H2O2	  at	  48	  hr)	  
can	  override	  the	  mild	  inhibition	  observed	  at	  24	  hr	  resulting	  in	  an	  overall	  enhancement	  
LPS-­‐induced	  activity.	  	  The	  higher	  concentrations	  (i.e.	  100-­‐200	  µM	  H2O2),	  however,	  have	  
a	  stronger	  initial	  inhibitory	  effect	  that	  more	  effectively	  suppresses	  the	  transcriptional	  
activity	  relative	  to	  the	  LPS	  control.	  The	  difference	  between	  the	  low	  and	  high	  
concentration	  dependent	  activities	  indicates	  there	  is	  a	  concentration	  threshold	  between	  
40	  and	  100	  µM	  H2O2	  that	  when	  reached	  triggers	  an	  inhibitory	  effect.	  	  	  
This	  occurrence	  of	  this	  effect	  with	  the	  3x-­‐NFκB-­‐Luc	  reporter	  plasmid	  in	  the	  
activated	  cells	  suggests	  that	  this	  H2O2-­‐inhibitory	  effect	  involves	  the	  NFκB/Rel	  pathway.	  	  
The	  entire	  mechanism	  of	  the	  H2O2-­‐mediated	  inhibition	  of	  the	  NFκB/Rel	  pathway	  is	  
beyond	  the	  scope	  of	  this	  study	  but	  it	  was	  observed	  that	  the	  100-­‐200	  µM	  H2O2-­‐
treatments	  resulted	  in	  truncations	  of	  the	  IκBα	  protein	  with	  a	  novel	  19	  kDa	  fragment	  
observed	  in	  the	  non-­‐activated	  cells	  and	  a	  34	  kDa	  fragment	  observed	  in	  the	  activated	  
cells	  (see	  figure	  22)(Romer	  &	  Sulentic,	  2011).	  	  As	  discussed	  previously	  (see	  background	  
pp	  28-­‐29),	  the	  ΔN-­‐IκBα	  has	  been	  characterized	  as	  a	  34	  kDa	  caspase	  cleavage	  product	  
that	  functions	  as	  a	  constitutive	  inhibitor	  of	  NFκB/Rel	  activity	  (Barkett	  et	  al.,	  1997;	  
Reuther	  &	  Baldwin,	  1999).	  	  Therefore,	  concentration-­‐dependent	  caspase	  targeting	  of	  
the	  NFκB/Rel	  pathway	  may	  be	  a	  critical	  component	  of	  the	  inhibitory	  mechanism.	  	  	  
	   The	  NFκB/Rel	  pathway	  is	  likely	  involved	  in	  mediating	  the	  H2O2	  enhancing	  effect.	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The	  IκBαAA-­‐mediated	  suppression	  of	  the	  H2O2-­‐enhancement	  of	  the	  VH-­‐Luc-­‐3’IghRR	  and	  
VH-­‐Luc-­‐hs4	  reporters	  that	  NFκB/Rel	  is	  highly	  involved	  in	  the	  enhancement	  of	  3’IghRR	  
related	  activity.	  	  The	  H2O2-­‐enhancement	  of	  the	  3x-­‐NFκB-­‐Luc	  reporter	  in	  the	  activated	  
cells,	  and	  subsequent	  suppression	  of	  the	  enhancement	  by	  IκBαAA	  expression	  further	  
supports	  the	  notion	  that	  H2O2	  can	  enhance	  transcriptional	  activity	  primarily	  regulated	  
by	  NFκB/Rel.	  	  
The	  enhancement	  of	  the	  Vh-­‐Luc-­‐hs4	  and	  the	  3x-­‐NFκB-­‐Luc	  reporters	  (not	  in	  the	  
presence	  of	  the	  IκBαAA)	  in	  the	  LPS-­‐activated	  state	  but	  not	  in	  the	  non-­‐activated	  state	  
suggest	  that	  the	  activated-­‐state	  may	  be	  a	  more	  conducive	  environment	  for	  H2O2-­‐
mediated	  enhancement	  of	  less	  sensitive	  κB	  binding	  sites.	  	  This	  effect,	  outlined	  in	  a	  study	  
by	  Oliveira-­‐Marques	  et	  al,	  was	  discussed	  earlier	  and	  more	  extensively	  in	  this	  document	  
(see	  background	  pp.	  20-­‐21),	  but	  briefly,	  lower	  affinity	  κB	  sites	  will	  be	  less	  likely	  to	  be	  
targeted	  with	  suboptimal	  NFκB/Rel	  activation	  (Oliveira-­‐Marques	  et	  al.,	  2009a).	  	  The	  
stimulation	  of	  a	  more	  robust	  NFκB/Rel	  activation	  	  (e.g.	  LPS-­‐activation	  with	  H2O2)	  can	  
result	  in	  a	  greater	  likelihood	  of	  targeting	  those	  lower	  affinity	  targets	  and	  a	  subsequent	  
enhancement	  (de	  Oliveira-­‐Marques	  et	  al.,	  2007).	  	  It	  was	  discussed	  in	  the	  background	  
section	  (see	  background	  pp	  20-­‐21)	  that	  the	  κB	  sequences	  in	  the	  Vh-­‐Luc-­‐hs4	  and	  3x-­‐
NFκB-­‐Luc	  may	  represent	  relatively	  lower	  affinity	  targets,	  which	  could	  explain	  why	  they	  
only	  appeared	  to	  be	  enhanced	  in	  the	  activated	  state.	  	  The	  activation	  of	  the	  Vh-­‐Luc-­‐
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3’IghRR	  in	  both	  the	  activated	  and	  non-­‐activated	  state	  is	  suggestive	  of	  co-­‐operativity	  
within	  the	  3’IghRR	  that	  promotes	  a	  more	  sensitive	  target	  for	  activated	  NFκB/Rel.	  	  
Further	  study	  of	  3’IghRR	  κB	  sites	  are	  required	  to	  further	  understand	  the	  redox	  mediated	  
enhancement	  of	  the	  3’IghRR.	  
	   In	  regards	  to	  how	  H2O2	  might	  be	  influencing	  NFκB/Rel	  targeting	  of	  κB	  sequences	  
in	  the	  3’IghRR,	  we	  found	  through	  an	  electrophoretic	  mobility	  shift	  assay	  (ESMA)	  that	  
nuclear	  extracts	  from	  a	  LPS	  and	  40	  µM	  H2O2	  co-­‐treatment	  resulted	  in	  a	  qualitatively	  
modest	  increase	  in	  binding	  to	  the	  hs4-­‐κB	  probe	  relative	  to	  the	  LPS	  control	  extracts,	  
while	  the	  LPS	  +	  100	  µM	  H2O2	  co-­‐treatment	  appeared	  to	  exhibit	  less	  binding	  relative	  to	  
LPS	  +	  40	  µM	  complex	  (figure	  11).	  	  The	  competitive	  inhibition	  of	  LPS-­‐derived	  nuclear	  
extracts	  binding	  the	  P32	  labeled	  hs4-­‐κB	  probe	  by	  co-­‐incubation	  of	  non-­‐P32	  labeled	  κB	  
consensus	  probe	  suggests	  that	  the	  observed	  complex	  does	  involve	  NFκB/Rel	  binding.	  
This	  data	  suggests	  that	  the	  40	  µM	  H2O2	  co-­‐treatment	  enhances	  κB	  binding	  in	  activated	  
cells,	  which	  is	  consistent	  with	  the	  increased	  NFκB/Rel-­‐dependent	  transcriptional	  
activation	  observed	  in	  the	  Vh-­‐hs4-­‐Luc	  reporter	  (and	  the	  Vh	  -­‐3’IghRR-­‐Luc)	  in	  the	  LPS-­‐
activated	  state.	  Further	  study	  of	  3’IghRR	  κB	  sites	  are	  required	  to	  more	  fully	  understand	  
the	  redox	  mediated	  enhancement	  of	  the	  3’IghRR.	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Figure	  11:	  	  H2O2	  differentially	  modulates	  NFκB/Rel	  binding	  in	  a	  concentration	  
dependent	  manner	  in	  LPS-­‐activated	  cells.	  
CH12IκBαAA	  cells	  were	  activated	  with	  1.0	  µg/mL	  LPS	  and	  experimental	  samples	  were	  
co-­‐treated	  with	  40	  or	  100	  µM	  H2O2	  for	  48	  hr.	  10	  µg	  of	  nuclear	  protein	  from	  
experimental	  and	  control	  groups	  were	  incubated	  with	  32P	  labeled	  probe	  containing	  a	  
murine	  hs4	  κB.	  	  The	  presence	  of	  artifacts	  was	  controlled	  for	  by	  competition	  of	  LPS-­‐
extract	  protein	  binding	  of	  the	  32P	  hs4	  complex	  by	  unlabeled	  hs4	  probe	  (cold	  competitor	  
“cc”	  hs4).	  	  Similarly,	  NFκB/Rel	  binding	  of	  the	  32P	  hs4	  probe	  was	  indicated	  by	  competition	  









ROI	  modulates	  µ 	  Igh	  transcription.	  
The	  effect	  of	  H2O2	  on	  wild-­‐type	  µ	  Igh	  mRNA	  transcript	  levels	  will	  be	  measured	  
via	  real-­‐time	  PCR	  at	  48	  hr	  post	  treatment	  as	  a	  control	  to	  determine	  if	  the	  3’IhgRR	  
reporter	  plasmids	  exhibited	  an	  expression	  profile	  similar	  to	  an	  endogenous	  Igh	  locus.	  
The	  40	  µM	  H2O2	  treatment	  did	  not	  significantly	  increase	  µ	  Igh	  transcript	  levels	  in	  
the	  non-­‐activated	  state,	  while	  it	  did	  enhance	  LPS-­‐activated	  µ	  Igh	  expression	  by	  2	  fold	  
(figure	  12A	  &	  B).	  	  The	  100	  µM	  H2O2	  treatment	  inhibited	  µ	  Igh	  transcripts	  to	  below	  naïve	  
control	  levels	  in	  the	  non-­‐activated	  state	  and	  suppressed	  the	  enhancement	  to	  modestly	  
below	  the	  LPS	  control	  in	  the	  activated	  state.	  	  	  Therefore,	  the	  3’IghRR	  reporter	  results,	  at	  
least	  in	  the	  LPS-­‐activated	  state,	  are	  consistent	  with	  the	  effects	  on	  endogenously	  
produced	  with	  µ	  Igh	  transcripts.	  	  	  
Figure	  12:	  	  H2O2	  modulates	  µ Igh	  transcript	  levels.	  
CH12IκBαAA	  cells	  were	  treated	  with	  40	  or	  100	  µM	  H2O2	  activated	  (B)	  with	  1.0	  µg/mL	  
LPS	  or	  remained	  non-­‐activated	  (A)	  and	  incubated	  for	  48	  hr.	  	  	  The	  cells	  were	  harvested	  
for	  total	  RNA,	  which	  was	  reverse	  transcribed	  into	  a	  cDNA	  library,	  and	  relative	  levels	  µ	  
Igh	  cDNA	  were	  determined	  via	  sybr-­‐green	  real-­‐time	  PCR	  utilizing	  β-­‐actin	  as	  a	  reference	  
gene.	  	  The	  results	  are	  displayed	  as	  Relative	  Quantification	  values	  (RQ	  values)	  derived	  by	  
the	  Pfaffl	  method	  equation	  RQ=2
-­‐ΔΔCt
.	  Statistically	  significant	  differences	  relative	  to	  the	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respective	  naïve	  (A)	  or	  LPS	  (B)	  control	  were	  determined	  via	  a	  1-­‐way	  ANOVA	  with	  a	  









The	  disparity	  in	  effect	  of	  the	  40	  µM	  H2O2	  treatment	  on	  the	  non-­‐activated	  cells	  
between	  the	  µ	  Igh	  (no	  enhancement,	  figure	  12A)	  and	  Vh-­‐3’IghRR-­‐Luc	  (2-­‐fold	  
enhancement,	  figure	  7A)	  suggests	  that	  there	  is	  a	  low-­‐level	  enhancing	  effect	  in	  the	  non-­‐
activated	  cells	  that	  is	  not	  robust	  enough	  to	  affect	  wild-­‐type	  Igh	  expression	  but	  can	  
enhance	  the	  3’IghRR	  in	  the	  context	  of	  a	  transiently	  expressed	  reporter.	  	  The	  context	  of	  
the	  3’IghRR	  may	  play	  a	  role	  in	  this	  issue.	  	  For	  example,	  there	  is	  likely	  more	  copies/cell	  of	  
the	  transient	  reporter	  plasmids	  than	  the	  2	  endogenous	  loci.	  	  The	  more	  transient	  copies	  
there	  are	  in	  the	  cell,	  the	  greater	  the	  likelihood	  they	  could	  be	  targeted	  by	  low	  level	  of	  


























































intervening	  sequences	  in	  the	  reporter	  (e.g.	  V,D,J,	  Eµ	  or	  heavy	  chain	  coding	  sequences)	  
places	  the	  3’IghRR	  closer	  in	  proximity	  to	  the	  promoter	  and	  could	  provide	  for	  a	  more	  
sensitive	  context	  for	  activation/enhancement.	  This	  might	  explain	  the	  15	  fold	  activation	  
of	  the	  Vh-­‐3’IghRR-­‐Luc	  versus	  the	  2-­‐fold	  activation	  of	  µ	  Igh	  by	  LPS.	  	  Furthermore,	  despite	  
the	  lack	  of	  enhancement	  of	  the	  non-­‐activated	  µ	  Igh,	  the	  H2O2-­‐enhancement	  of	  the	  Vh-­‐
3’IghRR-­‐Luc	  in	  the	  non-­‐activated	  cells	  may	  be	  a	  relevant	  result.	  	  The	  existence	  of	  
naturally	  occurring	  human	  Igh	  alleles	  that	  have	  polymorphisms	  in	  the	  hs1,2	  of	  the	  
3’IghRR	  containing	  up	  to	  4	  repeats	  of	  an	  invariant	  sequence	  that	  harbors	  a	  κB	  consensus	  
binding	  site	  along	  with	  many	  other	  transcription	  factor	  bindings	  sites,	  could	  be	  a	  more	  
sensitive	  target	  for	  ROI-­‐induced	  NFκB/Rel	  in	  the	  non-­‐activated	  state	  (Denizot	  et	  al.,	  
2001).	  	  Furthermore,	  there	  are	  chromosomal	  translocations	  associated	  with	  the	  
initiation	  and	  progression	  of	  cancers	  that	  ligate	  the	  3’IghRR	  with	  proto-­‐oncogenes,	  
which	  deregulates	  their	  expression.	  	  	  Some	  of	  these	  translocations	  lack	  the	  
aforementioned	  intervening	  Igh	  sequences	  placing	  the	  3’IghRR	  proximal	  to	  the	  proto-­‐
oncogene,	  which	  could	  provide	  a	  H2O2-­‐sensitive	  context	  that	  responds	  similarly	  to	  the	  
Vh-­‐Luc-­‐3’IghRR	  reporter	  (Busch	  et	  al.,	  2007).	  	  	  While	  these	  ideas	  are	  speculative,	  they	  
point	  toward	  an	  interesting	  horizon	  of	  future	  research	  aimed	  at	  understanding	  how	  
different	  alleles	  and	  contexts	  of	  the	  3’IghRR	  might	  respond	  to	  ROI.	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Specific	  aim	  2:	  determine	  if	  the	  inhibition	  of	  activation-­‐induced	  enzymatic	  ROI	  
production	  concomitantly	  inhibits	  NFκB/Rel	  activity	  and	  Ig	  expression	  via	  effects	  on	  
3’IghRR	  activity.	  
Rationale:	  SA2	  
	   Antigen-­‐mediated	  B-­‐cell	  activation	  is	  a	  critical	  event	  that	  triggers	  B-­‐cell	  function	  
in	  the	  adaptive	  immune	  response.	  	  B-­‐cell	  activation	  induces	  a	  transient	  increase	  in	  ROI	  
which	  involves	  the	  induction	  of	  enzymatic	  sources	  of	  ROI	  such	  as	  NADPH	  oxidase	  (Nox2	  
isoform)	  and	  ROI	  leakage	  from	  complex	  I	  of	  the	  mitochondrial	  electron	  transport	  chain	  
(ETC);	  this	  activation-­‐induced	  ROI	  is	  required	  for	  optimal	  Ig	  secretion	  (Vené	  et	  al.,	  2010;	  
Wheeler	  &	  DeFranco,	  2012).	  Vene	  et	  al	  found	  that	  the	  treatment	  of	  LPS-­‐activated	  B	  
lymphocytes	  with	  diphenyliodonium	  (DPI),	  a	  well	  characterized	  inhibitor	  of	  ROI	  
production,	  inhibits	  hallmark	  endpoints	  of	  B	  cell	  activation	  such	  as	  Ig	  secretion	  (Vené	  et	  
al.,	  2010).	  	  DPI	  is	  a	  flavin	  binding	  compound	  that	  inhibits	  enzymatic	  ROI	  production	  by	  
directly	  inhibiting	  the	  NADPH	  Oxidase	  and	  complex	  I	  of	  the	  ETC	  making	  it	  a	  useful	  tool	  
for	  analyzing	  the	  role	  of	  endogenously	  produced	  ROI	  in	  B	  cell	  activation	  (Ellis	  et	  al.,	  
1988;	  Lambert	  et	  al.,	  2008).	  
	   There	  are	  multiple	  points	  of	  redox	  regulation	  in	  the	  process	  leading	  from	  
antigen/receptor	  ligation	  to	  Ig	  secretion.	  	  Redox	  regulation	  can	  influence	  the	  
transmission	  of	  a	  signal	  that	  targets	  and	  activates	  the	  Ig	  genes	  or	  it	  can	  influence	  the	  
translation,	  packaging	  and	  secretion	  of	  the	  antibody	  (Masciarelli	  &	  Sitia,	  2008;	  Bertolotti	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et	  al.,	  2012).	  	  While	  it	  is	  known	  that	  inhibition	  of	  activation-­‐induced	  ROI	  producing	  
enzymes	  by	  DPI	  can	  inhibit	  Ig	  production,	  it	  is	  not	  known	  whether	  activation	  induced	  
ROI	  is	  influencing	  the	  transcriptional	  or	  the	  translational	  arms	  of	  antibody	  production	  or	  
both.	  	  Subsequently,	  this	  study	  was	  aimed	  at	  exploring	  the	  effects	  of	  activation-­‐induced	  
ROI	  on	  Ig	  related	  transcriptional	  activity	  via	  the	  3’IghRR.	  	  Furthermore,	  while	  we	  have	  
shown	  LPS	  can	  activate	  3’IghRR	  activity	  in	  an	  NFκB/Rel	  dependent	  manner,	  and	  that	  
exogenous	  ROI	  can	  enhance	  LPS-­‐induced	  NFκB/Rel	  activity	  in	  B	  lymphocytes,	  the	  effects	  
of	  activation-­‐induced	  endogenous	  ROI	  on	  NFκB/Rel	  activity	  on	  a	  B	  lymphocyte	  
population	  remains	  to	  be	  determined	  (Romer	  &	  Sulentic,	  2011).	  	  There	  is	  reason	  to	  
suspect	  that	  endogenous	  ROI	  promotes	  NFκB	  Rel	  activity	  as	  DPI	  and	  other	  antioxidants	  
inhibit	  NFκB/Rel	  activity	  in	  other	  cell	  types.	  (Mendes	  et	  al.,	  2001;	  Cárcamo	  et	  al.,	  2002;	  
Souvannavong	  et	  al.,	  2007).	  Therefore	  by	  utilizing	  DPI	  as	  a	  tool	  to	  inhibit	  activation-­‐
induced	  ROI,	  specific	  aim	  2	  is	  designed	  to	  determine	  if	  the	  exposure	  of	  activated	  B	  
Lymphocytes	  to	  DPI	  concomitantly	  inhibits	  NFκB/Rel	  activity	  and	  Ig	  expression	  via	  
effects	  on	  3’IghRR	  activity.	  	  These	  end-­‐points	  are	  important	  for	  understanding	  how	  
endogenous	  ROI	  supports	  B	  lymphocyte	  activation	  and	  ultimately	  Igh	  transcriptional	  
activity.	  Further	  defining	  the	  mechanistic	  elements	  of	  activation-­‐induced	  Ig	  expression	  
may	  help	  in	  the	  development	  of	  targeted	  therapies	  for	  immunodeficiency	  as	  well	  as	  
inappropriate	  activation	  (e.g.	  autoimmunity).	  
Results:	  SA2	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DPI	  treatment	  inhibits	  LPS-­‐induced	  3’IghRR	  activity.	  
	   To	  evaluate	  the	  effect	  of	  the	  inhibition	  of	  endogenous	  ROI	  production	  on	  LPS–
activated	  3’IghRR	  activity,	  B	  lymphocytes	  transiently	  transfected	  with	  the	  Vh-­‐Luc-­‐3’IghRR	  
or	  Vh-­‐Luc	  (control)	  were	  pre-­‐treated	  with	  DPI	  for	  1.5	  hr	  and	  then	  activated	  with	  LPS.	  	  DPI	  
treatment	  decreased	  LPS-­‐activated	  transcriptional	  activity	  of	  the	  Vh-­‐Luc-­‐3’IghRR	  
reporter	  plasmid,	  but	  no	  significant	  changes	  were	  observed	  in	  the	  Vh-­‐Luc	  reporter	  
activity	  (figure	  13B	  &	  A	  respectively),	  indicating	  that	  the	  inhibitory	  effect	  of	  DPI	  is	  
influencing	  the	  3’IghRR	  activity	  and	  not	  the	  Vh-­‐promoter	  alone.	  	  	  
Figure	  13:	  DPI	  treatment	  inhibits	  activation-­‐induced	  3’IghRR-­‐regulated	  Vh-­‐promoter	  
transcriptional	  activity.	  
CH12.LX	  cells	  were	  transiently	  transfected	  with	  a	  Vh-­‐Luc	  (A)	  or	  Vh-­‐3’IghRR-­‐Luc	  (B)	  
luciferase	  reporter	  plasmids	  (see	  figure	  2B),	  and	  either	  not	  treated	  (naïve)	  or	  pre-­‐
treated	  with	  500	  µM	  Diphenyliodonium	  (DPI)	  for	  1.5	  hours.	  	  The	  cells	  were	  either	  not	  
activated	  (naïve)	  or	  activated	  with	  1.0	  µg/mL	  LPS,	  plated	  in	  triplicate,	  incubated	  for	  48	  
hr,	  and	  finally	  harvested	  for	  whole	  cell	  protein	  lysates.	  	  The	  equal	  volumes	  of	  the	  lysates	  
were	  assayed	  for	  luciferase	  activity,	  and	  results	  are	  reported	  as	  relative	  light	  units.	  
Statistically	  significant	  differences	  relative	  to	  the	  respective	  naïve	  or	  LPS-­‐alone	  control	  
were	  determined	  via	  a	  1-­‐way	  ANOVA	  with	  a	  Dunnett	  ’	  s	  post-­‐hoc	  test;	  *	  p<0.05,	  n=3.	  





These	  results	  were	  further	  substantiated	  by	  evaluating	  the	  transcriptional	  
activity	  of	  a	  stably	  integrated	  transgene	  reporter	  that	  links	  a	  Vh-­‐promoter	  with	  the	  
3’IghRR	  driving	  the	  expression	  of	  an	  γ2b	  coding	  sequence,	  which	  allows	  for	  the	  
evaluation	  of	  3’IghRR	  activity	  within	  the	  context	  of	  genomic	  DNA.	  	  DPI	  significantly	  
inhibited	  LPS-­‐activated	  γ2b	  production	  by	  77%	  which	  is	  nearly	  identical	  to	  the	  79%	  
inhibition	  of	  Vh-­‐Luc-­‐3’IghRR	  reporter	  plasmid	  (figure	  14A).	  	  	  This	  cell	  line	  also	  
endogenously	  expresses	  IgA	  and	  DPI	  similarly	  inhibited	  the	  LPS-­‐activated	  production	  of	  
IgA	  as	  assayed	  by	  ELISA	  analysis	  of	  whole	  cell	  protein	  lysates	  (figure	  14B).	  	  By	  measuring	  
IgA	  in	  the	  whole	  cell	  lysates	  instead	  of	  secreted	  IgA	  in	  the	  media,	  it	  can	  be	  reasonably	  
speculated	  that	  any	  of	  the	  DPI-­‐mediated	  effects	  observed	  on	  IgA	  production	  likely	  
involves	  the	  transcriptional	  arm	  of	  Ig	  production	  rather	  than	  secretion.	  However,	  	  it	  is	  
















inhibition	  of	  IgA	  expression	  and	  3’IghRR-­‐activation	  by	  DPI	  treatment	  support	  the	  
hypothesis	  that	  low	  level	  ROI	  enzymatically	  produced	  during	  activation	  enhance	  Ig	  
expression	  via	  3’IghRR-­‐regulated	  transcriptional	  activity.	  	  
Figure	  14:	  	  DPI	  treatment	  inhibits	  activation-­‐induced	  3’IghRR-­‐regulated	  activity	  and	  
IgA	  expression.	  
CH12.LX	  cells	  containing	  a	  stable	  transgene	  designed	  to	  have	  the	  3’IghRR	  and	  variable	  Ig	  
promoter	  regulate	  the	  expression	  an	  IgG2b	  transgene	  (see	  materials	  and	  methods)	  were	  
either	  not	  treated	  (naïve)	  or	  pre-­‐treated	  with	  500	  µM	  Diphenyliodonium	  (DPI)	  for	  1.5	  hr.	  	  
The	  cells	  were	  either	  not	  activated	  (naïve)	  or	  activated	  with	  0.1	  µg/mL	  LPS,	  plated	  in	  
triplicate,	  incubated	  for	  48	  hr,	  and	  finally	  harvested	  for	  whole	  cell	  protein	  lysates.	  	  Equal	  
amounts	  of	  total	  protein	  from	  the	  lysate	  were	  assayed	  via	  sandwich	  ELISA	  method	  to	  
evaluate	  γ2b	  expression	  derived	  from	  the	  transgene	  (A)	  or	  to	  evaluate	  IgA	  protein	  
expression	  (B)	  derived	  from	  the	  wild	  type	  Igh	  allele.	  Results	  are	  reported	  as	  ng	  Ig/µg	  of	  
total	  protein.	  Statistically	  significant	  differences	  relative	  to	  the	  respective	  naïve	  or	  LPS-­‐
alone	  control	  were	  determined	  via	  a	  1-­‐way	  ANOVA	  with	  a	  Dunnett	  ’	  s	  post-­‐hoc	  test;	  *	  





DPI	  treatment	  inhibits	  LPS-­‐induced	  NFκB/Rel	  activity.	  
	   It	  was	  observed	  that	  pre-­‐treatment	  with	  DPI	  results	  in	  a	  significant	  decrease	  in	  
the	  LPS-­‐activated	  3x-­‐NFκB-­‐Luc	  reporter	  expression	  (figure	  15),	  suggesting	  that	  LPS-­‐
induced	  NFκB/Rel-­‐mediated	  transcriptional	  activity	  is	  disrupted	  by	  DPI	  treatment.	  	  
Nuclear	  translocation	  of	  p65/RelA	  is	  the	  canonical	  response	  to	  LPS	  activation	  in	  B	  
lymphocytes,	  and	  ROI	  has	  been	  found	  to	  influence	  NFκB/Rel	  signal	  transduction	  
upstream	  of	  p65/RelA	  nuclear	  translocation,	  therefore	  the	  effect	  of	  DPI	  treatment	  on	  
p65/RelA	  nuclear	  translocation	  was	  assessed	  (Lee	  &	  Koh,	  2003;	  Storz	  &	  Toker,	  2003;	  
Lawrence	  et	  al.,	  2005;	  Gloire	  et	  al.,	  2006a;	  Gloire	  et	  al.,	  2006b;	  Souvannavong	  et	  al.,	  
2007).	  The	  mean	  band	  intensity	  analysis	  of	  2	  separate	  experiments	  revealed	  that	  DPI	  
treatment	  decreased	  the	  levels	  of	  p65/RelA	  in	  the	  nuclear	  protein	  fraction	  relative	  to	  




















48	  hr	  (figure	  16A	  and	  B).	  This	  result	  indicates	  that	  the	  inhibition	  of	  activation-­‐induced	  
ROI-­‐production	  disrupts	  the	  early-­‐event	  (1.5	  hr)	  of	  p65/RelA	  nuclear	  translocation,	  a	  
hallmark	  of	  activation-­‐induced	  NFκB/Rel	  activation.	  
Figure	  15:	  	  DPI	  treatment	  inhibits	  activation-­‐induced	  NFκB/Rel	  transcriptional	  activity.	  
CH12.LX	  cells	  were	  transiently	  transfected	  with	  a	  3x-­‐NFκB-­‐Luc	  luciferase	  reporter	  
plasmid	  (see	  figure	  5B),	  and	  either	  not	  treated	  (naïve)	  or	  pre-­‐treated	  with	  500	  µM	  DPI	  
for	  1.5	  hours.	  	  The	  cells	  were	  then	  either	  not	  activated	  (naïve)	  or	  activated	  with	  0.1	  
µg/mL	  LPS,	  plated	  in	  triplicate,	  incubated	  for	  48	  hr,	  and	  finally	  harvested	  for	  whole	  cell	  
protein	  lysates.	  	  The	  equal	  volumes	  of	  the	  lysates	  were	  assayed	  for	  luciferase	  activity,	  
and	  results	  are	  reported	  as	  relative	  light	  units.	  Statistically	  significant	  differences	  
relative	  to	  the	  respective	  naïve	  or	  LPS-­‐alone	  control	  were	  determined	  via	  a	  1-­‐way	  










Figure	  16:	  DPI	  inhibits	  LPS-­‐mediated	  p65/RelA	  nuclear	  localization	  at	  1.5	  hours.	  
CH12.LX	  cells	  were	  either	  not	  treated	  (naïve)	  or	  pre-­‐treated	  with	  500	  µM	  
Diphenyliodonium	  (DPI)	  for	  1.5	  hour.	  	  The	  cells	  were	  then	  either	  not	  activated	  (naïve)	  or	  
activated	  with	  0.1	  µg/mL	  LPS,	  plated	  in	  triplicate,	  incubated	  for	  1.5	  hr	  (A)	  or	  48	  hr	  (B),	  
and	  then	  subjected	  to	  nuclear	  and	  cytoplasmic	  protein	  fractionation.	  	  Equal	  amounts	  of	  
total	  protein	  for	  both	  fractions	  were	  separated	  by	  SDS/PAGE	  and	  subjected	  to	  western	  
blotting	  with	  an	  antibody	  specific	  for	  p65/RelA.	  	  The	  integrity	  of	  the	  nuclear	  and	  
cytoplasmic	  fractions	  were	  determined	  by	  probing	  for	  a	  proteins	  known	  to	  reside	  























	   Additionally,	  DPI	  inhibited	  the	  LPS-­‐induced	  3x-­‐NFκB-­‐Luc	  activity	  by	  40%,	  which	  is	  
similar	  to	  the	  36%	  decrease	  in	  nuclear	  p65/RelA,	  but	  markedly	  less	  than	  the	  75-­‐80%	  
inhibition	  of	  3’IghRR	  reporter	  activity.	  	  This	  disparity	  in	  inhibition	  suggests	  that	  the	  
effects	  of	  DPI	  on	  3’IghRR	  activity	  may	  involve	  effects	  on	  other	  pathways	  in	  addition	  to	  
the	  NFκB/Rel	  pathway.	  	  One	  possibility	  might	  involve	  the	  AP1	  transcription	  factor	  
family,	  which	  can	  associate	  with	  the	  3’IghRR,	  and	  has	  been	  found	  to	  be	  activated	  by	  LPS	  
and	  endogenously	  produced	  ROI	  (Grant	  et	  al.,	  1995;	  Krappmann	  et	  al.,	  2004;	  Son	  et	  al.,	  
2009).	  	  
	   	  None-­‐the-­‐less,	  NFκB/Rel	  activity	  is	  required	  for	  LPS-­‐mediated	  3’IghRR	  activity	  
and	  IgM	  secretion	  as	  they	  both	  can	  be	  inhibited	  by	  the	  constitutive	  inhibition	  of	  
NFκB/Rel	  activity	  via	  IκBαAA	  (Hsing	  &	  Bishop,	  1999;	  Romer	  &	  Sulentic,	  2011).	  	  








and	  NFκB/Rel	  activity	  by	  DPI	  indicates	  that	  disrupting	  activation-­‐induced	  ROI-­‐production	  
inhibits	  3’IghRR-­‐activity	  in	  a	  manner	  that,	  at	  least	  in	  part,	  involves	  inhibition	  of	  NFκB/Rel	  
pathway.	  
Specific	  aim	  3	  determines	  if	  H2O2	  induces	  caspase	  activity	  that	  suppresses	  NFκB/Rel	  
activity	  and	  induces	  cleavage	  of	  IκBα	  and	  p65/RelA	  in	  B	  lymphocytes.	  
Rationale:	  SA3	  
	   Caspase	  activation	  is	  an	  integral	  part	  of	  a	  cell	  death	  system	  designed	  to	  shut	  
down	  the	  cell	  in	  an	  ordered	  manner.	  	  	  This	  is	  critical	  in	  cells	  such	  as	  B	  lymphocytes	  that	  
generate	  and	  harbor	  a	  variety	  of	  intercellular	  signaling	  factors	  and	  other	  proteins	  (e.g.	  
cytokines,	  Ig)	  that	  if	  released	  in	  an	  uncontrolled	  manner	  could	  result	  in	  harmful	  systemic	  
effects.	  	  	  Caspase	  activation	  can	  be	  triggered	  by	  extrinsic	  or	  intrinsic	  (i.e.	  mitochondrial	  
cell	  death)	  stimuli.	  	  Intrinsic	  stimuli	  such	  as	  H2O2-­‐mediated	  oxidative	  stress	  leads	  to	  
mitochondrial	  outer	  membrane	  permeability	  and	  cytochrome	  c	  release	  that	  initiates	  	  
caspase	  activity;	  this	  is	  a	  prevalent	  form	  of	  cell	  death	  in	  B	  lymphocytes	  (see	  background	  
pp	  25-­‐28)	  (Hampton	  &	  Orrenius,	  1997;	  Chen	  et	  al.,	  1998;	  Bouchon	  et	  al.,	  2000).	  	  The	  
diversity	  and	  expanse	  of	  identified	  caspase	  targets	  has	  burgeoned	  to	  hundreds	  of	  
proteins	  in	  recent	  years	  including	  proteins	  involved	  in	  scaffolding,	  transcription,	  cell	  
adhesion,	  and	  cell	  cycle,	  suggesting	  that	  caspase	  activation	  can	  function	  not	  merely	  as	  a	  
specific	  trigger	  for	  cells	  to	  die	  but	  as	  an	  integral	  part	  of	  a	  complex	  system	  of	  ordered	  cell	  
death	  (Figure	  17)	  (Fischer	  et	  al.,	  2003).	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Figure	  	  17:	  	  Mechanism	  of	  H2O2-­‐induced	  mitochondrial	  cell	  death.	  
The	  schematic	  represents	  H2O2-­‐mediated	  cell	  death.	  	  Exogenous	  H2O2	  (black	  stars)	  
exposure	  induces	  the	  extrusion	  of	  cytochrome	  c	  from	  the	  mitochondrial	  intermembrane	  
space	  into	  the	  cytoplasm.	  	  Cytochrome	  c	  interacts	  with	  caspase	  9	  and	  Apaf-­‐1	  subunits	  to	  
form	  a	  heteromeric	  apoptosome,	  which	  then	  catalytically	  cleaves	  effector	  caspases	  (e.g.	  
caspase	  3,	  7).	  	  Activated	  effector	  caspases	  target	  and	  cleave	  cellular	  substrates	  act	  
aspartic	  acid	  containing	  caspase	  consensus	  sequences.	  Caspase	  substrates	  include	  a	  
wide	  variety	  of	  cellular	  proteins	  such	  as	  those	  involved	  in	  transcription	  (e.g.	  IκBα	  and	  
p65),	  cytoplasmic	  and	  nuclear	  scaffolding,	  cellular	  adhesion,	  and	  cell	  cycle	  regulation	  
(Fischer	  et	  al.,	  2003).	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   Caspase	  cleavage	  promotes	  cell	  death	  by	  facilitating	  the	  activation	  of	  pro-­‐death	  
pathways	  in	  a	  manner	  that	  involves	  overcoming	  a	  viability	  threshold	  maintained	  by	  
many	  pathways	  such	  as	  pro-­‐survival,	  growth,	  and	  anti-­‐oxidant	  pathways.	  	  The	  viability	  
threshold	  is	  maintained	  by	  many	  proteins	  such	  as	  IAPs	  (inhibitor	  of	  apoptosis	  proteins),	  
which	  directly	  inhibit	  caspase-­‐3;	  or	  the	  bcl-­‐2	  family	  proteins	  (e.g.	  bcl-­‐2,	  bcl-­‐xL,	  bfl-­‐1),	  
which	  oppose	  mitochondrial	  outer	  membrane	  permeability	  (Deveraux	  et	  al.,	  1999;	  Scott	  
et	  al.,	  2005;	  Xu	  &	  Shi,	  2007).	  	  The	  inhibition	  or	  suppression	  of	  pro-­‐survival	  pathways	  can	  
foster	  a	  permissive	  environment	  for	  cell	  death	  to	  proceed,	  which	  can	  be	  achieved	  by	  
























instance,	  XIAP	  expression	  in	  DLBCL	  correlates	  with	  a	  poor	  prognosis,	  suggesting	  it	  could	  
be	  involved	  in	  chemoresistance	  (Muris	  et	  al.,	  2005).	  	  	  Treatment	  of	  B	  lymphocytes	  from	  
chemoresistant	  and	  chemosensitive	  DLBCL	  patients	  with	  an	  XIAP	  inhibitor	  significantly	  
induced	  cell	  death	  (Cillessen	  et	  al.,	  2008).	  	  This	  suggests	  that	  the	  expression	  and	  
function	  of	  XIAP	  can	  impact	  the	  viability	  of	  DLBCL	  cells	  and	  subsequently,	  patient	  
prognosis.	  Furthermore,	  in	  BCR-­‐mediated	  cell	  death	  of	  B	  lymphocytes,	  bcl-­‐xL	  expression	  
is	  initially	  enhanced,	  perhaps	  to	  acutely	  sustain	  viability	  and	  avoid	  aberrant	  cell	  death.	  	  
The	  enhancement	  is	  eventually	  repressed	  lowering	  the	  level	  of	  bcl-­‐xL	  expression,	  while	  
pro-­‐death	  signals	  sustain	  and	  allow	  the	  cell	  to	  surpass	  the	  viability	  threshold	  and	  initiate	  
cell	  death.	  Interestingly,	  co-­‐treatment	  of	  BCR-­‐activated	  cells	  	  with	  a	  mitogen	  (i.e.	  
unmethylated	  CpG)	  enhances	  bcl-­‐xL	  expression	  in	  a	  sustained	  fashion	  that	  protects	  
against	  cell	  death	  (Yi	  et	  al.,	  1996).	  	  Another	  study	  demonstrated	  that	  BCR-­‐mediated	  cell	  
death	  induces	  high	  levels	  of	  ROI	  that	  correlated	  with	  decreased	  Bcl-­‐xL	  expression,	  and	  
treatment	  with	  an	  anti-­‐oxidant	  prevented	  cell	  death	  and	  restored	  Bcl-­‐xL	  expression	  
indicating	  that	  ROI	  levels	  influence	  Bcl-­‐xL	  expression	  (Hamano	  et	  al.,	  2002).	  These	  
studies	  suggest	  that	  expression	  level	  of	  pro-­‐survival	  proteins	  relative	  to	  the	  strength	  of	  a	  
ROI-­‐dependent	  pro-­‐death	  signal	  is	  a	  critical	  checkpoint	  in	  the	  progression	  of	  
programmatic	  cell	  death,	  and	  leads	  to	  the	  question	  of	  how	  the	  expression	  levels	  of	  
these	  proteins	  are	  regulated.	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   The	  NFκB/Rel	  pathway	  is	  involved	  in	  transcriptionally	  driving	  the	  expression	  of	  
many	  pro-­‐survival,	  pro-­‐growth,	  and	  antioxidant	  genes	  such	  as	  Bcl2,	  Bcl-­‐xL,	  Bfl-­‐1/A1,	  
XIAP,	  c-­‐IAP1,	  c-­‐IAP2,	  DcR1,	  FBX10,	  cFLIP,	  A20,	  MnSOD,	  FHC,	  cyclin	  D2,	  and	  IRF4	  that	  help	  
foster	  viability	  (Davis	  et	  al.,	  2001;	  Fan	  et	  al.,	  2008;	  Baldwin,	  2012).	  There	  are	  confirmed	  
κB	  binding	  sites	  within	  the	  promoters	  of	  the	  XIAP	  and	  Bcl-­‐2	  family	  proteins	  (i.e.	  bcl-­‐2,	  
bcl-­‐xL,	  bfl-­‐1)	  (Dong	  et	  al.,	  2002;	  Viatour	  et	  al.,	  2003;	  Rosato	  et	  al.,	  2007;	  Loughran	  et	  al.,	  
2011).	  	  XIAP	  expression	  can	  be	  inhibited	  by	  decreased	  p65/RelA	  binding	  to	  a	  putative	  κB	  
site	  within	  its	  promoter	  in	  response	  to	  the	  exposure	  of	  a	  leukemic	  cell	  line	  to	  the	  
oxidative	  stress	  inducing	  agents	  flavopiridol/vorinostat	  (Rosato	  et	  al.,	  2007).	  	  Bcl-­‐xL	  
expression	  can	  be	  inhibited	  by	  the	  expression	  of	  ΔN-­‐IκBα,	  a	  constitutive	  inhibitor	  of	  
NFκB/Rel	  that	  is	  a	  form	  of	  IκBα	  lacking	  the	  regulatory	  N-­‐terminal	  domain.	  	  The	  loss	  of	  
the	  N-­‐terminus	  renders	  it	  resistant	  to	  phosphorylation-­‐induced	  destabilization	  that	  is	  
required	  for	  NFκB/Rel	  activity	  (Chen	  et	  al.,	  2000).	  Furthermore,	  treatment	  with	  
unmethylated	  CpG,	  a	  known	  activator	  of	  the	  NFκB/Rel	  pathway,	  prevented	  both	  BCR-­‐
mediated	  cell	  death	  and	  the	  inhibition	  of	  bcl-­‐xL	  expression	  (Yi	  et	  al.,	  1996).	  	  These	  data	  
provide	  insight	  into	  how	  NFκB/Rel	  activity	  can	  regulate	  pro-­‐survival	  genes	  that	  impact	  
cellular	  viability.	  	  The	  mechanisms	  by	  which	  ROI	  can	  inhibit	  NFκB/Rel	  transactivation	  of	  
pro-­‐survival	  genes,	  however,	  are	  not	  fully	  understood.	  
	   Chen	  et	  al,	  utilized	  the	  ΔN-­‐IκBα	  (mentioned	  above)	  as	  a	  tool	  to	  inhibit	  pro-­‐
survival	  gene	  expression,	  but	  the	  deletion	  of	  the	  N-­‐terminus	  of	  IκBα	  was	  originally	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discovered	  to	  be	  a	  caspase-­‐mediated	  (caspase-­‐3)	  cleavage	  product	  of	  IκBα	  that	  could	  be	  
formed	  in	  vivo	  in	  response	  to	  cellular	  stresses	  as	  was	  previously	  discussed	  (page	  28-­‐29	  
of	  background	  for	  review	  of	  caspase	  cleavage	  of	  NFκB/Rel	  family)	  (Barkett	  et	  al.,	  1997;	  
Reuther	  &	  Baldwin,	  1999;	  Chen	  et	  al.,	  2000;	  Kim	  et	  al.,	  2002;	  Baxa	  &	  Yoshimura,	  2003).	  	  
Similarly,	  caspase-­‐mediated	  cleavage	  of	  the	  NFκB/Rel	  protein,	  p65/RelA,	  has	  been	  
found	  to	  result	  in	  N	  and	  C-­‐terminal	  cleavage	  products	  (Ravi	  et	  al.,	  1998;	  Levkau	  et	  al.,	  
1999;	  Kim,	  2005).	  	  The	  cleavage	  of	  the	  p65/RelA	  and	  IκBα	  are	  associated	  with	  cell	  death	  
and	  the	  over-­‐expression	  of	  ΔN-­‐IκBα	  was	  found	  to	  sensitize	  cells	  to	  TNFα-­‐mediated	  cell	  
death.	  Furthermore,	  the	  ΔN-­‐IκBα	  and	  the	  N-­‐terminal	  and	  C-­‐terminal	  cleavage	  products	  
of	  p65/RelA	  were	  found	  to	  inhibit	  NFκB/Rel	  transcriptional	  activity	  (Reuther	  &	  Baldwin,	  
1999;	  Levkau	  et	  al.,	  1999;	  Kim,	  2005).	  	  These	  studies	  suggest	  that	  caspase-­‐mediated	  
cleavage	  of	  NFκB/Rel	  family	  proteins	  (i.e.	  IκBα	  and	  p65/RelA)	  inhibit	  NFκB/Rel	  
transcriptional	  activity	  in	  response	  to	  cell	  stress/death	  stimuli	  and	  permit	  or	  facilitate	  
cell	  death.	  	  Furthermore,	  in	  addition	  to	  H2O2	  exposure	  inducing	  caspase-­‐mediated	  cell	  
death,	  in	  B	  lymphocytes	  it	  has	  been	  shown	  to	  inhibit	  NFκB/Rel	  activity	  (Hampton	  &	  
Orrenius,	  1997;	  Liu	  et	  al.,	  2007).	  	  Therefore,	  it	  is	  reasonable	  to	  hypothesize	  that	  ROI	  can	  
induce	  caspase-­‐mediated	  cleavage	  of	  NFκB/Rel	  and	  inhibit	  this	  pathway	  in	  B	  
lymphocytes.	  	  
	   The	  role	  of	  ROI	  exposure	  in	  caspase	  cleavage	  of	  NFκB/Rel	  family	  proteins	  is	  not	  
clearly	  defined.	  It	  has	  been	  shown	  that	  cell	  death	  stimuli	  that	  induce	  caspase	  cleavage	  of	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NFκB/Rel	  family	  proteins	  such	  as	  serum	  deprivation	  (n-­‐terminal	  IκBα	  and	  c-­‐terminal	  
p65/RelA	  cleavage)	  the	  extrinsic	  cell	  death	  signal	  TRAIL	  (p65/RelA	  cleavage)	  both	  induce	  
higher	  levels	  of	  intracellular	  ROI	  (Lee	  et	  al.,	  2002;	  Pandey	  et	  al.,	  2003).	  	  These	  data	  
suggest	  that	  cell	  death	  stimuli	  that	  induce	  ROI	  correlate	  with	  caspase-­‐mediated	  cleavage	  
of	  NFκB/Rel	  family	  proteins	  but	  it	  is	  not	  known	  if	  and	  how	  ROI	  alone	  can	  induce	  caspase	  
cleavage	  of	  these	  proteins.	  Furthermore,	  the	  formation	  of	  different	  p65/RelA	  	  cleavage	  
products	  (N	  or	  C	  terminal	  fragments)	  as	  a	  function	  of	  different	  stimuli	  (TRAIL	  or	  TNFα	  
induce	  n-­‐terminal,	  and	  serum	  deprivation	  or	  Fas	  induce	  c-­‐terminal	  deletions)	  opens	  the	  
possibility	  that	  ROI	  alone	  may	  induce	  a	  unique	  pattern	  of	  NFκB/Rel	  family	  protein	  
caspase	  cleavage	  	  (Ravi	  et	  al.,	  1998;	  Levkau	  et	  al.,	  1999;	  Kim,	  2005).	  	  	  
As	  discussed	  previously,	  high	  NFκB/Rel	  activity	  in	  treatment	  resistant	  DLBCL	  
(lymphoma),	  the	  existence	  of	  a	  chemoresistant	  mechanism	  downstream	  of	  caspase	  
activation,	  and	  redox-­‐mediated	  sensitization	  of	  lymphoma	  cells	  involving	  caspase	  
activation	  (see	  background	  pp.	  28-­‐30	  and	  significance	  and	  central	  hypothesis	  pp.	  32,34-­‐
25)	  suggest	  that	  the	  NFκB/Rel	  pathway,	  caspase	  activity,	  and	  ROI	  are	  relevant	  factors	  
influencing	  B	  lymphocyte	  cell	  death,	  especially	  in	  lymphoma	  (Goldfeld	  et	  al.,	  1991;	  Davis	  
et	  al.,	  2001;	  Hirokawa	  et	  al.,	  2002;	  Friesen	  et	  al.,	  2004;	  Tsai	  et	  al.,	  2007;	  Pavan	  et	  al.,	  
2008)	  .	  The	  capacity	  of	  ROI	  to	  induce	  caspases	  and	  disable	  the	  NFκB/Rel	  pathway	  could	  
be	  an	  exploitable	  mechanism	  targeted	  by	  treatment	  regimens	  for	  these	  lymphomas.	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   Our	  laboratory	  has	  demonstrated	  that	  exposure	  of	  a	  mouse	  B-­‐cell	  lymphoma	  cell	  
line	  to	  high	  levels	  of	  ROI	  (100-­‐200	  µM	  H2O2)	  can	  result	  in	  the	  detection	  of	  a	  novel	  anti-­‐
IκBα	  immunoreactive	  band	  that	  migrates	  faster	  (≈	  18-­‐19	  kDa)	  than	  the	  full-­‐length	  IκBα	  
(37	  kDa)	  or	  the	  ΔN-­‐IκBα	  (34	  kDa)	  via	  western	  blotting	  (Romer	  &	  Sulentic,	  2011).	  We	  
believe	  this	  may	  be	  a	  novel	  caspase-­‐mediated	  cleavage	  product	  of	  IκBα,	  distinct	  from	  
the	  ΔN-­‐IκBα	  product	  (34	  kDa)	  originally	  characterized	  by	  Barkett	  et	  al	  (Barkett	  et	  al.,	  
1997).	  	  The	  novel	  cleavage	  product	  appears	  to	  be	  considerably	  smaller	  than	  the	  ΔN-­‐
IκBα	  form	  	  indicating	  that	  more	  of	  the	  total	  protein	  was	  cleaved	  than	  in	  the	  ΔN-­‐IκBα	  
cleavage.	  	  	  Utilizing	  the	  CASVM	  server	  for	  support	  vector	  machines	  (SVM)	  prediction	  of	  
caspase	  substrates	  cleavage	  Sites	  (www.casbase.org),	  a	  sequence	  analysis	  of	  the	  full-­‐
length	  IκBα	  predicted	  multiple	  potential	  caspase	  cleavage	  sites.	  	  	  Theoretically,	  if	  it	  was	  
assumed	  that	  one	  of	  the	  cleavage	  sites	  was	  the	  putative	  Asp31-­‐containing	  site	  that	  
yielded	  the	  ΔN-­‐IκBα,	  a	  cleavage	  at	  a	  theoretical	  site	  located	  closer	  to	  the	  C-­‐terminus	  
could	  yield	  an	  ≈19.0	  kDa	  product	  that	  is	  in	  the	  general	  size	  range	  observed	  for	  the	  novel	  
IκBα	  cleavage	  product	  we	  observed	  (Wee	  et	  al.,	  2006;	  Romer	  &	  Sulentic,	  2011).	  The	  
resultant	  peptide	  would	  likely	  be	  an	  effective	  constitutive	  inhibitor	  of	  NFκB/Rel	  activity	  
like	  the	  ΔN-­‐IκBα,	  because	  it	  would	  primarily	  be	  comprised	  of	  ankyrin	  repeat	  motifs	  
involved	  in	  NFκB/Rel	  binding	  and	  sequestration	  (figure	  18).	  	  	  
Figure	  18:	  Potential	  cleavage	  site	  of	  novel	  IκBα 	  cleavage	  product.	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The	  Schematic	  represents	  the	  human	  IκBα	  protein.	  	  A	  predicted	  19	  kDa	  novel	  IκBα	  
cleavage	  product	  could	  result	  from	  cleavage	  in	  the	  n-­‐terminal	  regulatory	  domain	  at	  the	  
DHRD	  caspase-­‐3	  cleavage	  site	  ending	  on	  D31,	  span	  the	  ankyrin	  repeat	  domain,	  and	  
cleave	  at	  a	  predicted	  c-­‐terminal	  caspase	  cleavage	  site	  (LGAD)	  ending	  on	  D270.	  	  The	  c-­‐
terminal	  site	  was	  predicted	  utilizing	  the	  CASVM	  server	  for	  support	  vector	  machines	  
(SVM)	  prediction	  software	  at	  www.casbase.org	  (Wee	  et	  al.,	  2006).	  
	  
Furthermore,	  as	  p65/RelA	  is	  a	  substrate	  for	  caspase	  cleavage	  it	  is	  reasonable	  to	  
speculate	  that	  it	  might	  also	  be	  cleaved	  as	  a	  function	  of	  oxidative	  stress.	  	  Therefore,	  
Specific	  aim	  3	  determines	  if	  H2O2	  induces	  caspase	  activity	  that	  inhibits	  NFκB/Rel	  activity	  
and	  induces	  cleavage	  of	  IκBα	  and	  p65/RelA	  in	  B	  lymphocytes.	  
Results:	  SA3	  
H2O2	  induces	  the	  formation	  of	  a	  novel	  IκBα 	  caspase	  cleavage	  product.	  
	   Our	  seminal	  observation	  that	  100-­‐200	  µM	  H2O2	  induces	  a	  novel	  faster	  migrating	  
form	  of	  IκBα	  in	  a	  single	  mouse	  cell	  line	  (CH12IκBαAA)	  was	  verified	  in	  multiple	  human	  B	  
lymphocyte	  cell	  lines,	  therefore	  the	  novel	  cleavage	  product	  does	  not	  appear	  to	  be	  
species	  or	  B	  lymphocyte	  cell	  line	  specific.	  The	  Ramos,	  IM-­‐9,	  and	  Pfeiffer	  human	  B	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increasing	  concentrations	  of	  µM	  H2O2	  for	  24	  hr	  and	  the	  western	  blot	  analysis	  response	  
revealed	  that	  the	  novel	  IκBα	  cleavage	  product	  appeared	  in	  the	  100	  and	  200	  µM	  H2O2	  
treatment	  groups	  in	  all	  the	  cell	  lines	  (figure	  19).	  	  Molecular	  weight	  analysis	  revealed	  
mean	  molecular	  weight	  of	  18.82	  +/-­‐0.19	  SEM	  kDa	  	  for	  the	  novel	  IκBα	  cleavage	  product.	  
	  Figure	  19:	  	  The	  novel	  IκBα 	  cleavage	  occurs	  in	  a	  H2O2	  concentration	  dependent	  
manner	  in	  mouse	  and	  human	  B	  lymphocyte	  cell	  lines.	  	  	  
Human	  B	  lymphocyte	  cell	  lines	  (Ramos,	  IM-­‐9,	  and	  Pfieffer)	  and	  the	  murine	  CH12IκBαAA	  
cell	  line	  were	  treated	  with	  increasing	  concentrations	  of	  µM	  H2O2	  (0,	  10,	  25,	  50,	  100,	  
200)	  for	  24	  hr.	  	  Following	  the	  treatment,	  the	  cells	  were	  harvested	  for	  whole	  cell	  protein	  
lysates	  and	  equal	  amounts	  of	  total	  protein	  were	  separated	  via	  SDS/PAGE	  and	  subjected	  
to	  western	  blotting	  utilizing	  a	  polyclonal	  anti-­‐IκBα	  antibody	  (or	  β-­‐actin).	  	  Full-­‐length	  
(black	  arrow)	  and	  the	  cleaved	  form	  (grey	  arrow)	  of	  IκBα	  are	  displayed	  only	  in	  the	  Ramos	  
cells	  (A),	  while	  only	  the	  cleaved	  form	  of	  IκBα	  is	  displayed	  in	  other	  cells	  lines	  (B-­‐D).	  
Throughout	  all	  western	  blot	  figures	  the	  black	  arrows	  will	  indicate	  the	  full-­‐length	  protein	  
and	  the	  gray	  arrows	  will	  indicate	  the	  cleavage	  products.	  The	  molecular	  weight	  analysis	  
of	  the	  cleavage	  product	  was	  performed	  by	  the	  Biorad	  image	  lab	  4.1	  software	  and	  a	  
mean	  molecular	  weight	  was	  averaged	  from	  the	  analysis	  of	  western	  blots	  from	  5	  














H2O2	  treatment	  decreases	  cellular	  viability	  and	  induces	  apoptosis	  and	  caspase-­‐3	  
activation	  in	  a	  concentration-­‐dependent	  manner.	  
	   H2O2	  treatment	  of	  lymphocytes	  has	  been	  found	  to	  decrease	  cellular	  viability	  
through	  mitochondrial	  cell	  death	  (Farber	  et	  al.,	  1984;	  Hampton	  &	  Orrenius,	  1997;	  Stridh	  
et	  al.,	  1998).	  	  Ramos	  cells	  treated	  with	  increasing	  concentrations	  of	  H2O2	  exhibited	  
decreased	  cellular	  viability	  at	  24	  hr	  via	  trypan	  blue	  exclusion	  assay.	  	  The	  viability	  
decreased	  precipitously	  as	  the	  H2O2	  concentration	  reached	  the	  100	  and	  200	  µM	  
concentrations	  (figure	  20A).	  This	  decrease	  in	  viability	  appears	  to	  involve	  apoptotic	  
pathways	  as	  the	  200	  µM	  H2O2-­‐treated	  cells	  exhibited	  increased	  annexin	  V	  staining	  
(figure	  20B).	  	  Annexin	  V	  staining	  detects	  phosphatidylserine	  expressed	  on	  the	  outer	  
plasma	  membrane,	  which	  is	  an	  early	  indicator	  of	  caspase-­‐dependent	  programmed	  cell	  
death	  in	  B	  lymphocytes	  (Koopman	  et	  al.,	  1994;	  Mandal	  et	  al.,	  2002).	  	  Therefore,	  the	  
H2O2-­‐induced	  IκBα	  cleavage	  appears	  to	  correlate	  with	  decreased	  in	  cellular	  viability	  in	  a	  
concentration-­‐dependent	  manner.	  	  
Figure	  20:	  	  H2O2	  treatment	  decreases	  cellular	  viability	  and	  induces	  apoptosis.	  
(A)	  Ramos	  cells	  were	  treated	  with	  increasing	  concentrations	  of	  µM	  H2O2	  (0,	  10,	  25,	  50,	  
100,	  200)	  for	  24	  hr.	  	  Following	  the	  treatment,	  1	  mL	  of	  cell	  suspension	  was	  subjected	  to	  
trypan	  blue	  exclusion	  assay	  to	  determine	  the	  percentage	  of	  viable	  cells	  (n=3	  separate	  
experiments).	  	  (B)	  Ramos	  cells	  were	  treated	  with	  200	  µM	  H2O2	  for	  24	  hours.	  	  Following	  
the	  incubation,	  the	  cells	  were	  stained	  with	  a	  FITC-­‐conjugated	  Annexin	  V	  antibody	  as	  a	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marker	  of	  apoptotic	  cell	  death	  and	  subjected	  to	  flow	  cytometric	  analysis.	  	  10,000	  cells	  













Detection	  of	  activated	  caspase-­‐3	  has	  been	  found	  to	  be	  a	  reliable	  method	  of	  
detecting	  general	  caspase	  activation	  in	  B	  lymphocytes	  and	  caspase-­‐3	  activation	  has	  
been	  observed	  in	  T	  lymphocyte	  in	  response	  to	  H2O2-­‐mediated	  mitochondrial	  cell	  death,	  
but	  it	  has	  not	  been	  reported	  in	  the	  B	  lymphocytes	  (Hampton	  &	  Orrenius,	  1997;	  Stridh	  et	  
al.,	  1998;	  Dumont	  et	  al.,	  1999;	  Dukers	  et	  al.,	  2002;	  Kessel	  et	  al.,	  2006).	  	  Activated	  















dependent	  manner	  with	  activation	  occurring	  maximally	  at	  100	  and	  200	  µM	  H2O2	  (figure	  
21).	  	  Basal	  levels	  of	  caspase	  activation	  in	  the	  naïve	  and	  lower	  level	  H2O2	  treated	  cells	  
was	  noted,	  which	  is	  not	  surprising	  as	  B	  lymphocytes	  are	  known	  for	  spontaneous	  cell	  
death	  and	  routine	  viability	  assessments	  of	  our	  cultured	  B-­‐cell	  lines	  consistently	  indicates	  
that	  5-­‐20%	  of	  cells	  in	  culture	  are	  not	  viable	  (Kessel	  et	  al.,	  2006).	  	  These	  data	  suggest	  that	  
the	  formation	  of	  the	  novel	  IκBα	  cleavage	  product	  appeared	  to	  correlate	  with	  the	  H2O2	  
concentration-­‐dependent	  effects	  on	  viability	  and	  caspase	  activation.	  
Figure	  21:	  H2O2	  treatment	  induces	  Caspase-­‐3	  activation	  in	  a	  concentration	  dependent	  
manner.	  
Ramos	  cells	  were	  treated	  with	  increasing	  concentrations	  of	  µM	  H2O2	  (0,	  10,	  25,	  50,	  100,	  
200)	  for	  24	  hr.	  	  Following	  the	  treatment,	  the	  cells	  were	  harvested	  for	  whole	  cell	  protein	  
lysates	  and	  equal	  amounts	  of	  total	  protein	  were	  separated	  via	  SDS/PAGE	  and	  subjected	  
to	  western	  blotting	  utilizing	  a	  polyclonal	  anti-­‐Caspase-­‐3	  (or	  β-­‐actin)	  antibody.	  	  Full-­‐
length	  (black	  arrow)	  and	  the	  activated	  forms	  (17	  kDa	  doublet,	  grey	  arrow)	  of	  Caspase-­‐3	  











H2O2	  does	  not	  induce	  the	  novel	  IκBα 	  cleavage	  in	  all	  cell	  types.	  
	   The	  novel	  nature	  of	  the	  IκBα	  cleavage	  product	  lead	  us	  to	  determine	  if	  µM	  H2O2	  
treatment	  causes	  it	  to	  be	  formed	  in	  non-­‐B	  lymphocyte	  cells.	  	  This	  is	  a	  relevant	  
consideration	  in	  that	  the	  NFκB/Rel	  pathway	  has	  been	  found	  to	  respond	  to	  ROI	  exposure	  
in	  a	  cell	  type	  and	  cell	  line	  specific	  manner	  that	  can	  involve	  variance	  in	  the	  effective	  
concentration.	  	  Moreover,	  epithelial	  and	  immune	  cells	  tend	  to	  be	  some	  of	  the	  more	  
prominently	  sensitive	  cell	  types,	  so	  the	  cervical	  epithelial	  HeLa	  cell	  line	  was	  chosen	  as	  a	  
non-­‐B	  lymphocyte	  model	  (Oliveira-­‐Marques	  et	  al.,	  2009b).	  HeLa	  cells	  were	  treated	  with	  
200	  and	  1000	  µM	  H2O2	  for	  24	  hr	  and	  no	  cleavage	  of	  IκBα	  or	  decrease	  in	  cellular	  viability	  
was	  observed.	  	  If	  the	  1000	  µM	  treatment	  was	  extended	  for	  48	  hr	  there	  was	  a	  marked	  








for	  caspase-­‐3	  activation	  as	  indicator	  of	  mitochondrial	  cell	  death,	  but	  no	  activation	  was	  
observed	  at	  24	  or	  48	  hr	  	  (figure	  22B).	  It	  was	  predicted	  that	  the	  HeLa	  cells	  would	  not	  
form	  the	  IκBα	  cleavage	  product	  in	  response	  to	  the	  high	  levels	  of	  H2O2	  because	  caspase	  
cleavage	  of	  NFκB/Rel	  proteins	  (e.g.	  IκBα	  and	  p65/RelA)	  is	  associated	  with	  an	  inhibition	  
of	  NFκB/Rel	  activity,	  and	  H2O2	  has	  been	  shown	  to	  induce	  NFκB/Rel	  activity	  in	  HeLa	  cells,	  
which	  is	  required	  for	  cell	  death	  in	  this	  cell	  line.	  	  The	  mechanism	  of	  cell	  death	  was	  
believed	  to	  involve	  a	  NFκB/Rel-­‐mediated	  up-­‐regulation	  of	  p53	  as	  over-­‐expression	  of	  
IκBα	  suppressed	  the	  H2O2-­‐mediated	  induction	  of	  p53	  at	  24	  hr	  time	  point	  (Dumont	  et	  al.,	  
1999).	  	  This	  pro-­‐cell	  death	  function	  of	  NFκB/Rel	  in	  HeLa	  cells	  verses	  the	  pro-­‐survival	  
effects	  in	  B	  lymphocytes,	  and	  greater	  sensitivity	  to	  H2O2	  of	  B	  lymphocytes	  in	  terms	  of	  
viability	  underscores	  the	  cell-­‐type	  differences	  in	  response	  to	  H2O2.	  
Figure	  22:	  H2O2-­‐induced	  novel	  IκBα 	  and	  Caspase-­‐3	  cleavage	  does	  not	  occur	  in	  all	  cell	  
types.	  
(A)	  Sub-­‐confluent	  HeLa	  cells	  were	  either	  not-­‐treated	  (0	  µM	  H2O2)	  or	  treated	  with	  200	  or	  
1000	  µM	  H2O2	  and	  incubated	  for	  24	  hr,	  and	  not-­‐treated	  (0	  µM	  H2O2)	  or	  treated	  with	  
1000	  µM	  H2O2	  and	  incubated	  for	  48	  hr.	  Following	  the	  incubation,	  1.0	  mL	  of	  the	  cells	  was	  
measured	  for	  percentage	  of	  cellular	  viability	  via	  trypan	  blue	  exclusion	  assay	  and	  the	  
remaining	  cells	  were	  harvested	  for	  whole	  cell	  protein	  lysates.	  	  Equal	  amounts	  of	  total	  
protein	  were	  separated	  via	  SDS/PAGE	  and	  subjected	  to	  western	  blotting	  utilizing	  a	  
polyclonal	  anti-­‐IκBα	  antibody	  (or	  β-­‐actin).	  	  Protein	  lysate	  from	  Ramos	  cells	  treated	  with	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200	  µM	  H2O2	  for	  24	  hr	  was	  included	  as	  a	  positive	  control	  for	  the	  detection	  of	  the	  novel	  
IκBα	  cleavage	  product.	  	  Full-­‐length	  (black	  arrow)	  and	  the	  cleaved	  forms	  (grey	  arrow)	  of	  
IκBα	  are	  indicated	  by	  the	  arrows,	  and	  a	  longer	  exposure	  of	  the	  blot	  was	  included	  in	  
panel	  A.	  	  The	  same	  lysates	  were	  similarly	  assayed	  via	  western	  blotting	  for	  Caspase-­‐3	  




























H2O2-­‐induced	  novel	  cleavage	  of	  IκBα 	  develops	  over	  a	  24	  hr	  time	  period.	  
	   Ramos	  cells	  were	  treated	  with	  100	  µM	  H2O2	  and	  harvested	  at	  1,	  4,	  8,	  12,	  16,	  20,	  
24	  and	  48	  hr	  post	  treatment	  to	  determine	  the	  kinetics	  of	  the	  formation	  and	  the	  
sustainability	  of	  the	  IκBα	  cleavage	  product.	  The	  time	  course	  analysis	  of	  the	  IκBα	  
cleavage	  revealed	  that	  the	  cleavage	  product	  faintly	  appeared	  (figure	  23A)	  as	  early	  as	  4	  
hr	  but	  did	  not	  become	  abundant	  until	  the	  16	  hr	  time	  point,	  suggesting	  that	  the	  cleavage	  
of	  IκBα	  is	  a	  delayed	  response.	  	  Activated	  caspase-­‐3	  a	  prominent	  (	  17	  kDa	  doublet)	  began	  
to	  significantly	  accumulate	  at	  the	  12-­‐16	  hr	  time	  points,	  but	  faint	  detection	  was	  observed	  
in	  the	  naïve	  cells	  and	  earlier	  time	  points	  of	  the	  treatment	  group	  (figure	  23B).	  The	  
cellular	  viability	  also	  demonstrated	  a	  delayed	  decrease	  in	  response	  to	  increasing	  
concentrations	  of	  H2O2	  	  (figure	  23C),	  indicating	  a	  correlation	  between	  the	  delayed	  IκBα	  
cleavage,	  caspase	  activity	  and	  decreased	  viability	  (compare	  figures	  17A	  &21A(IκBα	  
cleavage),	  19&21B	  (caspase	  activation),	  18A&21C	  (viability).	  	  A	  delayed	  H2O2-­‐mediated	  
cleavage	  of	  IκBα	  and	  decrease	  in	  viability	  is	  not	  unprecedented	  as	  other	  forms	  of	  B	  
lymphocyte	  mitochondrial	  cell	  death	  (e.g.	  B-­‐cell	  receptor-­‐mediated	  cell	  death)	  exhibit	  
delayed	  kinetics	  (Yi	  et	  al.,	  1996;	  Bouchon	  et	  al.,	  2000).	  	  	  
Figure	  23:	  	  H2O2-­‐induced	  novel	  cleavage	  of	  IκBα 	  develops	  over	  a	  24	  hr	  time	  period.	  
(A)	  Ramos	  cells	  were	  either	  not	  treated	  (naïve,	  N)	  or	  treated	  with	  100	  µM	  H2O2	  and	  
harvested	  for	  whole	  cell	  protein	  lysates	  at	  1,	  4,	  8,	  12,	  16,	  20,	  24,	  and	  48	  hr.	  Following	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the	  treatment,	  the	  cells	  were	  harvested	  for	  whole	  cell	  protein	  lysates	  and	  equal	  
amounts	  of	  total	  protein	  were	  separated	  via	  SDS/PAGE	  and	  subjected	  to	  western	  
blotting	  utilizing	  a	  polyclonal	  anti-­‐IκBα	  antibody	  (or	  β-­‐actin).	  	  Full-­‐length	  (black	  arrow)	  
and	  the	  cleaved	  form	  (grey	  arrow)	  of	  IκBα	  are	  indicated	  by	  arrows.	  	  (B)	  The	  activated	  
forms	  of	  Caspase-­‐3	  (17	  kDa	  doublet)	  were	  detected	  at	  the	  various	  time	  points	  as	  an	  
indicator	  Caspase	  activity.	  	  (C)	  Cellular	  viability	  was	  measured	  at	  each	  time	  point	  via	  
























Interestingly,	  a	  transient	  degradation	  of	  IκBα	  was	  observed	  at	  the	  4	  hr	  time	  
point	  (figure	  23A).	  	  Transient	  degradation	  of	  IκBα	  is	  a	  hallmark	  of	  NFκB/Rel	  activation	  
(Henkel	  et	  al.,	  1993).	  In	  a	  T-­‐cell	  line,	  H2O2	  induced	  NFκB/Rel-­‐mediated	  transcriptional	  
activation	  that	  peaked	  around	  the	  4	  hr	  time	  point	  (Schreck	  et	  al.,	  1991;	  Pyo	  et	  al.,	  2008).	  
This	  transient	  activation	  of	  NFκB/Rel	  may	  explain	  the	  delayed	  decrease	  in	  viability	  and	  
optimal	  caspase	  activation,	  as	  it	  has	  been	  found	  that	  NFκB/Rel	  activation	  can	  inhibit	  the	  
progression	  of	  cell	  death	  (Yi	  et	  al.,	  1996;	  Yi	  &	  Krieg,	  1998;	  Yi	  et	  al.,	  1999;	  Romer	  &	  
Sulentic,	  2011).	  	   	  	  
H2O2-­‐induced	  IκBα 	  cleavage	  product	  is	  suppressed	  by	  LPS	  activation.	  
	   The	  concept	  of	  NFκB/Rel	  activation	  contributing	  to	  the	  suppression	  of	  cell	  death	  
was	  substantiated	  by	  our	  observation	  that	  the	  treatment	  of	  B	  lymphocytes	  with	  LPS,	  a	  







!" %" '" %#"&" %$" ()*+"#!" #&" &'"
!"
97	  
viability	  by	  H2O2	  (Souvannavong	  et	  al.,	  2007;	  Romer	  &	  Sulentic,	  2011).	  	  Therefore,	  as	  the	  
novel	  IκBα	  cleavage	  product	  is	  associated	  with	  decreased	  viability,	  we	  wanted	  to	  
determine	  if	  protective	  effects	  of	  LPS-­‐activation	  included	  the	  suppression	  of	  IκBα	  
cleavage.	  CH12IκBαAA	  cells	  treated	  with	  100	  and	  200	  µM	  H2O2	  induced	  novel	  IκBα	  
cleavage	  at	  24	  and	  48	  hr,	  which	  was	  suppressed	  LPS	  co-­‐treatment	  (figure	  24A	  and	  B).	  
This	  confirms	  that	  cellular	  activation	  can	  prevent	  the	  cleavage	  of	  IκBα	  and	  cell	  death.	  
Furthermore,	  a	  band	  migrating	  slightly	  faster	  than	  the	  full-­‐length	  IκBα	  (≈34	  kDa)	  was	  
observed	  in	  the	  100	  and	  200	  µM	  H2O2	  lanes.	  	  This	  band	  likely	  represents	  the	  previously	  
characterized	  ΔN-­‐IκBα	  caspase	  cleavage	  product	  that	  has	  demonstrated	  a	  capacity	  to	  
suppress	  NFκB/Rel	  activity	  (Figure	  24A	  and	  B,	  ΔN-­‐IκBα)	  (Barkett	  et	  al.,	  1997;	  Reuther	  &	  
Baldwin,	  1999).	  	  In	  the	  non-­‐activated	  H2O2	  treatments,	  the	  ΔN-­‐IκBα	  bands	  appeared	  to	  
be	  more	  prominent	  in	  the	  24	  hr	  treatments	  than	  the	  48hr	  (compare	  figure	  24A	  and	  B).	  	  	  
It	  is	  tempting	  to	  speculate	  that	  the	  ΔN-­‐IκBα	  is	  also	  a	  substrate	  of	  caspase	  activity	  that	  
could	  be	  further	  cleaved	  by	  caspases	  to	  form	  the	  novel	  IκBα	  product.	  	  
Figure	  24:	  H2O2-­‐induced	  IκBα 	  cleavage	  product	  is	  suppressed	  by	  LPS	  activation.	  
CH12IκBαAA	  cells	  were	  either	  not	  treated	  (0	  µM	  H2O2)	  or	  treated	  with	  40,	  100,	  or	  200	  
µM	  H2O2	  and	  either	  remained	  non-­‐activated	  or	  were	  activated	  with	  1.0	  µg/mL	  LPS.	  	  The	  
cells	  were	  then	  incubated	  for	  either	  24	  hr	  (A)	  or	  48	  hr	  (B).	  Following	  the	  treatment,	  the	  
cells	  were	  harvested	  for	  whole	  cell	  protein	  lysates	  and	  equal	  amounts	  of	  total	  protein	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were	  separated	  via	  SDS/PAGE	  and	  subjected	  to	  western	  blotting	  utilizing	  a	  polyclonal	  
anti-­‐IκBα	  antibody	  (or	  β-­‐actin).	  Full-­‐length	  (black	  arrow)	  and	  the	  cleaved	  form	  (grey	  













The	  N-­‐terminus	  of	  IκBα 	  is	  not	  detectable	  in	  the	  novel	  cleavage	  of	  IκBα .	  
There	  is	  a	  caspase-­‐3	  cleavage	  site	  at	  Asp	  31	  that	  is	  the	  target	  of	  caspase-­‐mediated	  
formation	  of	  the	  ΔN-­‐IκBα	  product	  (Barkett	  et	  al.,	  1997;	  Reuther	  &	  Baldwin,	  1999).	  	  It	  is	  
therefore	  reasonable	  to	  predict	  that	  the	  novel	  cleavage	  of	  IκBα	  may	  involve	  the	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contains	  an	  N-­‐terminus,	  protein	  lysates	  from	  naïve	  and	  H2O2-­‐treated	  Ramos	  cells	  were	  
processed	  in	  duplicate	  for	  western	  blotting	  and	  probed	  with	  either	  the	  polyclonal	  anti-­‐
IκBα	  antibody	  that	  detects	  the	  novel	  cleavage	  product	  or	  a	  monoclonal	  anti-­‐IκBα	  
antibody	  that	  detects	  an	  epitope	  N-­‐terminal	  to	  the	  putative	  Asp	  31	  cleavage	  site.	  	  While	  
the	  cleavage	  product	  was	  observed	  with	  the	  polyclonal	  antibody	  (figure	  25A),	  it	  was	  not	  
observed	  with	  the	  N-­‐terminal	  antibody	  indicating	  that	  the	  novel	  cleavage	  of	  IκBα	  is	  
lacking	  the	  N-­‐terminus	  (figure	  25B).	  	  The	  N-­‐terminus	  renders	  IκBα	  susceptible	  to	  
activation-­‐induced	  ubiquitination	  and	  transient	  degradation,	  thus	  allowing	  NFκB/Rel	  
activation.	  	  The	  lack	  of	  an	  N-­‐terminus	  in	  the	  ΔN-­‐IκBα	  product	  was	  found	  to	  confer	  for	  
constitutive	  inhibition	  of	  NFκB/Rel	  activity	  (Reuther	  &	  Baldwin,	  1999).	  	  Therefore	  it	  is	  
reasonable	  to	  speculate	  that	  the	  lack	  of	  an	  N-­‐terminus	  in	  the	  novel	  IκBα	  product	  may	  
confer	  for	  a	  similar	  constitutive	  inhibitory	  effect	  on	  NFκB/Rel	  activity.	  
Figure	  25:	  The	  N-­‐terminus	  of	  IκBα 	  is	  not	  detected	  in	  the	  novel	  cleavage	  of	  IκBα 	  post	  
H2O2	  treatment.	  	  
Ramos	  cells	  were	  either	  not	  treated	  (0	  µM)	  or	  treated	  with	  200	  µM	  H2O2	  for	  24	  hr	  and	  
harvested	  for	  whole	  cell	  protein	  lysates.	  Equal	  amounts	  of	  total	  protein	  were	  separated	  
via	  SDS/PAGE	  and	  transferred	  to	  a	  membrane	  in	  duplicate.	  	  The	  membrane	  in	  (A)	  was	  
probed	  with	  the	  polyclonal	  anti-­‐IκBα	  antibody	  found	  to	  detect	  the	  novel	  cleavage	  
product	  at	  an	  epitope	  considered	  by	  the	  manufacturer	  to	  be	  “c-­‐terminal”.	  	  The	  
membrane	  in	  panel	  B	  was	  probed	  with	  a	  monoclonal	  antibody	  designed	  to	  detect	  the	  n-­‐
100	  
terminus	  of	  IκBα	  at	  an	  epitope	  n-­‐terminal	  to	  serine	  32.	  Full-­‐length	  (black	  arrow)	  and	  the	  










Exogenous	  H2O2	  treatment	  is	  not	  necessary	  to	  induce	  the	  formation	  of	  the	  novel	  IκBα 	  
cleavage	  product.	  	  	  
To	  determine	  if	  novel	  cleavage	  of	  IκBα	  could	  be	  induced	  by	  a	  stimulus	  that	  did	  
not	  involve	  exogenous	  H2O2,	  Ramos	  cells	  were	  treated	  with	  cyclohexamide.	  	  
Cyclohexamide	  is	  a	  potent	  protein	  synthesis	  inhibitor	  found	  to	  induce	  mitochondrial-­‐
mediated	  cell	  death	  in	  Ramos	  cells	  that	  involves	  the	  disabling	  of	  bcl-­‐2	  (Ning	  et	  al.,	  1995).	  	  	  
Cyclohexamide	  is	  not	  characterized	  as	  an	  ROI,	  and	  there	  are	  no	  studies	  demonstrating	  it	  
directly	  produces	  of	  ROI.	  	  A	  study	  in	  hepatocytes	  suggests	  cyclohexamide	  alone	  has	  no	  










al.,	  1997).	  	  A	  24	  hr	  treatment	  of	  Ramos	  cells	  with	  cyclohexamide	  resulted	  in	  the	  
formation	  of	  the	  IκBα	  cleavage	  product	  along	  with	  a	  marked	  decrease	  in	  cellular	  
viability	  indicating	  that	  exogenous	  H2O2	  is	  not	  necessary	  for	  the	  novel	  IκBα	  cleavage	  and	  
it	  could	  be	  an	  integral	  process	  in	  all	  mitochondrial-­‐mediated	  cell	  death	  in	  B	  lymphocytes	  
(figure	  26).	  	  	  
Figure	  26:	  Exogenous	  H2O2	  treatment	  is	  not	  necessary	  to	  induce	  the	  formation	  of	  the	  
novel	  IκBα 	  cleavage	  product.	  	  	  
Ramos	  cells	  were	  either	  not	  treated	  (naïve;	  N)	  or	  treated	  with	  5.0	  µg/mL	  cyclohexamide	  
(CHX)	  or	  dimethylsulfoxide	  (DMSO)	  as	  a	  vehicle	  control	  for	  24	  hr.	  Following	  the	  
incubation,	  1.0	  mL	  of	  the	  cell	  suspension	  was	  measured	  for	  percentage	  of	  cellular	  
viability	  via	  trypan	  blue	  exclusion	  assay	  and	  the	  remaining	  cells	  were	  harvested	  for	  
whole	  cell	  protein	  lysates.	  	  Equal	  amounts	  of	  total	  protein	  were	  separated	  via	  SDS/PAGE	  
and	  subjected	  to	  western	  blotting	  utilizing	  a	  polyclonal	  anti-­‐IκBα	  antibody	  (or	  β-­‐actin).	  











H2O2-­‐induced	  novel	  IκBα 	  product	  formation	  is	  suppressed	  by	  caspase	  inhibition.
	   To	  verify	  that	  IκBα	  is	  a	  direct	  target	  of	  H2O2-­‐mediated	  proteolytic	  cleavage	  and	  
that	  caspases	  are	  involved	  in	  the	  formation	  of	  the	  product,	  we	  utilized	  the	  CH12IκBαAA	  
cell	  line	  to	  over	  express	  the	  IκBαAA	  that	  is	  susceptible	  to	  caspase	  cleavage	  (Reuther	  &	  
Baldwin,	  1999).	  	  	  When	  the	  transgene	  is	  over-­‐expressed	  (+IPTG/-­‐H2O2),	  the	  IκBαAA	  is	  
distinguishable	  from	  the	  wild-­‐type	  IκBα	  protein	  because	  it	  migrates	  at	  a	  discernibly	  
higher	  molecular	  weight	  in	  an	  SDS-­‐PAGE	  gel	  (figure	  27A).	  	  The	  IκBαAA	  level	  was	  
markedly	  reduced	  when	  the	  cells	  were	  co-­‐treated	  with	  200	  µM	  H2O2	  (+IPTG/+H2O2),	  
suggesting	  that	  the	  IκBαAA	  form	  was	  being	  cleaved	  (figure	  27A).	  	  Concordantly,	  the	  
level	  of	  the	  IκBα	  cleavage	  product	  was	  higher	  in	  the	  cells	  expressing	  the	  IκBαAA	  
(+IPTG/+H2O2)	  than	  in	  than	  in	  the	  cells	  expressing	  the	  only	  the	  native	  form	  of	  IκBα	  (-­‐






of	  cleavage	  product	  bands	  which	  was	  found	  to	  be	  markedly	  higher	  in	  the	  IκBαAA	  
expressing	  cells	  (figure	  27D),	  suggesting	  that	  the	  higher	  levels	  of	  the	  cleavage	  products	  
are	  likely	  derived	  from	  the	  over-­‐expressed	  IκBαAA	  form.	  	  This	  is	  further	  validation	  that	  
the	  product	  detected	  by	  western	  blotting	  is	  indeed	  derived	  from	  the	  cleavage	  of	  IκBα.	  	  
The	  specificity	  of	  our	  polyclonal	  anti-­‐IκBα	  antibody	  	  (C-­‐21	  clone)	  purchased	  from	  Santa	  
Cruz	  Biotechnology	  was	  also	  verified	  by	  detecting	  the	  cleavage	  product	  with	  another	  
anti-­‐IκBα	  antibody	  purchased	  from	  Genetex	  which	  was	  not	  derived	  from	  the	  anti-­‐IκBα	  
C-­‐21	  clone	  (figure	  27E).	  	  
The	  H2O2	  treatments	  also	  induced	  a	  decrease	  in	  cellular	  viability	  (figure	  27C),	  
which	  was	  almost	  completely	  reversed	  by	  co-­‐treatment	  with	  a	  potent	  pan-­‐caspase	  
inhibitor,	  QVD-­‐OPh	  (figure	  27A)	  (Caserta	  et	  al.,	  2003).	  	  A	  salient	  finding	  of	  this	  study	  was	  
that	  the	  formation	  of	  the	  cleavage	  product	  was	  almost	  completely	  suppressed	  by	  co-­‐
treatment	  with	  QVD-­‐OPh	  (figure	  27B)	  and	  IκBα/IκBαAA	  levels	  were	  restored	  to	  near	  
control	  levels	  (figure	  27A).	  	  The	  previously	  characterized	  ΔN-­‐IκBα	  (34	  kDa	  band)	  was	  
observed	  in	  the	  H2O2	  treatment	  but	  was	  absent	  in	  the	  QVD-­‐OPh	  treatment,	  indicating	  
that	  the	  inhibition	  of	  caspase	  activity	  suppressed	  its	  formation	  (figure	  27A).	  	  Therefore	  it	  
was	  concluded	  that	  caspase	  inhibition	  suppresses	  the	  H2O2	  mediated	  cell	  death	  and	  
IκBα	  cleavage,	  which	  is	  strong	  evidence	  that	  the	  novel	  IκBα	  cleavage	  product	  is	  formed	  
by	  caspase-­‐mediated	  cleavage	  of	  IκBα.	  	  	  
Figure	  27:	  H2O2-­‐induced	  novel	  IκBα 	  cleavage	  product	  formation	  is	  suppressed	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by	  caspase	  inhibition	  in	  the	  CH12IκBαAA	  mouse	  cell	  line.	  	  
CH12IκBαAA	  cells	  were	  either	  not	  pre-­‐treated	  (-­‐IPTG/-­‐H2O2	  and	  (-­‐IPTG/+H2O2)	  or	  pre-­‐
treated	  (2	  hours)	  with	  100	  µM	  IPTG	  to	  activate	  the	  expression	  of	  the	  IκBαAA	  transgene	  
(+IPTG/-­‐H2O2)	  and	  then	  treated	  with	  H2O2	  alone	  (+IPTG/+H2O2),	  or	  H2O2	  and	  DMSO	  
vehicle	  control	  (+IPTG/+H2O2/+DMSO)	  or	  treated	  with	  H2O2	  and	  20	  µM	  QVD-­‐OPh	  
(+IPTG/+H2O2/+QVD).	  	  The	  20	  µM	  QVD	  treatment	  and	  the	  respective	  DMSO	  control	  
treatment	  were	  applied	  at	  0	  hr	  and	  again	  at	  12	  hr.	  	  	  The	  cells	  were	  incubated	  for	  a	  total	  
of	  24	  hr.	  	  Following	  the	  incubation,	  each	  group	  was	  measured	  for	  percentage	  of	  cellular	  
viability	  via	  trypan	  blue	  exclusion	  assay	  and	  the	  remaining	  cells	  were	  harvested	  for	  
whole	  cell	  protein	  lysates.	  	  Equal	  amounts	  of	  total	  protein	  were	  separated	  via	  SDS/PAGE	  
and	  subjected	  to	  western	  blotting	  utilizing	  a	  polyclonal	  anti-­‐IκBα	  antibody	  (or	  anti-­‐β-­‐
actin).	  	  (A)	  exhibits	  the	  full	  length	  form	  of	  IκBα.	  (B)	  exhibits	  the	  novel	  IκBα	  product	  at	  a	  
longer	  exposure	  than	  (A).	  (C)	  exhibits	  the	  mean	  percentage	  of	  viable	  cells	  for	  4	  separate	  
experiments	  (n=4)	  as	  measured	  by	  trypan	  blue	  exclusion	  assay.	  The	  asterisk	  (*)	  indicates	  
significant	  difference	  (p<0.05	  )	  relative	  to	  the	  +IPTG/+H2O2/+DMSO	  control	  utilizing	  a	  1-­‐
way	  ANOVA	  with	  Dunnett’s	  post	  hoc	  test.	  	  (D)	  This	  data	  exhibits	  the	  mean	  volume	  
intensity	  of	  the	  novel	  IκBα	  cleavage	  product	  bands	  in	  (-­‐IPTG/+H2O2),	  (+IPTG/+H2O2),	  and	  
(+IPTG/+H2O2/+DMSO)	  treated	  cells	  normalized	  to	  the	  (-­‐IPTG/+H2O2)	  control	  (white	  bar).	  	  
The	  data	  represents	  the	  mean	  intensity	  of	  bands	  from	  4	  separate	  experiments.	  	  (E)	  This	  
data	  demonstrates	  the	  detection	  of	  the	  novel	  IκBα	  cleavage	  product	  in	  whole	  cell	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lysates	  of	  Ramos	  cells	  treated	  with	  200	  µM	  H2O2	  by	  a	  unique	  polyclonal	  anti-­‐IκBα	  
antibody	  produced	  by	  Genetex.	  


















































Furthermore,	  this	  effect	  was	  also	  observed	  in	  the	  H2O2-­‐treated	  human	  Ramos	  
cells,	  in	  which	  the	  cleavage	  product	  produced	  from	  the	  endogenous	  IκBα	  was	  
suppressed	  by	  QVD-­‐OPh	  (figure	  28A).	  It	  is	  interesting	  to	  note,	  that	  in	  contrast	  to	  the	  
CH12IκBαAA	  cells,	  the	  suppression	  of	  the	  cleavage	  product	  formation	  was	  not	  complete	  
in	  the	  Ramos	  cell	  line,	  and	  while	  QVD-­‐OPh	  significantly	  increased	  viability	  relative	  to	  the	  
H2O2	  control,	  the	  cellular	  viability	  was	  not	  restored	  to	  naïve	  levels	  (figure	  28B).	  	  This	  is	  
likely	  due	  to	  an	  incomplete	  blockade	  by	  QVD-­‐OPh	  of	  sustained	  caspase	  activity.	  	  It	  may	  
also	  be	  suggestive	  that	  Ramos	  cells	  exhibit	  a	  more	  robust	  caspase	  activity	  than	  the	  
CH12IκBαAA,	  which	  exhibit	  a	  near	  complete	  suppression	  of	  the	  cleavage	  product	  
formation	  and	  decreased	  viability	  with	  QVD-­‐OPh	  co-­‐treatment.	  	  These	  differences	  may	  
be	  consistent	  with	  findings	  that	  have	  shown	  that	  the	  level	  of	  caspase	  activation	  can	  vary	  
between	  sub-­‐types	  of	  B	  cell	  lymphomas	  with	  DLBCL	  and	  Burkitt	  lymphomas	  having	  
















lymphomas	  (e.g.	  follicular	  lymphomas).	  	  Moreover,	  there	  can	  be	  wide	  ranges	  in	  caspase	  
activation	  between	  different	  cases	  of	  Burkitt	  lymphomas	  (Dukers	  et	  al.,	  2002).	  
It	  is	  also	  interesting	  to	  note	  that	  while	  H2O2	  appeared	  to	  induce	  the	  formation	  of	  
the	  ΔN-­‐IκBα	  (34	  kDa)	  product	  in	  the	  CH12IκBαAA	  cells,	  it	  was	  not	  consistently	  observed	  
in	  the	  Ramos	  cells,	  and	  it	  when	  it	  was	  observed	  it	  was	  faintly	  detectable.	  	  As	  was	  
previously	  speculated	  with	  regard	  to	  figure	  24,	  the	  ΔN-­‐IκBα	  may	  be	  a	  transitional	  form	  
of	  the	  novel	  IκBα	  cleavage	  product,	  which	  is	  substantiated	  by	  the	  absence	  of	  an	  N-­‐
terminus	  in	  the	  novel	  cleavage	  product	  (figure	  25).	  	  If	  caspase	  activity	  is	  more	  robust	  in	  
Ramos	  cells,	  it	  could	  be	  speculated	  that	  the	  scarcity	  of	  the	  ΔN-­‐IκBα	  in	  Ramos	  cells	  
(relative	  to	  CH12IκBαAA	  cells)	  may	  indicate	  that	  caspases	  are	  efficiently	  cleaving	  ΔN-­‐
IκBα	  to	  form	  the	  novel	  IκBα	  product.	  	  
	   Caspase-­‐3	  is	  an	  effector	  caspase	  involved	  in	  mediating	  H2O2-­‐induced	  lymphocyte	  
cell	  death	  and	  was	  implicated	  in	  the	  formation	  of	  the	  ΔN-­‐IκBα	  product	  (Barkett	  et	  al.,	  
1997;	  Hampton	  &	  Orrenius,	  1997;	  Dumont	  et	  al.,	  1999;	  Reuther	  &	  Baldwin,	  1999).	  	  Co-­‐
treatment	  of	  H2O2-­‐treated	  Ramos	  cells	  with	  20	  µM	  DEVD-­‐OPh,	  a	  caspase-­‐3	  specific	  
inhibitor,	  resulted	  in	  a	  partial	  blockade	  of	  the	  formation	  of	  the	  novel	  IκBα	  cleavage	  
product	  (figure	  28C).	  	  	  While	  caspase-­‐3	  can	  be	  involved	  in	  the	  formation	  of	  the	  novel	  
cleavage	  product,	  it	  does	  not	  appear	  to	  be	  singularly	  responsible	  for	  its	  formation.	  	  This	  
is	  not	  an	  altogether	  surprising	  result	  as	  there	  is	  only	  one	  caspase-­‐3	  cleavage	  site	  in	  the	  
IκBα	  protein	  characterized	  by	  Reuther	  et	  al	  and	  no	  other	  caspase-­‐3	  consensus	  cleavage	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sites	  (DEXD)	  found	  in	  the	  human	  IκBα	  protein	  sequence	  making	  it	  at	  least	  possible	  if	  not	  
likely	  that	  other	  caspases	  are	  involved	  in	  targeting	  caspase	  cleavage	  sites	  that	  are	  less	  
susceptible	  to	  caspase-­‐3	  cleavage.	  	  Moreover,	  there	  is	  considerable	  overlap	  in	  caspase	  
selectivity	  for	  cleavage	  motifs	  opening	  up	  the	  possibility	  for	  redundancy	  within	  the	  field	  
of	  caspases	  that	  could	  possibly	  target	  IκBα	  when	  Caspase-­‐3	  is	  inhibited	  by	  the	  DEVD-­‐
OPh	  inhibitor	  (McStay	  et	  al.,	  2007).	  	  However,	  it	  cannot	  be	  ruled	  out	  that	  the	  20	  µM	  
concentration	  of	  DEVD-­‐OPh	  utilized	  is	  not	  sufficient	  to	  completely	  inhibit	  all	  caspase-­‐3	  
activity,	  albeit,	  20	  µM	  is	  at	  the	  high	  end	  of	  the	  recommended	  concentrations	  suggested	  
by	  the	  manufacturer.	  
Figure	  28:	  H2O2-­‐induced	  novel	  IκBα 	  cleavage	  product	  formation	  is	  suppressed	  	  
by	  caspase	  inhibition	  in	  a	  human	  Ramos	  cell	  line.	  	  	  
(A)	  Ramos	  cells	  were	  either	  not	  treated	  (N,	  naïve)	  or	  treated	  with	  100	  µM	  H2O2	  alone,	  
H2O2	  and	  DMSO	  (vehicle	  control),	  or	  H2O2	  and	  20	  µM	  QVD.	  	  (B)	  Ramos	  cells	  were	  also	  
treated	  with	  an	  identical	  experimental	  design	  with	  the	  exception	  of	  utilizing	  a	  Caspase-­‐3	  
specific	  inhibitor	  DEVD-­‐OPh	  at	  20	  µM.	  	  The	  20	  µM	  inhibitor	  treatments	  and	  the	  
respective	  DMSO	  control	  treatments	  were	  applied	  at	  0	  hr	  and	  again	  at	  12	  hr.	  	  	  The	  cells	  
were	  incubated	  for	  at	  total	  of	  24	  hr.	  	  Following	  the	  incubation,	  each	  group	  was	  
harvested	  for	  whole	  cell	  protein	  lysates.	  	  Equal	  amounts	  of	  total	  protein	  were	  separated	  
via	  SDS/PAGE	  and	  subjected	  to	  western	  blotting	  utilizing	  a	  polyclonal	  anti-­‐IκBα	  antibody	  
(or	  anti-­‐β-­‐actin).	  Full-­‐length	  (black	  arrow)	  and	  the	  cleaved	  form	  (grey	  arrow)	  of	  IκBα	  are	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indicated	  by	  arrows.	  (C)	  Cellular	  viability	  was	  measured	  via	  trypan	  blue	  exclusion	  assay.	  	  
The	  asterisk	  (*)	  indicates	  significant	  difference	  (p<0.05)	  relative	  to	  the	  	  H2O2	  and	  DMSO	  























The	  novel	  IκBα 	  cleavage	  product	  associates	  with	  the	  NFκB/Rel	  pathway.	  
	  IκBα	  binds	  and	  sequesters	  NFκB/Rel	  proteins	  (p50,	  p65,	  cRel)	  in	  the	  cytoplasm,	  
which	  inhibits	  NFκB/Rel	  dimer	  nuclear	  translocation	  and	  subsequent	  regulation	  of	  gene	  
expression.	  	  If	  the	  novel	  IκBα	  cleavage	  product	  retains	  its	  ability	  to	  interact	  with	  
NFκB/Rel	  proteins,	  it	  would	  be	  evidence	  of	  IκBα	  functionality.	  	  The	  ΔN-­‐IκBα	  cleavage	  
product	  has	  been	  shown	  to	  interact	  with	  p65/RelA	  and	  constitutively	  inhibit	  NFκB/Rel	  
activity,	  suggesting	  that	  caspase	  cleavage	  of	  IκBα	  not	  only	  retains	  but	  enhances	  its	  
inhibitory	  function	  (Reuther	  &	  Baldwin,	  1999).	  To	  test	  for	  an	  association	  with	  NFκB/Rel	  
and	  the	  novel	  IκBα	  cleavage	  product	  was	  co-­‐immunoprecipitated	  with	  p65/RelA.	  	  	  
p65/RelA	  was	  immunoprecipitated	  with	  an	  anti-­‐p65/RelA	  antibody	  and	  full-­‐length	  IκBα	  
was	  co-­‐immunoprecipitated	  with	  it	  but	  the	  H2O2	  treatment	  resulted	  in	  detection	  of	  
lower	  amounts	  of	  both	  proteins	  (figure	  29A).	  	  	  This	  is	  likely	  due	  to	  decreased	  levels	  of	  
full-­‐length	  perhaps	  due	  to	  proteolysis.	  The	  novel	  IκBα	  cleavage	  product	  was	  also	  co-­‐
immunoprecipitated	  with	  p65/RelA	  indicating	  that	  the	  cleavage	  product	  interacts	  with	  
NFκB/Rel	  transactivating	  family	  members	  (figure	  29A,	  grey	  arrow).	  	  IgG	  conjugated	  
control	  beads,	  a	  commonly	  utilized	  control	  for	  immuno-­‐precipitations,	  were	  incubated	  
with	  H2O2-­‐treated	  lysates	  to	  control	  non-­‐specific	  protein	  binding	  to	  bead	  antibody	  
complex	  which	  is	  an	  issue	  with	  this	  technique.	  	  Low-­‐level	  background	  binding	  of	  the	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IκBα	  cleavage	  product	  was	  detected	  but	  multiple	  repeat	  experiments	  demonstrated	  
that	  it	  was	  consistently	  much	  less	  than	  with	  the	  anti-­‐p65/RelA	  precipitates.	  	  
Figure	  29:	  Co-­‐immunoprecipitation	  of	  the	  novel	  IkBa	  cleavage	  product	  with	  p65/RelA.	  
Ramos	  cells	  were	  either	  not	  treated	  (N,	  naive)	  or	  treated	  with	  200	  µM	  H2O2	  for	  24	  hr	  
and	  harvested	  for	  whole	  cell	  protein	  lysates	  utilizing	  a	  co-­‐immunoprecipitation	  buffer.	  	  
1-­‐2	  mg	  of	  total	  protein	  pre-­‐cleared	  with	  unconjugated	  beads	  were	  incubated	  with	  
magnetic	  protein	  G	  agarose	  beads	  conjugated	  with	  an	  anti-­‐p65/RelA	  antibody.	  	  
Additionally,	  beads	  conjugated	  to	  a	  rabbit	  IgG	  were	  incubated	  with	  H2O2	  lysates	  to	  
control	  for	  non-­‐specific	  immunoprecipitation.	  	  The	  immunoprecipitated	  complexes	  were	  
eluted	  from	  the	  beads	  and	  separated	  on	  SDS/PAGE	  gel	  and	  subjected	  to	  western	  
blotting	  with	  p65/Rel	  antibody	  (WB:p65),	  or	  with	  a	  polyclonal	  anti-­‐IκBα	  antibody	  (WB:	  
IκBα).	  (B)	  Whole	  cell	  lysates	  (not	  immunoprecipitated)	  were	  also	  separated	  and	  blotted	  











The	  novel	  IκBα 	  cleavage	  product	  and	  p65/RelA	  predominately	  localize	  in	  the	  
cytoplasm	  post	  H2O2	  treatment.	  
	   IκBα	  mediates	  its	  inhibitory	  function	  by	  sequestering	  NFκB/Rel	  dimers	  in	  the	  
cytoplasm,	  therefore	  the	  predominant	  cytoplasmic	  localization	  of	  IκBα	  is	  critical	  to	  its	  
inhibitory	  functionality.	  	  Analysis	  of	  nuclear	  and	  cytoplasmic	  extracts	  from	  naïve	  and	  
H2O2	  treated	  Ramos	  cells	  revealed	  that	  similar	  to	  the	  full-­‐length	  IκBα,	  the	  novel	  
cleavage	  product	  (figure	  30A)	  and	  p65/RelA	  (figure	  30B)	  are	  predominantly	  localized	  in	  
the	  cytoplasm.	  	  These	  results	  in	  conjunction	  the	  association	  of	  the	  novel	  IκBα	  cleavage	  
product	  with	  p65/RelA	  make	  it	  reasonable	  to	  speculate	  that	  the	  novel	  IκBα	  cleavage	  
product	  retains	  some	  of	  the	  functional	  characteristics	  of	  the	  full-­‐length	  IκBα	  that	  are	  










Figure	  30:	  The	  IκBα  cleavage	  product	  and	  p65/RelA	  predominantly	  localize	  in	  the	  
cytoplasm	  post-­‐H2O2	  treatment.	  	  
Ramos	  cells	  were	  either	  not	  treated	  (0	  µM)	  or	  treated	  with	  200	  µM	  H2O2	  for	  24	  hr.	  	  The	  
cells	  were	  subjected	  for	  nuclear	  and	  cytoplasmic	  protein	  fractionation.	  Equal	  amounts	  
of	  total	  protein	  for	  both	  fractions	  where	  subjected	  to	  SDS/PAGE	  and	  western	  blotting,	  
and	  the	  blots	  were	  probed	  with	  antibodies	  specific	  for	  IκBα	  and	  p65/RelA.	  	  A	  
contaminating	  band	  was	  observed	  in	  the	  cytosolic	  fraction	  at	  approximately	  30	  kDa.	  The	  
integrity	  of	  the	  nuclear	  and	  cytoplasmic	  fractions	  was	  determined	  by	  probing	  for	  
proteins	  known	  to	  reside	  primarily	  in	  the	  cytoplasm	  (GAPDH),	  and	  the	  nucleus	  (p84)	  and	  



















H2O2	  induces	  caspase-­‐mediated	  cleavage	  of	  p65/RelA.	  
	   As	  mentioned	  previously,	  p65/RelA	  is	  a	  well-­‐characterized	  substrate	  for	  caspase	  
cleavage,	  and	  cleaved	  forms	  of	  p65/RelA	  can	  inhibit	  NFκB/Rel	  transcriptional	  activity	  
(see	  background	  pp	  28-­‐29).	  	  It	  was	  therefore	  hypothesized	  that	  H2O2	  treatment	  of	  B	  
lymphocytes	  could	  result	  in	  caspase-­‐mediated	  cleavage	  of	  p65/RelA.	  	  	  The	  H2O2	  
concentrations	  	  (figure	  19)	  that	  induced	  novel	  IκBα	  cleavage	  resulted	  in	  the	  appearance	  
immunoreactive	  bands	  at	  approximately	  40	  and	  50	  kDa	  upon	  western	  blotting	  with	  a	  
polyclonal	  anti-­‐p65/RelA	  antibody	  	  (Figure	  31).	  Interestingly,	  the	  50	  kDa	  fragment	  
appeared	  in	  100	  and	  200	  µM	  H2O2	  treatment	  while	  the	  40	  kDa	  fragment	  was	  observable	  
in	  the	  naïve	  cells	  but	  was	  increased	  at	  the	  higher	  concentrations	  (100	  and	  200	  µM	  
H2O2).	  	  The	  200	  µM	  H2O2	  treatment	  revealed	  a	  marked	  decrease	  in	  full-­‐length	  p65/RelA,	  
along	  with	  the	  highest	  levels	  of	  cleavage	  products.	  The	  H2O2	  time	  course	  treatment	  
revealed	  a	  profile	  of	  p65/RelA	  cleavage	  that	  accrued	  over	  time	  with	  similar	  kinetics	  to	  
the	  novel	  IκBα	  cleavage	  and	  the	  effects	  on	  viability	  (figure	  32).	  
Figure	  31:	  	  p65/RelA	  cleavage	  occurs	  in	  a	  H2O2-­‐concentration	  dependent	  manner.	  
Ramos	  cells	  were	  treated	  with	  increasing	  concentrations	  of	  µM	  H2O2	  (0,	  10,	  25,	  50,	  100,	  
200)	  for	  24	  hr.	  	  Following	  the	  treatment,	  the	  cells	  were	  harvested	  for	  whole	  cell	  protein	  
lysates	  and	  equal	  amounts	  of	  total	  protein	  were	  separated	  via	  SDS/PAGE	  and	  subjected	  
to	  western	  blotting	  utilizing	  a	  polyclonal	  anti-­‐p65/RelA	  antibody	  (or	  β-­‐actin).	  	  The	  full-­‐
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Figure	  32:	  	  H2O2-­‐induced	  cleavage	  of	  p65/RelA	  develops	  over	  time.	  	  	  
Ramos	  cells	  were	  either	  not	  treated	  (naïve,	  N)	  or	  treated	  with	  100	  µM	  H2O2	  and	  
harvested	  for	  whole	  cell	  protein	  lysates	  at	  1,	  4,	  8,	  12,	  16,	  20,	  24,	  and	  48	  hr.	  Following	  
the	  treatment,	  the	  cells	  were	  harvested	  for	  whole	  cell	  protein	  lysates	  and	  equal	  
amounts	  of	  total	  protein	  were	  separated	  via	  SDS/PAGE	  and	  subjected	  to	  western	  
blotting	  utilizing	  a	  polyclonal	  anti-­‐p65/RelA	  antibody	  (or	  β-­‐actin	  control).	  	  The	  full-­‐length	  














The	  formation	  of	  these	  products	  was	  suppressed	  by	  co-­‐treatment	  with	  QVD-­‐OPh	  
(figure	  33A)	  but	  only	  minimally	  by	  DEVD-­‐OPh	  (figure	  33B).	  	  The	  inability	  of	  DEVD-­‐OPh	  to	  
substantially	  inhibit	  caspase	  cleavage	  suggests	  that	  other	  caspases	  are	  involved	  in	  the	  
cleavage	  of	  p65/RelA	  or	  can	  compensate	  for	  caspase-­‐3	  in	  the	  presence	  of	  DEVD-­‐OPh	  
inhibition	  as	  was	  discussed	  above	  (see	  page	  106).	  	  The	  potential	  for	  of	  overlapping	  
caspase	  specificity	  for	  p65/RelA	  was	  addressed	  by	  Levkau	  et	  al,	  with	  in	  vitro	  experiments	  
demonstrating	  that	  multiple	  caspases	  (caspase	  3,	  6,	  and	  7)	  could	  cleave	  p65/RelA	  
(Levkau	  et	  al.,	  1999).	  	  
Figure	  33:	  H2O2-­‐induced	  p65/RelA	  cleavage	  is	  suppressed	  by	  caspase	  inhibition.	  	  	  
(A)	  Ramos	  cells	  were	  either	  not	  treated	  (N,	  naïve)	  or	  treated	  with	  100	  µM	  H2O2	  alone,	  
H2O2	  and	  DMSO	  (vehicle	  control),	  or	  H2O2	  and	  20	  µM	  QVD.	  	  	  (B)	  Ramos	  cells	  were	  also	  
treated	  with	  an	  identical	  experimental	  design	  with	  the	  exception	  of	  utilizing	  a	  Caspase-­‐3	  
specific	  inhibitor	  DEVD-­‐OPh	  at	  20	  µM.	  	  The	  20	  µM	  inhibitor	  treatments	  and	  the	  
respective	  DMSO	  control	  treatments	  were	  applied	  at	  0	  hr	  and	  again	  at	  12	  hr.	  	  	  The	  cells	  
were	  incubated	  for	  a	  total	  of	  24	  hr.	  Equal	  amounts	  of	  total	  protein	  were	  separated	  via	  
SDS/PAGE	  and	  subjected	  to	  western	  blotting	  utilizing	  a	  polyclonal	  anti-­‐p65/RelA	  
antibody	  (or	  β-­‐actin	  control).	  Full-­‐length	  (black	  arrow)	  and	  the	  cleaved	  form	  (grey	  













The	  inhibition	  of	  p65/RelA	  expression	  by	  short	  hair-­‐pin	  interfering	  RNA	  has	  been	  
found	  to	  cause	  a	  cell	  death	  in	  mature	  B	  lymphocyte	  cell	  lines	  suggesting	  that	  disabling	  of	  
p65/RelA	  is	  pro-­‐apoptotic	  (Piva,	  2005).	  Caspase	  activation	  induced	  by	  cell	  death	  and	  
stress	  stimuli	  (TRAIL,	  Fas,	  growth	  factor	  starvation)	  result	  in	  p65/RelA	  cleavage	  products	  
in	  the	  size	  range	  observed	  in	  this	  study,	  and	  cleaved	  p65/RelA	  inhibits	  NFκB/Rel	  activity	  
(Ravi	  et	  al.,	  1998;	  Levkau	  et	  al.,	  1999;	  Kim,	  2005).	  Specifically,	  ectopic	  expression	  of	  a	  
mutant	  caspase	  cleavage	  resistant	  form	  of	  p65/RelA	  was	  able	  to	  sustain	  NFκB/Rel	  
transcriptional	  activity	  and	  cellular	  viability	  during	  growth	  factor	  starvation	  while	  wild-­‐
type	  cells	  could	  not	  (Levkau	  et	  al.,	  1999).	  	  These	  data	  demonstrate	  that	  p65/RelA	  can	  be	  
necessary	  for	  B	  lymphocyte	  viability	  and	  caspase	  cleavage	  of	  p65/RelA	  inhibits	  NFκB/Rel	  











of	  ROI	  on	  p65/RelA	  cleavage.	  	  Our	  data	  suggest	  that	  ROI	  can	  directly	  induce	  p65/RelA	  
caspase	  cleavage,	  resulting	  in	  two	  fragments.	  	  The	  concentration	  dependent	  appearance	  
of	  the	  50	  kDa	  verses	  the	  background	  levels	  of	  the	  40	  kDa	  fragment	  that	  are	  increased	  
with	  H2O2	  concentration	  indicates	  that	  there	  may	  be	  distinct	  patterns	  of	  cleavage	  for	  
the	  two	  fragments.	  	  	  
Caspase	  activity	  suppresses	  NFκB/Rel	  transcriptional	  activity	  during	  H2O2	  exposure.	  
	   In	  the	  context	  of	  this	  study,	  other	  studies	  demonstrating	  the	  inhibitory	  effects	  of	  
caspase	  cleavage	  of	  NFκB/Rel	  family	  proteins	  (e.g.	  p65/RelA	  and	  IκBα)	  on	  NFκB/Rel	  
activity	  (Ravi	  et	  al.,	  1998;	  Levkau	  et	  al.,	  1999;	  Kim,	  et	  al	  2005)	  are	  apparently	  juxtaposed	  
to	  the	  well	  documented	  enhancing	  effects	  of	  H2O2	  on	  NFκB/Rel	  activity	  in	  T	  
lymphocytes	  	  (Schreck	  et	  al.,	  1991;	  Takada	  et	  al.,	  2003).	  	  It	  is	  important	  to	  note	  that	  in	  
these	  studies,	  the	  activation	  of	  NFκB/Rel	  by	  high	  levels	  of	  H2O2	  (e.g.	  100-­‐300	  µM	  range)	  
was	  observed	  at	  early	  time	  points	  (e.g.	  2-­‐4	  hr)	  (Schreck	  et	  al.,	  1991;	  Takada	  et	  al.,	  2003).	  	  
One	  study	  that	  performed	  a	  more	  extensive	  time	  course	  found	  that	  a	  T-­‐cell	  line	  treated	  
with	  500	  µM	  H2O2	  enhanced	  a	  luciferase	  reporter	  driven	  by	  a	  HIV-­‐long	  terminal	  repeat	  
sequence	  that	  is	  NFκB/Rel	  dependent	  at	  4	  hr	  but	  the	  expression	  of	  the	  reporter	  was	  
dramatically	  decreased	  to	  near	  control	  levels	  by	  24	  hr	  (Pyo	  et	  al.,	  2008).	  	  	  While	  the	  
authors	  offered	  little	  explanation	  for	  the	  delayed	  inhibitory	  effect	  of	  the	  peak	  
enhancement	  (i.e.	  4	  hr),	  it	  may	  have	  involved	  caspase-­‐mediated	  targeting	  of	  NFκB/Rel	  
family	  proteins	  as	  has	  been	  observed	  in	  this	  study.	  These	  data	  lead	  to	  the	  question	  of	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whether	  or	  not	  H2O2-­‐mediated	  caspase	  activation	  could	  have	  a	  suppressive	  effect	  on	  
NFκB/Rel	  transcriptional	  activity,	  or	  conversely	  if	  inhibition	  of	  caspase	  activity	  will	  
enhance	  NFκB/Rel	  activity	  in	  H2O2	  treated	  lymphocytes.	  	  To	  this	  end,	  Ramos	  cells	  were	  
transiently	  transfected	  with	  a	  3x-­‐NFκB-­‐Luc	  reporter	  as	  a	  measure	  of	  NFκB/Rel	  activity	  
and	  treated	  with	  H2O2	  in	  the	  presence	  and	  absence	  of	  the	  pan-­‐caspase	  inhibitor	  QVD-­‐
OPh.	  	  The	  co-­‐treatment	  of	  cells	  with	  high	  level	  H2O2	  (200	  µM)	  and	  caspase	  inhibitor	  
(QVD-­‐OPh)	  resulted	  in	  increased	  3x-­‐NFκB-­‐Luc	  expression	  relative	  to	  the	  H2O2	  control	  
(figure	  34).	  	  	  The	  results	  of	  the	  luciferase	  assay	  were	  normalized	  to	  percent	  cell	  viability	  
to	  account	  for	  any	  effects	  of	  cell	  death	  on	  global	  cellular	  transcription.	  Interestingly,	  
QVD	  alone	  demonstrated	  a	  relatively	  modest	  enhancing	  effect	  on	  the	  3x-­‐NFκB-­‐Luc	  
reporter.	  	  	  The	  cells	  were	  transiently	  transfected	  using	  electroporation,	  which	  is	  known	  
to	  induce	  cell	  death,	  perhaps	  through	  activation	  of	  caspases,	  and	  therefore	  may	  account	  
for	  this	  enhancing	  effect	  of	  QVD-­‐OPh.	  However,	  the	  reporter	  activity	  was	  still	  enhanced	  
by	  the	  H2O2	  and	  QVD-­‐OPh	  co-­‐treatment	  to	  statistical	  significance	  when	  compared	  to	  
either	  the	  QVD-­‐OPh	  alone	  or	  H2O2	  treated	  controls.	  	  This	  demonstrates	  that	  H2O2	  
treatment	  strongly	  enhances	  3x-­‐NFκB-­‐Luc	  activity	  if	  caspases	  are	  inhibited	  by	  QVD-­‐OPh	  
treatment.	  	  It	  is	  therefore	  reasonable	  to	  speculate	  that	  in	  B	  lymphocytes,	  ROI-­‐exposure	  
(e.g.	  200	  µM	  H2O2)	  can	  induce	  NFκB-­‐mediated	  transcriptional	  activity	  that	  is	  suppressed	  
by	  H2O2-­‐induced	  caspase	  activity.	  	  While	  it	  is	  possible	  that	  other	  mechanisms	  could	  be	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involved	  in	  the	  caspase-­‐mediated	  suppression	  of	  NFκB/Rel	  activity	  in	  response	  to	  H2O2	  
exposure,	  it	  is	  likely	  that	  the	  p65/RelA	  and	  the	  novel	  IκBα	  cleavage	  products	  play	  a	  role.	  
Figure	  34:	  	  Caspase	  activity	  suppresses	  NFκB/Rel	  transcriptional	  activity	  in	  H2O2	  
treated	  cells.	  	  	  
Ramos	  cells	  were	  transiently	  transfected	  with	  the	  3x-­‐NFκB-­‐Luc	  luciferase	  reporter	  
plasmid	  and	  either	  treated	  with	  DMSO	  or	  20	  µM	  QVD-­‐OPh	  alone,	  or	  treated	  with	  DMSO	  
or	  20	  µM	  QVD-­‐OPh	  in	  the	  presence	  of	  200	  µM	  H2O2.	  The	  20	  µM	  inhibitor	  treatments	  
and	  the	  respective	  DMSO	  control	  treatments	  were	  applied	  at	  0	  hr	  and	  again	  at	  12	  hr.	  
The	  treated	  cells	  were	  then	  plated	  in	  triplicate,	  incubated	  for	  24	  hr,	  and	  harvested	  for	  
whole	  cell	  protein	  lysates,	  which	  were	  assayed	  for	  luciferase	  activity.	  	  Results	  are	  
displayed	  as	  mean	  relative	  light	  units/%	  viability	  for	  3	  separate	  experiments.	  *	  p<0.05	  
signifies	  statistically	  significant	  differences	  between	  H2O2	  +	  QVD	  and	  QVD	  alone	  or	  H2O2	  
+	  DMSO	  as	  per	  1-­‐way	  ANOVA	  with	  a	  Dunnett’s	  post-­‐hoc	  test.	  Error	  bars	  represent	  









Caspase	  activity	  suppresses	  mRNA	  of	  the	  NFκB/Rel-­‐dependent	  genes	  xiap	  and	  bcl-­‐xl	  
during	  H2O2	  exposure.	  
Pro-­‐survival	  genes	  that	  oppose	  programmatic	  cell	  death	  such	  as	  xiap	  and	  bcl-­‐xL	  
are	  regulated	  by	  the	  NFκB/Rel	  pathway	  and	  can	  be	  influenced	  by	  ROI	  exposure	  (Yi	  et	  al.,	  
1996;	  Chen	  et	  al.,	  2000;	  Hamano	  et	  al.,	  2002;	  Rosato	  et	  al.,	  2007).	  	  Caspase-­‐mediated	  
suppression	  of	  NFκB/Rel-­‐activity	  (figure	  34)	  may	  lead	  to	  suppression	  of	  pro-­‐survival	  
NFκB/Rel-­‐dependent	  genes	  linking	  caspase-­‐mediated	  disabling	  of	  the	  NFκB/Rel	  
pathway	  with	  cell	  death	  in	  H2O2-­‐exposed	  B	  lymphocytes.	  	  Therefore,	  the	  effect	  of	  H2O2	  
and	  caspase	  inhibition	  on	  the	  expression	  of	  the	  pro-­‐survival	  genes	  xiap	  and	  bcl-­‐xl	  was	  
evaluated.	  	  It	  was	  found	  that	  while	  H2O2	  with	  or	  without	  DMSO	  (or	  QVD-­‐OPh	  alone)	  had	  
no	  effect,	  co-­‐treatment	  with	  H2O2	  and	  QVD-­‐OPh	  resulted	  in	  an	  increase	  in	  xiap	  and	  bcl-­‐xl	  
















Figure	  35:	  	  Caspase	  activity	  suppresses	  NFκB/Rel-­‐dependent	  gene	  transcript	  levels	  in	  
H2O2	  treated	  cells.	  
Ramos	  cells	  were	  either	  not	  treated	  (N,	  naïve)	  or	  treated	  with	  100	  µM	  H2O2	  alone,	  H2O2	  
and	  DMSO	  (vehicle	  control),	  or	  H2O2	  and	  20	  µM	  QVD.	  	  Cells	  were	  also	  similarly	  treated	  
with	  QVD	  and	  DMSO	  (and	  Naïve	  control)	  in	  the	  absence	  of	  H2O2	  to	  control	  for	  effects	  of	  
QVD.	  	  The	  cells	  were	  then	  plated	  in	  triplicate	  (5	  mL/well)	  and	  incubated	  for	  24	  hr.	  The	  20	  
µM	  inhibitor	  treatments	  and	  the	  respective	  DMSO	  control	  treatments	  were	  applied	  at	  0	  
hr	  and	  again	  at	  12	  hr.	  	  The	  cells	  were	  incubated	  for	  a	  total	  of	  24	  hr.	  The	  cells	  were	  
harvested	  for	  total	  RNA,	  which	  was	  reverse	  transcribed	  into	  a	  cDNA	  library,	  and	  relative	  
levels	  xiap	  (A)	  or	  bcl-­‐xl	  (B)	  cDNA	  were	  determined	  via	  sybr-­‐green	  real-­‐time	  PCR	  utilizing	  
β-­‐actin	  as	  a	  reference	  gene.	  	  The	  results	  are	  derived	  from	  representative	  experiments	  
and	  displayed	  as	  relative	  quantification	  values	  (RQ	  values)	  derived	  by	  the	  Pfaffl	  method	  
equation	  RQ=2
-­‐ΔΔCt
	  and	  normalized	  to	  naïve	  controls.	  Statistically	  significant	  differences	  
relative	  to	  the	  DMSO	  controls	  were	  determined	  via	  a	  1-­‐way	  ANOVA	  with	  a	  Dunnett	  ’s	  




















Western	  blots	  were	  performed	  to	  determine	  if	  H2O2	  exposure	  in	  the	  absence	  or	  
presence	  of	  caspase	  inhibition	  also	  affected	  the	  protein	  expression	  of	  XIAP	  and	  Bcl-­‐xL.	  
XIAP	  protein	  levels	  were	  moderately	  decreased	  in	  the	  cells	  co-­‐treated	  with	  H2O2	  and	  
DMSO	  but	  co-­‐treatment	  with	  H2O2	  and	  QVD-­‐OPh	  appeared	  to	  reverse	  the	  decreased	  
expression	  (figure	  36A).	  	  The	  XIAP	  protein	  itself	  has	  been	  found	  to	  be	  a	  target	  of	  caspase	  












































performed	  in	  this	  study	  (Hornle	  et	  al.,	  2011).	  	  While	  the	  QVD-­‐OPh-­‐mediated	  blockade	  of	  
caspase	  activity	  could	  be	  enhancing	  protein	  expression	  via	  effects	  on	  NFκB/Rel-­‐
mediated	  xiap	  transcription,	  it	  cannot	  be	  ruled	  out	  that	  direct	  caspase	  cleavage	  of	  XIAP	  
protein	  may	  in	  part,	  be	  involved	  in	  the	  H2O2-­‐	  and	  QVD-­‐OPh-­‐mediated	  effects	  on	  XIAP	  
protein	  levels	  observed	  in	  this	  study.	  	  
	  H2O2	  exposure	  had	  minimal	  effects	  on	  Bcl-­‐xL	  protein	  expression,	  and	  the	  H2O2	  
and	  QVD-­‐OPh	  co-­‐treatment	  on	  Bcl-­‐xL	  protein	  levels	  varied	  between	  no	  effect	  and	  a	  
slight	  enhancement	  in	  4	  separate	  experiments	  leading	  to	  the	  conclusion	  that	  Bcl-­‐xL	  
protein	  levels	  are	  not	  significantly	  altered	  by	  QVD-­‐OPh	  under	  these	  conditions	  (figure	  
36B).	  	  The	  modest	  effects	  of	  QVD-­‐OPh	  on	  Bcl-­‐xL	  mRNA	  expression	  may	  make	  it	  
challenging	  to	  discern	  differences	  at	  the	  protein	  level.	  	  Moreover,	  It	  is	  important	  to	  note	  
that	  QVD-­‐OPh	  only	  partially	  reversed	  the	  H2O2-­‐mediated	  decrease	  in	  cellular	  viability	  in	  
the	  Ramos	  cell	  line	  (figure	  28B).	  	  It	  is	  possible	  that	  the	  presence	  of	  viable	  cells	  in	  the	  
H2O2	  and	  QVD-­‐OPh	  co-­‐treatment	  group	  might	  be	  masking	  a	  modest	  yet	  discernable	  
QVD-­‐OPh	  effect	  in	  the	  Bcl-­‐xL	  protein	  levels	  of	  non-­‐viable	  cells,	  if	  suppressed	  bcl-­‐xL	  	  
expression	  correlates	  with	  B	  lymphocyte	  cell	  death	  as	  has	  been	  previously	  
demonstrated	  (Yi	  et	  al.,	  1996).	  	  
Figure	  36:	  	  Effects	  of	  caspase	  inhibition	  on	  XIAP	  and	  Bcl-­‐xL	  protein	  expression.	  
Ramos	  cells	  were	  either	  not	  treated	  (N,	  naïve)	  or	  treated	  with	  100	  µM	  H2O2	  alone,	  H2O2	  
and	  DMSO	  (vehicle	  control),	  or	  H2O2	  and	  20	  µM	  QVD.	  	  The	  20	  µM	  inhibitor	  treatments	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and	  the	  respective	  DMSO	  control	  treatments	  were	  applied	  at	  0	  hr	  and	  again	  at	  12	  hr.	  	  	  
The	  cells	  were	  incubated	  for	  a	  total	  of	  24	  hr.	  Equal	  amounts	  of	  total	  protein	  were	  
separated	  via	  SDS/PAGE	  and	  subjected	  to	  western	  blotting	  XIAP	  (A)	  or	  Bcl-­‐xL	  (B)	  or	  







XIAP	  and	  Bcl-­‐xL	  are	  only	  two	  in	  a	  number	  of	  NFκB/Rel-­‐dependent	  genes	  that	  
support	  cellular	  viability.	  	  The	  c-­‐IAP-­‐2	  gene	  is	  also	  a	  NFκB/Rel-­‐dependent	  pro-­‐survival	  
gene	  that	  codes	  for	  a	  protein	  that	  functionally	  opposes	  mitochondrial-­‐mediated	  cell	  
death.	  	  A	  study	  showed	  that	  treatment	  of	  B	  lymphocyte	  cell	  lines	  with	  15-­‐deoxy-­‐Δ12,14-­‐
prostaglandin	  J2	  (PDGJ2),	  a	  known	  inducer	  of	  ROI	  and	  NFκB/Rel	  inhibitor,	  inhibited	  
cellular	  viability	  in	  a	  caspase	  dependent	  manner,	  and	  inhibited	  NFκB/Rel	  activity	  and	  
cIAP-­‐	  2	  (and	  XIAP)	  protein	  expression	  (Alvarez-­‐Maqueda	  et	  al.,	  2004;	  Piva,	  2005).	  	  
Interestingly,	  PGDJ2	  did	  not	  decrease	  Bcl-­‐xL	  expression	  suggesting	  that	  caspase	  inhibition	  






study	  showed	  that	  in	  a	  T-­‐cell	  lymphoma	  line	  ciap-­‐1	  and	  2	  exhibited	  higher	  occupancy	  of	  
p65	  within	  their	  promoters	  than	  the	  NFκB/Rel-­‐dependent	  bcl-­‐family	  protein	  bcl-­‐2,	  and	  
treatment	  with	  bortezomib,	  an	  ROI-­‐producing	  proteosome	  inhibitor,	  caused	  cell	  death	  
and	  significant	  decreases	  in	  p65	  occupancy	  of	  the	  ciap-­‐1	  and	  2	  promoters	  as	  well	  as	  
decreased	  mRNA	  and	  protein	  expression.	  Alternatively,	  bortezomib	  caused	  no	  effect	  on	  
p65/RelA	  occupancy	  in	  the	  bcl-­‐2	  promoter	  and	  subsequently	  no-­‐effect	  on	  bcl-­‐2	  mRNA	  or	  
protein	  expression	  (Perez-­‐Galan	  et	  al.,	  2006;	  Juvekar	  et	  al.,	  2011).	  	  Therefore,	  the	  
Juvekar	  et	  al	  study	  demonstrates	  the	  capacity	  for	  stimulus-­‐induced	  gene-­‐specific	  
regulation	  by	  the	  NFκB/Rel	  pathway,	  which	  could	  occur	  in	  response	  to	  H2O2	  exposure	  
and	  explain	  the	  minimal	  effect	  on	  bcl-­‐xL.	  The	  potential	  for	  caspase-­‐mediated	  
suppression	  of	  NFκB/Rel	  activity	  in	  response	  to	  ROI	  exposure	  demonstrated	  in	  this	  study	  
therefore	  compels	  further	  comprehensive	  investigation	  into	  how	  this	  response	  can	  
affect	  specific	  NFκB/Rel-­‐dependent	  genes	  involved	  in	  mediating	  cell	  survival	  and	  death.	  
Chapter	  III:	  Conclusion	  
The	  results	  of	  this	  study	  indicate	  that	  B	  lymphocyte	  function	  and	  viability	  can	  be	  
significantly	  influenced	  by	  ROI.	  	  	  	  The	  nature	  of	  the	  effect	  of	  ROI	  is	  dependent	  on	  the	  
concentration	  and	  the	  activation	  state	  of	  the	  cell.	  	  Low	  concentrations	  of	  exogenous	  
H2O2	  (e.g.	  30-­‐50	  µM)	  and/or	  activation-­‐induced	  ROI,	  enhanced	  3’IghRR	  activity.	  These	  
effects	  were	  most	  pronounced	  in	  the	  activated	  state.	  The	  ROI-­‐mediated	  enhancement	  
of	  3’IghRR	  activity	  likely	  impacts	  processes	  associated	  with	  the	  3’IghRR	  such	  as	  Igh	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expression	  and	  class	  switch	  recombination	  during	  activation,	  and	  the	  enhancement	  of	  
these	  processes	  could	  support	  adaptive	  immunity	  (Gregor	  &	  Morrison,	  1986;	  Lieberson	  
et	  al.,	  1995;	  Vincent-­‐Fabert	  et	  al.,	  2010).	  	  High	  concentrations	  of	  exogenous	  H2O2	  were	  
capable	  of	  suppressing	  3’IghRR	  activity	  in	  both	  non-­‐activated	  and	  activated	  cells,	  and	  
substantially	  decreased	  viability	  in	  the	  non-­‐activated	  state.	  There	  appears	  to	  be	  a	  
concentration	  dependent	  threshold	  that	  delineates	  between	  the	  enhancing	  effects	  and	  
the	  inhibitory	  cytotoxic	  effects	  of	  ROI.	  	  The	  ROI-­‐mediated	  inhibition	  of	  3’IghRR	  activity	  
could	  suppress	  Ig	  expression	  or	  class-­‐switch	  recombination	  resulting	  in	  decreased	  BCR	  
expression	  or	  secreted	  forms	  of	  Ig	  both	  of	  which	  facilitate	  immune	  surveillance.	  	  
A	  common	  functional	  target	  that	  appears	  to	  link	  both	  the	  enhancing	  and	  
inhibitory	  effects	  of	  ROI	  is	  the	  NFκB/Rel	  pathway.	  	  Our	  results	  demonstrated	  an	  
NFκB/Rel-­‐dependent	  activation	  of	  the	  3’IghRR	  by	  low	  concentrations	  of	  H2O2.	  
Moreover,	  the	  high	  concentrations	  of	  H2O2	  relatively	  inhibited	  3’IghRR	  and	  NFκB/Rel	  
activity.	  	  
While	  3’IghRR	  activity	  is	  an	  intriguing	  endpoint	  of	  this	  study,	  we	  also	  found	  that	  
ROI	  affects	  viability,	  particularly	  in	  non-­‐activated	  cells.	  Interestingly,	  we	  found	  that	  the	  
viability	  of	  LPS-­‐activated	  cells,	  which	  are	  activated	  primarily	  through	  the	  NFκB/Rel	  
pathway,	  appears	  to	  be	  more	  tolerant	  to	  the	  higher	  concentrations	  of	  H2O2	  than	  the	  
non-­‐activated	  cells.	  	  While	  the	  pro-­‐survival	  mechanism	  of	  LPS-­‐activation	  is	  complex	  and	  
requires	  further	  investigation,	  we	  observed	  that	  100-­‐200	  µM	  H2O2	  induced	  the	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formation	  of	  a	  novel	  caspase-­‐mediated	  cleavage	  product	  of	  IκBα	  that	  was	  repressed	  by	  
LPS	  activation.	  	  This	  suggests	  that	  the	  novel	  IκBα	  cleavage	  product	  is	  associated	  with	  cell	  
death.	  Furthermore,	  it	  demonstrates	  that	  H2O2-­‐induced	  pro-­‐death	  caspase	  activity	  
targets	  the	  NFκB/Rel	  family	  members	  (i.e.	  IκBα),	  which	  can	  be	  prevented	  by	  activating	  B	  
lymphocytes	  with	  an	  NFκB/Rel	  activating	  stimulus.	  	  Therefore	  the	  ROI	  concentration	  
and	  activation	  state	  of	  the	  B	  lymphocyte	  influence	  the	  effect	  of	  ROI	  on	  the	  NFκB/Rel	  
pathway.	  	  
The	  aforementioned	  ROI	  concentration	  threshold	  that	  delineates	  between	  the	  
enhancing	  and	  inhibitory	  effects	  of	  ROI	  may	  be,	  at	  least	  in	  part,	  defined	  by	  the	  caspase	  
activation.	  	  	  Utilizing	  capase-­‐3	  as	  an	  indicator	  for	  caspase	  activation	  we	  found	  that	  
treatment	  with	  higher	  concentrations	  of	  H2O2	  increased	  levels	  of	  activated	  caspase-­‐3.	  	  
At	  these	  higher	  concentrations,	  caspase	  activation	  correlates	  with	  decreased	  viability,	  as	  
well	  as	  decreased	  3’IghRR	  and	  NFκB/Rel	  activity.	  	  	  	  
A	  salient	  finding	  of	  this	  study	  was	  that	  inhibition	  of	  H2O2-­‐induced	  caspase	  activity	  
(e.g.	  QVD-­‐OPh	  treatment)	  enhanced	  NFκB/Rel	  activity.	  	  This	  links	  caspase	  activity	  to	  the	  
suppression	  of	  H2O2-­‐mediated	  NFκB/Rel	  activity.	  	  The	  fact	  that	  QVD-­‐OPh	  also	  either	  
completely	  (CH12IκBαAA	  cells)	  or	  partially	  (Ramos	  cell	  line)	  reversed	  viability	  correlates	  
caspase-­‐dependent	  NFκB/Rel	  activity	  with	  the	  viability	  of	  the	  cell.	  	  Considering	  that	  
NFκB/Rel	  activity	  has	  been	  found	  to	  be	  strongly	  associated	  with	  B	  lymphocyte	  viability	  it	  
appears	  that	  the	  targeting	  of	  the	  NFκB/Rel	  pathway	  by	  caspases	  is	  likely	  involved	  in	  the	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process	  of	  cell	  death	  (Wu	  et	  al.,	  1996;	  Grossmann	  et	  al.,	  1999;	  Levkau	  et	  al.,	  1999;	  
Reuther	  &	  Baldwin,	  1999;	  Claudio	  et	  al.,	  2002).	  	  H2O2	  exposure	  resulting	  in	  the	  activation	  
of	  caspases	  that	  cleave	  NFκB/Rel	  family	  proteins	  (IκBα	  and	  p65/RelA)	  could	  collectively	  
result	  in	  the	  suppression	  of	  NFκB/Rel-­‐dependent	  expression	  of	  pro-­‐survival	  genes	  such	  
as	  xiap	  and	  bcl-­‐xl,.	  	  	  While	  the	  effects	  of	  H2O2-­‐mediated	  caspase	  activity	  on	  the	  
NFκB/Rel-­‐dependent	  Bcl-­‐xL	  and	  XIAP	  proteins	  were	  not	  entirely	  conclusive,	  the	  pro-­‐
survival	  gene-­‐specific	  NFκB/Rel	  regulation	  demonstrated	  by	  the	  Juvekar	  et	  al	  warrants	  
the	  investigation	  the	  H2O2	  effect	  on	  other	  NFκB/Rel-­‐dependent	  pro-­‐survival	  genes	  such	  
as	  cIAP-­‐1	  and	  -­‐2	  (Juvekar	  et	  al.,	  2011).	  	  
The	  direct	  effects	  of	  H2O2-­‐mediated	  caspase	  activity	  on	  the	  NFκB/Rel	  pathway	  
were	  in	  part	  determined	  by	  the	  detection	  of	  p65/RelA	  and	  IκBα	  cleavage	  products.	  	  Cell	  
death	  stimuli	  have	  been	  found	  to	  cause	  the	  formation	  of	  similar	  sized	  p65/RelA	  
fragments	  in	  other	  cell	  types,	  and	  the	  cleavage	  of	  p65/RelA	  causes	  decreased	  NFκB/Rel	  
activity	  and	  cellular	  viability	  (Levkau	  et	  al.,	  1999;	  Kim,	  2005).	  	  	  	  The	  formation	  of	  these	  
products	  in	  response	  to	  H2O2	  treatment	  of	  B	  lymphocytes	  is	  suggestive	  of	  at	  least	  part	  of	  
the	  mechanism	  involving	  the	  disabling	  of	  NFκB/Rel	  activity.	  	  	  	  
The	  formation	  of	  the	  novel	  IκBα	  cleavage	  product	  presents	  yet	  another	  likely	  
mechanism	  for	  the	  disabling	  of	  the	  NFκB/Rel	  pathway.	  	  Cleavage	  at	  its	  N-­‐terminus,	  its	  
ability	  to	  associate	  with	  p65/RelA,	  and	  its	  primarily	  cytoplasmic	  localization	  with	  p65	  are	  
inhibitory	  features	  similar	  to	  that	  of	  the	  ΔN	  and	  full	  length	  forms	  of	  IκBα,	  albeit	  further	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research	  is	  required	  for	  direct	  evidence	  of	  its	  inhibitory	  function.	  	  The	  H2O2-­‐induced	  
formation	  of	  the	  novel	  IκBα	  cleavage	  product	  in	  multiple	  B	  cell	  lines	  but	  not	  in	  HeLa	  
cells	  indicates	  that	  while	  its	  formation	  is	  likely	  a	  feature	  of	  B	  lymphocyte	  oxidative	  stress	  
it	  is	  not	  a	  universal	  oxidative	  stress	  response	  in	  all	  cell	  types.	  	  This	  underlies	  the	  
importance	  of	  evaluating	  the	  effects	  of	  ROI	  and	  caspase	  targeting	  of	  the	  NFκB/Rel	  
pathway	  when	  determining	  mechanisms	  of	  cell	  death	  in	  other	  tissues.	  	  Cyclohexamide,	  a	  
non-­‐ROI	  molecule	  found	  to	  induce	  mitochondrial-­‐mediated	  cell	  death	  in	  the	  Ramos	  cell	  
line,	  caused	  the	  formation	  of	  the	  novel	  IκBα	  cleavage	  product.	  	  This	  shows	  that	  the	  
novel	  IκBα	  cleavage	  product	  formation	  does	  not	  require	  H2O2	  exposure	  and	  suggests	  it	  
may	  be	  a	  general	  feature	  of	  caspase-­‐mediated	  cell	  death	  in	  B	  lymphocytes.	  
These	  results	  collectively	  increase	  our	  understanding	  of	  how	  B	  lymphocytes	  
function	  in	  the	  context	  of	  ROI,	  which	  could	  impact	  our	  understanding	  of	  the	  B	  
lymphocyte’s	  role	  in	  immunity	  as	  well	  as	  the	  exploration	  of	  treatment	  options	  for	  B	  
lymphocyte	  related	  disease.	  	  Such	  effects	  on	  immunity	  could	  involve	  the	  decline	  in	  
adaptive	  immunity	  associated	  with	  aging	  which	  is	  characterized	  by	  declines	  in	  peripheral	  
mature	  B	  lymphocyte	  cell	  numbers,	  serum	  Ig,	  and	  antibody	  response	  (Buckley	  &	  Dorsey,	  
1970;	  Paganelli	  et	  al.,	  1992;	  Frasca	  et	  al.,	  2010;	  Frasca	  &	  Blomberg,	  2011).	  	  Furthermore,	  
aging	  is	  associated	  with	  increased	  levels	  of	  ROI	  and	  decreased	  levels	  of	  key	  anti-­‐oxidant	  
enzymes	  in	  lymphocytes	  (Reddy	  Thavanati	  et	  al.,	  2008).	  	  The	  ROI	  level	  dependent	  effects	  
on	  3’IgRR-­‐mediated	  Igh	  expression,	  NFκB/Rel	  activity,	  and	  viability	  uncovered	  in	  this	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study	  could	  be	  an	  important	  context	  for	  future	  studies	  designed	  to	  understand	  and	  treat	  
the	  decline	  of	  adaptive	  immunity	  in	  aging.	  	  	  	  
Furthermore,	  there	  are	  a	  number	  of	  B	  lymphocyte	  disease	  states	  that	  could	  be	  
impacted	  by	  ROI-­‐mediated	  modulations	  of	  the	  3’IghRR	  and	  NFκB/Rel	  activity.	  	  Pervasive	  
autoimmune	  diseases	  like	  rheumatoid	  arthritis	  (RA),	  have	  been	  found	  to	  correlate	  with	  a	  
polymorphism	  within	  the	  hs1,2	  of	  the	  3’IghRR	  (Tolusso	  et	  al.,	  2009).	  	  Moreover,	  RA	  is	  
associated	  with	  increased	  levels	  of	  ROI	  and	  increased	  levels	  of	  NFκB/Rel	  in	  B	  
lymphocytes	  of	  RA	  patients	  (Remans	  et	  al.,	  2005;	  Pedersen-­‐Lane	  et	  al.,	  2007;	  Woo	  et	  al.,	  
2011).	  	  Rituximab,	  an	  efficacious	  adujvant	  RA	  treatment,	  that	  targets	  and	  depletes	  
CD20-­‐positive	  activated	  B	  lymphocytes	  has	  been	  found	  to	  be	  most	  efficacious	  in	  
seropositive	  patients	  (e.g.	  patients	  expressing	  auto-­‐antibodies),	  suggesting	  that	  the	  
elimination	  of	  antibody	  producing	  B	  lymphocytes	  is	  an	  effective	  treatment	  of	  disease	  
(Edwards	  et	  al.,	  2004;	  Jazirehi	  et	  al.,	  2005).	  	  	  More	  work	  is	  required	  to	  fully	  understand	  
the	  impact	  of	  RA	  autoantibodies	  in	  the	  disease,	  but	  they	  have	  been	  shown	  to	  be	  reliable	  
biomarkers	  for	  RA	  disease	  progression	  and	  to	  be	  involved	  in	  causative	  mechanisms	  of	  
the	  disease	  (Lal	  et	  al.,	  2011;	  Darrah	  et	  al.,	  2013).	  	  Future	  research	  focused	  on	  NFκB/Rel-­‐
mediated	  3’IghRR	  activity	  in	  RA-­‐associated	  B	  lymphocytes	  and	  how	  it	  is	  influenced	  by	  
ROI	  exposure	  could	  prove	  beneficial	  in	  understanding	  RA	  autoantibody	  production	  and	  
in	  identifying	  treatable	  mechanisms	  to	  inhibit	  their	  production.	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Increased	  ROI	  levels	  are	  associated	  with	  cancers	  (Schumacker,	  2006;	  
Trachootham	  et	  al.,	  2006),	  and	  can	  be	  facilitated	  by	  an	  attenuated	  capacity	  of	  the	  
antioxidant	  system	  to	  metabolize	  ROI	  as	  has	  been	  observed	  in	  B	  lymphocyte	  
malignancies	  (Tome	  et	  al.,	  2005;	  Lightfoot	  et	  al.,	  2006;	  Wang,	  2006).	  It	  is	  reasonable	  to	  
speculate	  that	  a	  more	  oxidizing	  intracellular	  environment	  is	  not	  oxidizing	  enough	  to	  
surpass	  a	  viability	  threshold,	  but	  oxidizing	  enough	  to	  persistently	  activate	  redox	  nodes	  
of	  control	  such	  as	  the	  thioredoxin	  system	  or	  redox-­‐sensitive	  pro-­‐survival	  pathways	  such	  
as	  NFκB/Rel.	  	  These	  redox-­‐activated	  pathways	  could	  act	  in	  concert	  to	  promote	  redox	  
adaptation	  and	  chemoresistance.	  	  A	  study	  of	  DLBCL	  demonstrated	  that	  lymphomas	  with	  
decreased	  antioxidant	  defense	  and	  increased	  thioredoxin	  system	  function	  correlated	  
with	  a	  worse	  prognosis	  (Tome	  et	  al.,	  2005).	  	  Moreover,	  chemoresistance	  in	  B	  
lymphocyte	  malignancies	  has	  been	  found	  to	  be	  redox-­‐dependent.	  	  A	  vincristine-­‐resistant	  
lymphoma	  cell	  line	  demonstrates	  resistance	  to	  vincristine	  as	  well	  as	  H2O2-­‐mediated	  
caspase	  activation	  and	  cell	  death	  (Tsai	  et	  al.,	  2007).	  Another	  study	  showed	  that	  
chemoresistance	  in	  a	  B	  cell	  lymphoma	  was	  lost	  after	  being	  cultured	  for	  several	  weeks	  
but	  chemoresistance	  could	  be	  restored	  if	  the	  derived	  cell-­‐line	  (DOGUM)	  was	  pre-­‐
exposed	  to	  H2O2	  for	  24	  hr	  or	  periodic	  exposure	  to	  doxorubicin	  (a	  ROI-­‐producing	  
anthracycline),	  suggesting	  that	  chemoresistance	  can	  be	  plastic.	  	  Therapeutically	  
overcoming	  chemoresistance	  might	  be	  potentially	  achieved	  through	  further	  oxidizing	  
the	  cell	  by	  disabling	  redox-­‐mediated	  chemoresistance	  mechanisms	  (e.g.	  thioredoxin	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system)	  via	  the	  disruption	  of	  glutathione	  homeostasis	  (thioredoxin	  function	  is	  
dependent	  on	  glutathione).	  This	  theory	  is	  supported	  by	  a	  study	  showed	  that	  oncogenic	  
transformation	  of	  ovarian	  epithelial	  cells	  by	  the	  expression	  of	  a	  h-­‐ras	  oncogene	  resulted	  
in	  increased	  levels	  or	  ROI.	  	  Treatment	  of	  the	  cells	  with	  the	  oxidizing	  agent,	  β-­‐
phenylethyl-­‐isothiocyanate,	  resulted	  in	  further	  increases	  in	  intracellular	  ROI,	  depletion	  
of	  glutathione	  levels,	  and	  ROI-­‐dependent	  cell	  death	  (Trachootham	  et	  al.,	  2006).	  	  
Furthermore,	  a	  study	  utilizing	  a	  doxorubicin-­‐resistant	  T	  lymphocyte	  cell	  line,	  
demonstrated	  the	  cell	  line	  could	  be	  sensitized	  to	  doxorubicin	  by	  co-­‐treatment	  with	  a	  
glutathione	  synthesis	  inhibitor	  (buthionine	  sulfoximine).	  This	  co-­‐treatment	  enhanced	  
caspase	  activity	  and	  cell	  death	  in	  a	  manner	  that	  involved	  the	  inhibition	  of	  Bcl-­‐xL	  protein	  
expression	  (a	  NFκB/Rel-­‐dependent	  gene)	  (Friesen	  et	  al.,	  2004).	  	  
As	  mentioned	  above,	  increased	  ROI	  could	  be	  activating	  thioredoxin	  function	  and	  
the	  NFκB/Rel	  pathway	  and	  supporting	  chemoresistance	  and/or	  viability	  in	  B	  lymphocyte	  
malignancies.	  	  It	  is	  important	  to	  note	  that	  thioredoxin	  and	  NFκB/Rel	  could	  exhibit	  
integrated	  or	  synergistic	  function	  as	  NFκB/Rel	  activity	  can	  be	  regulated	  by	  thioredoxin	  
(Matthews	  et	  al.,	  1992).	  Increased	  NFκB/Rel	  activity	  has	  been	  found	  to	  be	  a	  key	  factor	  in	  
the	  diagnosis	  and	  treatment	  of	  many	  B	  lymphocyte	  malignancies	  (Furman	  et	  al.,	  2000;	  
Cuní	  et	  al.,	  2004;	  Pavan	  et	  al.,	  2008;	  Hewamana	  et	  al.,	  2009),	  and	  direct	  inhibition	  of	  
NFκB/Rel	  activity	  can	  be	  sufficient	  to	  sensitize	  or	  induce	  malignant	  B	  lymphocytes	  to	  cell	  
death	  (Wu	  et	  al.,	  1996;	  Dai	  et	  al.,	  2004;	  Jazirehi	  et	  al.,	  2005;	  Piva,	  2005;	  Hewamana	  et	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al.,	  2008).	  Subsequently,	  ROI-­‐inducing	  therapeutics	  that	  inhibit	  NFκB/Rel	  have	  been	  
shown	  to	  be	  effective	  in	  inducing	  cell	  death	  in	  malignant	  B	  lymphocytes	  (Jazirehi	  et	  al.,	  
2005;	  Piva,	  2005;	  Hewamana	  et	  al.,	  2008).	  	  Therefore,	  in	  the	  context	  of	  this	  study,	  
malignancy-­‐induced	  ROI	  could	  enhance	  NFκB/Rel-­‐dependent	  gene	  expression	  involved	  
in	  pro-­‐survival	  and	  chemoresistance	  mechanisms.	  	  Moreover,	  therapeutically	  increasing	  
the	  level	  of	  ROI	  to	  surpass	  a	  viability	  threshold	  could	  involve	  triggering	  mechanisms	  that	  
inhibit	  NFκB/Rel-­‐dependent	  pro-­‐survival	  mechanisms	  and	  cause	  cell	  death.	  	  	  These	  
mechanisms	  would	  likely	  involve	  caspase-­‐mediated	  inhibition	  of	  NFκB/Rel	  activity.	  	  
Chemoresistant	  B	  lymphocyte	  malignancies	  that	  involve	  activated	  NFκB/Rel	  such	  as	  
activated	  B	  cell-­‐diffuse	  large	  B	  cell	  lymphoma	  may	  require	  disruption	  of	  the	  thioredoxin	  
pathway	  to	  reach	  a	  viability	  threshold,	  inhibit	  NFκB/Rel	  activity,	  and	  induce	  cell	  death	  
(Pavan	  et	  al.,	  2008).	  	  	  
Further	  investigation	  into	  the	  effects	  of	  ROI-­‐induced	  caspase	  targeting	  of	  the	  
NFκB/Rel	  pathway	  on	  pro-­‐survival	  gene	  expression	  could	  develop	  our	  knowledge	  of	  
NFκB/Rel-­‐dependent	  viability	  in	  B	  lymphocyte	  malignancy.	  	  The	  vincristine-­‐resistant	  cell	  
line	  demonstrated	  a	  lack	  of	  caspase	  activation	  while	  another	  B-­‐cell	  lymphoma	  model	  
demonstrated	  chemoresistance	  downstream	  of	  caspase	  activation	  (Hirokawa	  et	  al.,	  
2002;	  Tsai	  et	  al.,	  2007).	  This	  suggests	  that	  there	  may	  be	  sub-­‐classes	  of	  chemoresistant	  B	  
lymphocyte	  malignancies	  that	  involve	  resistance	  to	  caspase	  activation	  or	  ineffective	  
targeting	  or	  cleavage	  of	  substrates	  like	  NFκB/Rel	  proteins	  by	  caspases.	  	  With	  regard	  to	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resistance	  of	  caspase	  activity,	  there	  are	  many	  NFκB/Rel-­‐dependent	  genes	  involved	  in	  
the	  direct	  (IAPs)	  or	  indirect	  (bcl-­‐2	  family)	  inhibition	  of	  caspase	  activity	  that	  may	  present	  
exploitable	  mechanisms	  for	  sensitization	  of	  cells	  to	  caspase	  activation	  and	  cell	  death	  
(Chen	  et	  al.,	  2000;	  Viatour	  et	  al.,	  2003;	  Rosato	  et	  al.,	  2007;	  Juvekar	  et	  al.,	  2011).	  
Furthermore,	  it	  might	  prove	  interesting	  to	  determine	  if	  chemoresistance	  downstream	  of	  
caspase	  activation	  involves	  resistance	  to	  cleavage	  of	  IκBα	  and	  p65/RelA.	  	  	  
Lastly,	  oncogenes	  arising	  from	  chromosomal	  translocations	  involving	  the	  3’IghRR	  
have	  been	  found	  in	  a	  number	  of	  B	  lymphocyte	  malignancies,	  can	  be	  sufficient	  to	  induce	  
oncogenesis	  and	  promote	  tumor	  progression,	  and	  can	  be	  regulated	  by	  NFκB/Rel	  activity	  
(Kanda,	  2000;	  Wang	  &	  Boxer,	  2005;	  Truffinet	  et	  al.,	  2007;	  Boerma	  et	  al.,	  2008).	  	  
Therefore,	  redox	  mechanisms	  in	  some	  B	  lymphocyte	  malignancies	  may	  not	  be	  only	  
affecting	  pro-­‐survival	  mechanisms	  but	  oncogenic	  mechanisms	  involving	  NFκB/Rel-­‐
dependent	  3’IghRR	  activity.	  
In	  moving	  the	  understanding	  the	  caspase-­‐mediated	  inhibition	  of	  NFκB/Rel	  
activity	  forward,	  it	  will	  be	  important	  to	  identify	  the	  amino	  acid	  sequence	  of	  the	  novel	  
IκBα	  cleavage	  product	  and	  the	  p65	  cleavage	  products.	  	  This	  information	  allow	  for	  the	  
determination	  caspase	  cleavage	  sites	  of	  the	  full-­‐length	  proteins,	  and	  the	  remaining	  
function	  of	  the	  product.	  	  Furthermore,	  the	  DNA	  coding	  sequence	  code	  be	  derived	  from	  
the	  amino	  acid	  sequence	  information	  would	  enable	  the	  construction	  of	  plasmids.	  	  These	  
expression	  plasmids	  could	  be	  conditionally	  expressed	  in	  B	  cell	  lines	  to	  determine	  the	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role	  functional	  effects	  of	  the	  cleavage	  products	  on	  NFκB/Rel-­‐dependent	  gene	  
expression	  and	  B	  lymphocyte	  viability.	  	  	  	  	  	  
Comprehensively,	  this	  study	  demonstrates	  that	  the	  ROI	  exposure	  can	  
significantly	  influence	  critical	  functions	  in	  the	  B	  lymphocyte.	  	  The	  3’IghRR	  is	  essential	  to	  
the	  adaptive	  immune	  response,	  can	  be	  necessary	  for	  the	  initiation	  of	  lymphoma,	  and	  is	  
associated	  with	  autoimmunity.	  The	  impact	  of	  ROI	  exposure	  on	  the	  3’IghRR	  activity	  could	  
therefore	  significantly	  affect	  health	  and	  disease.	  	  Likewise,	  the	  NFκB/Rel	  pathway	  is	  
highly	  integrated	  in	  to	  B	  lymphocyte	  function	  and	  disease.	  	  The	  ROI-­‐dependent	  effects	  
on	  NFκB/Rel-­‐mediated	  transcriptional	  activity	  and	  IκBα	  and	  p65/RelA	  protein	  structure	  
are	  important	  insights	  into	  further	  understanding	  B	  lymphocyte	  function	  and	  viability.	  	  
Chapter	  IV:	  Materials	  and	  Methods	  
Biological	  models	  and	  materials:	  
	   The	  CH12IκBαAA	  mouse	  B	  cell	  lymphoma	  (IgM+)	  cell	  line	  was	  utilized	  in	  specific	  
aim	  1	  and	  3	  as	  an	  in	  vitro	  experimental	  model,	  which	  harbors	  a	  stably	  integrated	  IκBαAA	  
super-­‐repressor	  transgene.	  	  The	  protein	  product	  of	  this	  transgene	  is	  a	  mutant	  form	  of	  
IκBα	  (Serine	  32/36	  to	  Alanine)	  that	  has	  been	  characterized	  to	  be	  resistant	  to	  activation-­‐
induced	  destabilization	  making	  it	  a	  constitutive	  inhibitor	  of	  the	  NFκB/Rel	  pathway	  
(Hsing	  &	  Bishop,	  1999).	  The	  cells	  were	  treated	  with	  100	  µM	  Isopropyl	  β-­‐D-­‐1-­‐
thiogalactopyranoside	  (IPTG)	  for	  2	  hours	  to	  conditional	  induce	  the	  expression	  of	  the	  
transgene	  driven	  by	  a	  lac	  operon-­‐derived	  promoter.	  This	  transgene	  was	  utilized	  as	  a	  tool	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to	  inhibit	  NFκB/Rel	  activity.	  	  	  
	   Another	  variant	  of	  the	  CH12.LX	  line	  was	  utilized	  in	  specific	  aim	  2.	  	  The	  CH12.γ2b-­‐
3’IghRR	  cell	  line	  harbors	  a	  stably	  integrated	  transgene	  reporter	  that	  links	  a	  Vh-­‐	  promoter	  
with	  the	  3’IghRR	  driving	  the	  expression	  of	  an	  γ2b	  coding	  sequence	  of	  the	  Igh	  gene.	  	  This	  
cell	  line	  also	  endogenously	  expresses	  IgA	  isotype	  through	  wild-­‐type	  alleles	  (Henseler	  et	  
al.,	  2009)	  (Henseler	  et	  al.,	  2009).	  
	   A	  diverse	  selection	  of	  mature	  human	  B	  lymphocyte	  cell	  lines	  will	  also	  be	  utilized	  
in	  this	  study	  to	  determine	  if	  the	  appearance	  of	  the	  novel	  IκBα	  product	  occurs	  in	  human	  
B	  lymphocytes.	  	  The	  Ramos	  line	  is	  derived	  from	  a	  Burkitt	  lymphoma	  patient	  and	  harbors	  
a	  t(8;14)	  chromosomal	  translocation	  that	  created	  an	  oncogenic	  mutation	  linking	  the	  c-­‐
myc	  locus	  with	  the	  Igh	  locus	  (Bemark	  &	  Neuberger,	  2000).	  The	  Pfeiffer	  line	  was	  derived	  
from	  diffuse	  large	  B	  cell	  lymphoma	  and	  harbors	  a	  t(14;18)	  chromosomal	  translocation	  
that	  created	  an	  oncogenic	  mutation	  linking	  the	  bcl2	  locus	  with	  the	  Igh	  locus	  (Gabay	  et	  
al.,	  1999).	  The	  IM-­‐9	  line	  is	  a	  lymphoblastic	  Epstein-­‐Barr	  virus	  transformed	  line	  (Fahey	  et	  
al.,	  1971).	  	  HeLa	  cells	  were	  utilized	  as	  a	  non-­‐B	  lymphocyte	  model.	  	  All	  lymphocyte	  cell	  
lines	  were	  cultured	  in	  RMPI-­‐1640	  supplemented	  with	  10%	  Bovine	  Calf	  Serum,	  50	  µM	  β-­‐
mercaptoethanol,	  non-­‐essential	  amino	  acids,	  and	  sodium	  pyruvate	  at	  37°C	  and	  5%	  CO2.	  	  
The	  HeLa	  cell	  line	  was	  cultured	  in	  DMEM	  supplemented	  with	  10%	  Fetal	  Bovine	  Serum	  
and	  incubated	  at	  37°C	  and	  5%	  CO2.	  
	   The	  Vh-­‐Luc,	  Vh-­‐Luc-­‐3’IghRR,	  and	  Vh-­‐Luc-­‐hs4	  reporter	  plasmids	  utilized	  in	  this	  
138	  
study	  were	  constructed	  utilizing	  the	  pGL3	  plasmid	  (Promega)	  and	  were	  provided	  by	  
Robert	  Roeder	  previously	  described	  and	  characterized	  in	  the	  following	  publications	  (Ong	  
et	  al.,	  1998;	  Stevens	  et	  al.,	  2000;	  Sulentic	  et	  al.,	  2004a).	  	  The	  3x-­‐NFκB-­‐Luc	  plasmid	  was	  
derived	  from	  the	  pCLuc	  plasmid	  and	  contains	  3	  consensus	  κB	  sequences	  isolated	  from	  
the	  Ig	  κ	  light	  chain	  placed	  immediately	  5’	  of	  a	  conalbumin	  promoter.	  	  The	  plasmid	  was	  
provided	  by	  R.T.	  Hay	  and	  previously	  described	  and	  characterized	  in	  the	  following	  
publication	  (Arenzana-­‐Seisdedos	  et	  al.,	  1993).	  	  
Methods:	  
Transient	  Transfection:	  	  The	  reporter	  plasmids	  were	  transiently	  transfected	  by	  
electroporation	  at	  a	  ratio	  of	  10	  µg	  plasmid	  DNA/1.0x107	  cells	  utilizing	  BTX	  ECM	  630	  
electroporator.	  	  The	  CH12IκBαAA	  and	  CH12.LX	  cells	  were	  electroporated	  in	  a	  2	  mm	  
cuvette	  at	  250V,	  150	  μF,	  and	  75	  ohms.	  	  The	  Ramos	  cell	  line	  was	  electroporated	  in	  a	  2	  
mm	  cuvette	  at	  150V,	  1500	  μF,	  and	  75	  ohms.	  	  The	  cells	  were	  suspended	  at	  2.0e5	  C/mL	  
and	  treated	  accordingly,	  plated	  in	  triplicate	  and	  incubated	  at	  37°C	  and	  5%	  CO2.	  
Luciferase	  assay:	  Following	  the	  treatment	  and	  incubation,	  the	  cells	  were	  harvested	  for	  
protein	  lysates	  by	  suspension	  in	  50	  µL	  reporter	  lysis	  buffer	  (Promega)	  and	  stored	  at	  -­‐
80°C.	  	  	  The	  lysates	  were	  assayed	  for	  luciferase	  activity	  by	  exposing	  20	  µL	  of	  the	  cleared	  
lysate	  to	  100	  µL	  of	  a	  luciferase	  substrate	  (Promega)	  and	  measured	  over	  a	  15	  second	  
span	  with	  a	  Bertholdt	  detection	  systems	  luminometer.	  
Electrophoretic	  mobility	  shift	  assay:	  	  Nuclear	  proteins	  were	  isolated	  via	  salt	  extraction	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method	  (Sulentic	  et	  al.,	  2000).	  Specifically,	  cell	  were	  incubated	  on	  ice	  in	  10	  mM	  HEPES	  
(pH	  7.5)	  for	  5	  min.	  	  The	  HEPES	  was	  cleared	  by	  microcentrifugation	  and	  the	  pellet	  was	  re-­‐
suspended	  in	  1	  mL	  of	  MDH	  buffer	  (25mM	  HEPES,	  1	  mM	  dithiothreitol	  (DTT),	  3	  mM	  
MgCl2,	  and	  Complete	  protease	  inhibitor	  cocktail	  (Roche))	  and	  dounce	  homogenized	  25	  
times.	  The	  nuclei	  were	  microcentrifuged	  and	  washed	  twice	  with	  MDHK	  (25mM	  HEPES,	  1	  
mM	  dithiothreitol	  (DTT),	  3	  mM	  MgCl2,	  and	  100	  mM	  KCl,	  and	  complete	  protease	  
inhibitor	  cocktail	  (Roche)).	  The	  nuclei	  were	  then	  suspended	  in	  100	  µL	  of	  HEDGK	  (25	  mM	  
HEPES,	  400	  mM	  KCl,	  1	  mM	  DTT,	  1	  mM	  EDTA,	  10%	  glycerol,	  and	  Complete	  protease	  
inhibitor	  cocktail	  (Roche)	  and	  intermittently	  agitated	  over	  a	  45	  minute	  period	  while	  on	  
ice.	  	  The	  nuclei	  were	  then	  microcentrifuged	  at	  14,000	  x	  g	  for	  15	  minutes,	  and	  extracts	  
were	  separated	  from	  the	  pellet	  and	  stored	  at	  -­‐80°C.	  10	  µg	  of	  nuclear	  protein	  was	  
incubated	  with	  a	  hs4	  P32	  labeled	  oligodinucleotide	  probes	  containing	  the	  wild-­‐type	  (wt)	  
CGTGGAAAGCCCCATTCAC.	  Cold	  competitor	  probes	  (probes	  not	  P32	  labeled)	  were	  
utilized	  to	  determine	  non-­‐specific	  banding	  (aforementioned	  hs4	  probe)	  and	  a	  separate	  
probe	  designed	  with	  a	  non-­‐Igh	  consensus	  κB	  sequence	  
GATCTCTCGGGGATTCCCCTCTGA.	  The	  protein/DNA	  complexes	  were	  separated	  on	  a	  6%	  
native	  acrylamide	  gel	  and	  imaged	  by	  radiography.	  
Cell	  Viability	  Assays:	  	  Cells	  (1.0	  mL	  of	  cell	  suspension)	  were	  tested	  for	  viability	  by	  Trypan	  
blue	  exclusion	  assay	  using	  a	  Beckman	  Coulter	  ViCell	  cell	  viability	  analyzer.	  	  Annexin	  V	  
detection	  was	  performed	  by	  incubating	  cells	  at	  room	  temperature	  with	  a	  fluorescien	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isothiocyanate	  labeled	  anti-­‐Annexin	  V	  antibody	  (eBiosciences).	  	  The	  cells	  were	  then	  
detected	  for	  Annexin	  V	  positivity	  via	  flow	  cytometry	  with	  an	  Accuri	  C6	  flow	  cytometer.	  
Enzyme	  linked	  immunosorbent	  assay	  (ELISA):	  	  The	  ELISA	  was	  performed	  using	  equal	  
amounts	  of	  total	  protein	  suspended	  in	  100	  µL	  of	  PBS	  for	  each	  treatment	  group.	  	  	  The	  
samples	  were	  loaded	  on	  to	  a	  plate	  coated	  with	  poly	  Ig	  capture	  antibody	  and	  a	  
monoclonal	  anti-­‐IgA	  HRP-­‐conjugated	  antibody	  (horse	  radish	  peroxidase)	  or	  a	  
monoclonal	  anti-­‐IgG2b	  to	  detect	  Ig.	  	  The	  plate	  will	  be	  exposed	  to	  2,2'-­‐azino-­‐bis(3-­‐
ethylbenzothiazoline-­‐6-­‐sulphonic	  acid	  (ABTS)	  substrate	  and	  kinetically	  measured	  for	  
absorbance	  at	  405	  nm	  for	  1	  hr	  at	  1	  minute	  intervals.	  	  
SDS/PAGE	  and	  Western	  Blotting:	  	  Equal	  µg	  amounts	  of	  total	  protein	  (e.g.	  50	  µg)	  were	  
separated	  by	  SDS-­‐PAGE	  (e.g.	  4%	  stacking	  and	  13%	  separating	  gel),	  and	  transferred	  to	  a	  
polyvinyldifloride	  membrane	  overnight	  at	  18	  volts.	  The	  membrane	  was	  blocked	  with	  5%	  
Non-­‐fat	  dairy	  milk	  and	  probed	  with	  an	  appropriate	  primary	  detection	  antibody	  specific	  
for	  the	  protein	  of	  interest	  (rabbit	  anti-­‐IκBα	  C-­‐21	  (Santa	  Cruz;	  cat#	  sc-­‐371)	  1:1000	  
(detects	  novel	  IκBα	  cleavage	  product),	  mouse	  anti-­‐IκBα	  n-­‐terminus	  epitope	  L35A5	  clone	  
(Cell	  Signaling;	  cat#	  4814)	  1:1000,	  rabbit	  anti-­‐IκBα	  N1C3	  clone	  (Genetex;	  cat#	  
GTX110521)	  1:1000,	  mouse	  anti-­‐Caspase-­‐3	  (Cell	  Signaling;	  Cat#	  9662S),	  rabbit	  anti-­‐Bcl-­‐xL	  
(Cell	  Signaling,	  cat#	  2764P)	  1:1000,	  rabbit	  anti-­‐XIAP	  (Cell	  Signaling;	  cat#	  2045P)	  1:1000,	  	  
anti-­‐p65/RelA	  (Abcam;	  cat#	  Ab7979-­‐1)	  1:1000,	  	  and	  mouse	  anti-­‐β-­‐actin	  (1:10,000)	  
(Sigma;	  cat#	  A2228).	  The	  blots	  were	  washed	  5	  times	  for	  5	  minutes	  in	  TBS	  and	  then	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incubated	  with	  a	  secondary	  antibody	  raised	  against	  the	  appropriate	  host	  Ig	  conjugated	  
to	  horse	  radish	  peroxidase	  (HRP)	  (goat	  anti-­‐rabbit-­‐HRP	  1:2,500	  (Promega)	  or	  goat	  anti-­‐
mouse-­‐HRP	  1:10,000	  (Thermoscientific)).	  The	  probed	  membrane	  was	  exposed	  to	  a	  
Super	  Signal	  West	  Pico	  chemiluminescent	  substrate	  (Thermoscientific)	  and	  imaged	  by	  a	  
Biorad	  ChemidocTM	  MP	  imager.	  
Co-­‐immunoprecipitation:	  	  Cells	  were	  harvested	  using	  centrifugation	  at	  600	  x	  g	  for	  8	  
minutes	  and	  then	  washed	  in	  1x	  TBS.	  	  The	  pellets	  were	  re-­‐suspending	  in	  1.0	  mL	  of	  a	  co-­‐
immunoprecipitation	  buffer	  (150	  mM	  NaCl,	  50	  mM	  Tris-­‐HCl	  (pH=8.0),	  2	  mM	  EDTA,	  1	  
mM	  DTT,	  1%	  NP-­‐40	  and	  Complete	  protease	  inhibitor	  cocktail	  (Roche).	  	  The	  lysates	  were	  
rotated	  at	  4°C	  for	  35	  minutes,	  dounce	  homogenized	  on	  ice,	  and	  microcentrifuged	  at	  
14,000	  x	  g	  for	  10	  minutes.	  	  The	  lysates	  were	  placed	  in	  a	  separate	  tube	  with	  50	  µL	  of	  
unconjugated	  (no	  antibody)	  protein	  G	  magnetic	  beads	  (Thermoscientific)	  and	  rotated	  at	  
4°C	  for	  1	  hr	  to	  reduce	  non-­‐specific	  binding.	  	  The	  beads	  were	  separated	  from	  the	  lysate	  
with	  magnetism	  and	  stored	  on	  ice.	  	  	  	  	  
	  A	  100	  µL	  volume	  of	  the	  protein	  G	  magnetic	  beads	  were	  placed	  in	  1.1	  mL	  of	  NET	  
buffer	  (150	  mM	  NaCl,	  50	  mM	  Tris-­‐HCl,	  0.5	  mM	  EDTA,	  and	  0.5%	  NP-­‐40)	  containing	  4	  µg	  
of	  a	  rabbit	  anti-­‐p65/RelA	  antibody	  (Bethyl	  A301-­‐823A)	  or	  a	  rabbit	  anti-­‐IgG	  control	  
antibody	  (Cell	  Signaling)	  and	  incubated	  at	  4°C	  for	  3	  hr.	  	  Following	  the	  3	  hr	  incubation,	  
the	  anti-­‐p65/RelA	  (and	  anti-­‐IgG	  control)	  labeled	  beads	  were	  washed	  3x	  with	  ice	  cold	  TBS	  
and	  then	  blocked	  for	  1	  hr	  with	  5%	  Bovine	  Serum	  Albumin	  in	  TBS.	  	  Following	  the	  block,	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the	  beads	  were	  washed	  once	  with	  TBS	  and	  then	  incubated	  with	  equal	  amounts	  of	  total	  
protein	  lysate	  (e.g.	  1.5	  mg	  per	  condition),	  which	  were	  rotated	  overnight	  at	  4°C.	  	  
Following	  the	  incubation,	  the	  beads	  were	  washed	  once	  in	  cold	  co-­‐immunoprecipitation	  
lysis	  buffer	  and	  2x	  in	  cold	  TBS,	  then	  placed	  in	  35	  µL	  of	  2x	  laemmli	  loading	  buffer	  (with	  2-­‐
ME)	  and	  boiled	  at	  95°C	  for	  8	  minutes	  for	  elution.	  	  The	  eluted	  proteins	  were	  magnetically	  
separated	  from	  the	  beads	  and	  subjected	  to	  SDS-­‐PAGE	  electrophoresis	  and	  western	  
blotting.	  	  The	  blots	  were	  probed	  with	  anti-­‐IκBα	  antibody	  (C-­‐21	  clone)	  or	  p65/RelA	  
(Abcam)	  primary	  antibodies	  described	  in	  SDS/PAGE	  and	  western	  blotting	  methods.	  The	  
full-­‐length	  products	  were	  immuno-­‐blotted	  with	  a	  CleanblotTM	  (Thermoscientific)	  goat	  
anti-­‐rabbit-­‐HRP	  secondary	  antibody	  that	  is	  less	  sensitive	  but	  does	  not	  detect	  the	  Ig	  
chains,	  which	  can	  obfuscate	  the	  detection	  of	  the	  full-­‐length	  IκBα	  band.	  	  The	  cleavage	  
product	  was	  immuno-­‐blotted	  with	  a	  more	  sensitive	  goat	  anti-­‐rabbit-­‐HRP	  secondary	  
antibody	  (Promega)	  that	  does	  detect	  the	  Ig	  chains	  but	  the	  blot	  was	  also	  cut	  to	  eliminate	  
the	  detection	  of	  those	  bands.	  
Nuclear	  and	  Cytosolic	  Extraction:	  This	  procedure	  was	  derived	  from	  a	  previously	  
published	  protocol	  by	  Merluzzi	  et	  al	  (Merluzzi	  et	  al.,	  2004).	  	  Briefly,	  the	  cells	  were	  
washed	  3x	  in	  1	  mL	  ice	  cold	  PBS,	  and	  re-­‐suspended	  in	  50	  µL	  of	  the	  cytosolic	  lysis	  buffer	  
(10	  mM	  Hepes,	  pH	  7.9,10	  mM	  KCl,	  1.5	  mM	  MgCl2,	  0.1	  mM	  EDTA,	  0.5	  mM	  DTT	  and	  0.5%	  
NP-­‐40),	  and	  then	  micro-­‐centrifuged	  at	  800	  x	  g	  for	  10	  minutes.	  	  The	  supernatant	  
(cytosolic	  protein	  fraction)	  was	  removed	  and	  placed	  in	  a	  separate	  tube.	  	  The	  remaining	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pellet	  was	  placed	  in	  a	  nuclear	  extraction	  buffer	  (20	  mM	  Hepes,	  pH	  7.9,	  400	  mM	  NaCl,	  
1.5	  mM	  MgCl2,	  0.1	  mM	  EDTA,	  5%	  glycerol,	  0.5	  mM	  DTT),	  incubated	  on	  ice	  for	  30	  
minutes,	  and	  microcentrifuged	  at	  10,000	  x	  g	  for	  30	  minutes.	  The	  nuclear	  extracts	  were	  
stored	  at	  -­‐80°C.	  	  
Real-­‐time	  PCR:	  	  RNA	  from	  purified	  B	  lymphocytes	  was	  isolated	  utilizing	  Trizol™	  reagent.	  	  
0.5-­‐1	  µg	  of	  total	  RNA	  was	  reverse	  transcribed	  into	  a	  cDNA	  library	  utilizing	  Taqman	  
Reverse	  Transcription	  reagent	  kit	  (Life	  Technologies)	  (µIgh)	  or	  iScript	  cDNA	  synthesis	  kit	  
(Biorad)	  (bcl-­‐xl	  and	  XIAP).	  5	  ng	  of	  cDNA	  was	  analyzed	  by	  quantitative	  real-­‐time	  PCR.	  The	  
µ	  Igh	  reactions	  were	  performed	  utilizing	  a	  2x	  sybr	  green	  reagent	  mix	  (Life	  Technologies)	  
with	  a	  ABI	  7500	  Real-­‐Time	  PCR	  system	  and	  primers	  designed	  to	  amplify	  µ	  Igh:	  	  forward	  
primer	  5’	  TCTGCCTTCACCACAGAAGA	  3’;	  μ	  Igh	  reverse	  primer,	  5’	  
GCTGACTCCCTCAGGTTCAG3’.	  	  The	  µ	  Igh	  PCR	  results	  were	  normalized	  to	  β-­‐actin	  as	  a	  
house	  keeping	  control:	  mouse	  β	  -­‐actin	  forward	  primer,	  5’	  GCTACAGCTTCACCACCACA	  3’;	  
mouse	  β	  -­‐actin	  reverse	  primer,	  5’	  TCTCCAGGGAG	  GAAGAGGAT	  3’.	  	  	  
The	  human	  bcl-­‐xl	  and	  xiap	  reactions	  were	  performed	  utilizing	  a	  2x	  SSoAdvanced	  
Sybr	  green	  supermix	  (Biorad)	  with	  a	  Biorad	  CFX	  96	  real-­‐time	  PCR	  detection	  system	  and	  
primers	  designed	  to	  amplify	  human	  bcl-­‐xl:	  forward	  primer	  5’	  
GAATGACCACCTAGAGCCTTGG	  3’;	  reverse	  primer	  5’	  TGTTCCCATAGAGTTCCACAAAAG	  3’	  
or	  human	  xiap:	  forward	  primer	  5’	  TGGGACATGGATATACTCAGTTAACAA	  3’	  and	  reverse	  
primer	  5’	  GTTAGCCCTCCTCCACAGTGAA	  3’.	  	  The	  bcl-­‐xl	  and	  xiap	  PCR	  results	  were	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normalized	  to	  β-­‐actin	  as	  a	  house	  keeping	  control:	  human	  β	  -­‐actin	  forward	  primer	  5’	  
TCACCCACACTGTGCCCATCTACGA	  3’	  and	  reverse	  primer	  5’	  
CAGCGGAACCGCTCATTGCCAATGG	  3’.	  The	  results	  were	  analyzed	  by	  the	  relative	  
quantification	  method	  of	  analysis	  (2^-­‐ΔΔCt	  method)	  (Pfaffl,	  2001).	  
Statistical	  analysis:	  	  The	  statistical	  analyses	  utilized	  the1-­‐way	  ANOVA	  test	  with	  
Dunnett’s	  post	  test	  or	  the	  2-­‐way	  ANOVA	  with	  Bonferonni	  post	  test.	  	  All	  statistical	  
analyses	  were	  performed	  utilizing	  Graphpad	  Prism	  version	  5.0a.	  
Key	  Reagents:	  DEVD-­‐OPh	  (Biovision),	  diphenyliodonium	  choloride	  (Acros),	  H2O2	  (Sigma),	  
E.	  coli	  LPS	  (Sigma),	  Cyclohexamide	  (Sigma),	  QVD-­‐OPh	  (Apoptrol).	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